Tun yaushe waɗannan alamun suka kasance?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman a shekarunka
kuma tare da zazzabi
kuma za a iya gwada hawan jini da kuma yawan cholesterol.
kuma kana da zazzabi a yanzu?
kuma kuna jin wannan ciwon kirji a yanzu?
kuma kuna da wahalar numfashi?
kuma za ku iya gaya mana wasu cututtukan da kuke fuskanta tare da waɗannan cututtukan?
kuma ka taba kaiwa ga yawan zazzabinka?
kuma ina da tari
kuma ina da zazzabi da kuma tari
kuma ina jin zafi sosai a kirjina a yau
kuma wannan shine lokacin allergy na rhinitis
kuma na ji ciwon kirji
kuma ina ganin ina da zazzabi kuma
kuma ina so ka bayyana inda ciwon kirjinka yake
kuma suna da zazzabi
da kuma tarihin ciwon sukari
Kuma ka san, ƙirjina suna jin kamar za su karye
Kuma ka san, mutane suna yawan tari a kaina
kuma kuna jin ciwon kirji
kuma ka ce akwai matsin lamba a kirjinka
kowa a cikin iyali da ke da matsalar zuciya, cututtukan zuciya, bugun zuciya, yawan cholesterol, hauhawar jini
Shin akwai wasu alamun cututtuka ko kuma wasu matsalolin da kuke lura da su tare da ciwon tsoka?
Shin akwai wani mutum a cikin gidan da yake da irin wannan rashin lafiya?
Shin kana jin wasu alamun cututtuka?
Shin, ka taɓa samun numfashi mai wuya?
Shin har yanzu kana jin ciwon kirji?
Domin wannan lokacin na mura ne.
Amma kuma ba za mu iya ware ciwon kirji da ke fitowa daga zuciya ba.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
kuma ina jin wahalar numfashi
amma na san mutane da yawa suna tari a wurina
Amma muna bukatar mu dauki kowane ciwon kirji da muhimmanci sosai.
amma yanzu za ka iya numfashi sosai?
Na manta da dalilin wannan ciwon kirji.
Kana jin kamar wani yana matsa maka ƙirjin?
Har yanzu ina jin kamar ina numfashi.
Shin suna da irin wannan rashin lafiya?
Shin kana da wata matsala ta kullum kamar hauhawar jini ko wani abu?
kuna da wata cuta ko wata cuta mai tsanani kamar ciwon sukari?
Shin kana jin numfashi mai wuya tare da ciwon kirji?
Shin kana fama da hauhawar jini?
Shin kana jin numfashi tare da bayyanar cututtuka?
Shin kun san alamun da ke damun ta?
Ka ga hoton?
sha ruwa mai yawa a yau
amma na yi gwajin ciwon sukari
amma yana da alamun da suka yi kama da na.
Yaya zafin jikinka yake?
Yaya karfin jini kake?
idan zazzabinka ya ci gaba
idan zazzabinka ya kai ɗari biyu ko fiye
Idan kana ganin akwai wata cuta ko wata matsala kana bukatar ka yi bincike sosai
Na yi zazzabi a jiya.
Ina da zazzabi kuma.
Na yi zazzabi a jiya.
Ina jin zafi a cikin kirji a nan.
Ina kuma samun wahalar numfashi.
Zan aika muku da hotuna
Ina jin zafi a kirji a yau
Na ji kawai wani ɗan ciwon kai da zazzabi a yau
A ganina, wannan shi ne mura.
A ganina, wannan ɗan ɗan mura ne.
Kana jin kamar wani mutum mai nauyi ne yake zaune a kirjinka?
duk sun fara ne daga ciwon kai tare da zazzabi a lokaci guda
Na ji zafi a tsakiyar ƙirjina
matsa lamba kamar ciwon kirji
a cikin ƙirjina
a tsakiyar ƙirjina
a tsakiyar ƙirjin
Ina jin zafi a kirji
Ina matukar damuwa game da wannan ciwon kirji
Ina so ka bayyana wannan ciwon kirji
irin su hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Don zazzabinsa, za ka iya sha da tachipirina mai daɗi
Mary, kwana nawa ka sha fama da wannan alamun?
Ka ce kana jin ciwon kirji
Wani lokaci ina jin zafi a ƙirjina
To, shin akwai wasu alamun da ke tattare da wannan alamun banda ciwon?
ko kuma wani yana zaune a kirjinka?
kusan daidai yake da zazzabi, tari, ciwon kai, da kuma ciwon tsoka
a tsakiyar ƙirjina
nuna a wannan hoton inda kake jin zafi
saboda kuna da zazzabi
Shin, kuna ganin wasu daga cikin wadannan cututtukan suna da alaƙa da ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mini game da ciwon kirjinka
zazzabi ya ƙaru da dare
Na yi kwanaki biyu ina da zazzabi.
Jii ya fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter a cibiyar Triase na asibiti.
Za ka iya gaya mana game da ciwon kirjinka?
Na ji zafi a gaba na jiki, a nan, a kirji.
Na ji zafi sosai a kirji.
Lokacin da na ji wannan ciwon a kirjina
Yaya za ka ji a kirji?
Yaushe ne wannan ciwon ya fara?
a wane ɓangare kake jin zafi a kirji?
a wane ɓangare kake jin ciwon kirji?
Kana jin kamar ka yi ta matsawa a kirjinka
Ka san cewa ina da ciwon sukari da sauran cututtuka?
Ka ce kana jin wannan ciwon kirji
Kasancewar kamuwa da cutar coronavirus (COVID-19) da ke ƙaruwa cikin sauri a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya, Janairu 1 zuwa 15 ga Maris, 2020
Kasuwancin kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya wanda ya tabbatar da cewa, duk da cewa matakan sun bambanta dangane da ƙasa, cutar COVID-19 tana haɓaka cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, jihohi, asibitoci, da kuma cibiyoyin gaggawa suna bukatar su kara shirye-shiryen su don karuwar marasa lafiya na COVID-19 da za su bukaci kulawar lafiya, musamman ma na gaggawa.
A ranar 31 ga Disamba, 2019, an samu rahoton wani tarin cututtukan cutar huhu da ba a san asalinsa ba a Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar kasar Sin ta ruwaito cewa sabon coronavirus ne wanda yanzu ake kira coronavirus cuta mai tsanani ta numfashi 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
Shaidar da aka samu har zuwa yanzu ta nuna cewa kusan kashi 80 cikin dari na mutanen da ke fama da cutar COVID-19 suna da wata cuta mai sauƙi, wato kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin mutanen da ke fama da cutar sun warke.
A cikin kusan kashi 14 cikin dari na shari'o'in, COVID-19 ya zama mummunan cuta kuma yana buƙatar asibiti, yayin da sauran kashi 6 cikin dari na shari'o'in ke fama da mummunan cuta wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti sakamakon COVID-19 ya kai kusan kashi 4%.
A cikin wannan binciken, mun bincika yanayin abubuwan da suka faru na COVID-19 a cikin ƙasashen EU/EEA da Burtaniya sannan muka kwatanta su da abubuwan da suka faru a lardin Hubei, China.
Mun kuma kwatanta adadin masu dauke da cutar COVID-19 a kasashen EU/EEA da Birtaniya da adadin wadanda suka kamu da ita a Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Kasuwancin COVID-19 a cikin EU/EEA da Burtaniya
Bayan China, COVID-19 ya sami ƙarin yaduwar ƙasa kuma tasirin cutar COVID-19 a sauran sassan duniya yana bin tasirin cutar a China.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin Eurosurveillance 2020 na 5 ga Maris, Spiteri et al. sun ba da rahoton farkon Turawa da suka tabbatar da COVID-19 dangane da ma'anar WHO.
A cikin EU/EEA, Faransa ta fara bayar da rahoton mutum uku da aka tabbatar da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da Burtaniya (UK), tsakanin 31 ga Disamba, 2019 da 15 ga Maris, 2020 tare da waɗannan kwanakin, akwai shari'o'i 39,768 da mutuwar 1,727 da aka ruwaito, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun adadi na COVID-19 da kuma adadi na al'amura
A Cibiyar Tsare Kariya da Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin shari'o'in COVID-19 da kowace ƙasa a duniya ta ruwaito kowace rana da karfe 8.00.
Ana amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya, da kuma kwatanta shi da yanayin Italiya.
A matsayin wakili na yaduwar cutar COVID-19 mai aiki, mun lissafa lokutan da aka rage na kwanaki 14, don haka muna la'akari da tafiya ta al'ada ta COVID-19, a kowace ƙasa ta EU/EEA da Burtaniya, a cikin lokacin Janairu 1 zuwa 15 ga Maris 2020.
Mun kuma gabatar da jimlar adadin shari'o'in da aka ruwaito a kowace ƙasa zuwa 15 ga Maris, 2020 da karfe 8.00 na dare idan aka kwatanta da na Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da Burtaniya
Kasashen EU/EEA da Birtaniya sun bi halin da ake ciki a lardin Hubei (Tiongkok) (Hotuna na 1).
Ga EU/EEA da kuma Birtaniya gaba ɗaya, adadin abubuwan da suka faru na COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, sannan ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (Ƙarin Bayani).
Wannan yanayin yafi karuwa da sauri a cikin adadin shari'o'in da aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan yanayin karuwar abubuwan da suka faru na COVID-19 (Karin Bayani).
Hoton 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya idan aka kwatanta da adadin da aka samu a Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Bayanai sun nuna cewa, a ranar 15 ga Maris da karfe 8:00, sauran ƙasashen EU/EEA 15 da Burtaniya sun ba da rahoton adadin adadin shari'o'in da suka yi daidai da adadin Italiya na makonni uku da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka ruwaito suna ƙaruwa cikin sauri a cikin EU/EEA da Burtaniya.
Hanyoyin da aka lura da abubuwan da suka faru na COVID-19 sun nuna cewa annobar tana ƙaruwa a daidai wannan saurin a duk ƙasashe.
Wannan ya faru ne duk da bambancin matakan da ƙasashe ke fuskanta, bambancin amsawar lafiyar jama'a, da kuma yiwuwar bambancin ma'anar shari'a tsakanin ƙasashe da bambancin yarjejeniya don zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, wanda ya haɗa da gwaji na gaba.
A farkon watan Maris na shekarar 2020, likitoci a yankin Italiya da ke fama da cutar sun bayyana halin da ake ciki na kimanin kashi 10 cikin dari na marasa lafiya da ke fama da cutar COVID-19 da ke bukatar kulawa mai tsanani kuma kafofin watsa labarai sun ruwaito cewa asibitoci da wuraren kula da gaggawa a yankin sun kai ga iyakar ƙarfin su.
A halin yanzu, bayanan karɓar shari'ar COVID-19 a asibitoci da/ko cibiyoyin kulawa mai tsanani a matakin EU/EAA kawai suna samuwa ga kashi 6% da 1% na shari'ar (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara bayanai a cikin tsari don a kammala bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
Binciken da aka yi a shekara ta 2010 zuwa 2011 ya nuna bambancin da ke tsakanin samun gado mai tsanani da kuma kula da lafiya a Turai, yana daga 29.2 a Jamus zuwa 4.2 a kowace 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe za su iya samun albarkatu da yawa ko kaɗan fiye da Italiya (12.5 wuraren kwana na kulawa mai tsanani da kulawa ta jiki a kowace 100,000 na yawan jama'a a cikin 2010-2011).
An ba da labarin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin COVID-19 na kowace ƙasa ta EU / EEA da UK wanda ke da haɗarin > 90% fiye da ƙarfin kwanciyar hankali, a cikin sabuntawar ECDC ta shida game da COVID-19.
Tun da yake har yanzu ana tattara shari'o'i a wasu yankuna a cikin EU/EEA da UK, kuma asibitoci da wuraren kulawa da gaggawa suna yawanci bauta wa yawan jama'a a cikin wani yanki na sabis, ya kamata a samar da bayani game da shari'o'i da wuraren kula da gaggawa a matakin Sunan Sashin Yankin don Statistics 2 (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana tasowa cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, jihohi, asibitoci, da kuma cibiyoyin gaggawa ya kamata su shirya kansu don yanayin watsawar al'umma na SARS-CoV-2 da kuma karuwar yawan marasa lafiya na COVID-19 da ke buƙatar kula da lafiya, musamman ma kula da gaggawa, kamar yadda yake faruwa a yankunan da aka shafa a Italiya.
Kamar yadda aka nuna a cikin binciken ECDC na kwanan nan, hanzari, mai aiki, da kuma cikakkiyar hanyar da za a yi amfani da ita don rage yaduwar SARS-CoV-2, tare da sauyawa daga hanyar dakatarwa zuwa hanyar ragewa, saboda ƙaruwa cikin sauri a cikin adadin shari'o'in, kamar yadda aka yi tsammani, bazai ba da isasshen lokaci ga masu yanke shawara da asibitoci don fahimta, karɓa, da daidaitawa da amsa mai dacewa ba idan ba a yi amfani da shi ba a baya.
Wannan saurin kimantawa na haɗari ya kuma haɗa da matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai gajeren damar da za a samu a lokacin da kasar ta samu damar kara inganta kokarin da take yi wajen rage yaduwar SARS-CoV-2 da kuma rage matsin lamba a kan kiwon lafiya.
Idan hakan bai yi nasara ba, sauran tsarin kula da lafiyar EU/EEA na iya fuskantar karuwar marasa lafiya da ke bukatar kulawa mai tsanani a cikin 'yan kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus ta haifar da cutar ta 2 ta cutar ta jiki mai tsanani (SARS-CoV-2), ya zuwa yanzu ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Kamar yadda yake da cutar SARS-CoV, wadda ta haifar da SARS a dubban mutane a shekara ta 2003, SARS-CoV-2 na iya kuma kamuwa da cutar daga bats kuma ta haifar da irin wannan bayyanar ta hanyar irin wannan tsari.
Duk da haka, COVID-19 yana da ƙananan haɗari da mutuwa fiye da SARS, amma yana da yawa kuma yana shafar tsofaffi fiye da matasa, kuma yana da yawa a cikin maza fiye da mata.
A sakamakon yawan littattafai da ake wallafawa game da wannan sabon cuta, wannan talifin ya yi ƙoƙari ya ba da cikakken bayani game da yanayin bincike da ke ci gaba da sauri.
Za mu tattauna fannonin cututtuka, ilimin halayyar mutum, ilimin cututtuka, ganewar asali, magani, ganewar asali, da kuma rigakafin cututtuka.
Ko da yake har yanzu akwai tambayoyi da yawa da ba a amsa ba, muna fata wannan binciken zai taimaka mana mu fahimci wannan cuta mai tsanani da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu 2020 ya zama abin tunawa da ba za a iya mantawa da shi ba ga duk Sinawa da aka umarce su su zauna a gida a lokacin hutu da kuma makonni da suka biyo baya saboda barkewar cutar.
Wannan kwayar cutar tana kama da coronavirus (CoV) wanda ya haifar da barkewar cutar cutar ta cutar huhu mai tsanani (SARS) a shekara ta 2003; saboda haka, an sake sanya sunan SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma cutar da ta haifar an kira ta CoV Disease-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a fadin kasar da kuma kusan kasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, cutar ta haifar da tabbatar da shari'o'in COVID-19 80,000, tare da dawo da marasa lafiya sama da 40,000 da mutuwar marasa lafiya 3,000.
WHO ta yi gargadin cewa COVID-19 ita ce magabcin jama'a na 1 kuma tana da ikon yin barna fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu tun daga rahoton farko a ranar 7 ga Janairu 2020 wanda ya kafa jerin cututtukan da aka keɓe daga wasu marasa lafiya, an buga takardu sama da 200 game da COVID-19, wanda ya shafi ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Wannan bita yana nufin taƙaita ci gaban bincike a wannan sabon fannin da ke ci gaba da sauri.
Idan za mu iya, za mu gwada COVID-19 da SARS da kuma wasu cututtukan da CoV ke haifarwa, wato cututtukan numfashi na Gabas ta Tsakiya (MERS, annoba a shekara ta 2012).
Za mu kuma tattauna abin da muka koya game da rigakafi da kuma sanin za mu iya kamuwa da cutar da kuma wasu tambayoyi da ba a amsa su ba, amma suna da muhimmanci.
A al'adar, ana ganin CoV ba mai cutar ba ne ga mutane, musamman ma yana haifar da kusan 15% na mura 4.
Duk da haka, a cikin wannan karni, mun sami CoVs biyu masu cutarwa ga mutane, SARS-CoV da MERS-CoV, kowannensu ya haifar da annoba wanda ya fara a China a 2003 da Saudi Arabia a 2012, kuma nan da nan ya bazu zuwa wasu ƙasashe da yawa tare da mummunan kamuwa da cutar da mutuwa.
Saboda haka, COVID-19 a halin yanzu shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a Feb. 1.1, an fara bayar da rahoton cluster na cutar huhu da asalin da ba a san shi ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin.
Bayan kwana bakwai, an ƙaddamar da jerin abubuwan CoV.
A ranar 15 ga Janairu, 2020, an samu rahoton mutuwar farko daga Wuhan.
A lokacin, annobar ta yi saurin yaduwa zuwa birane da larduna da kuma ƙasashen da ke kusa da birnin.
A ranar 20 ga Janairu, an samu rahoton kamuwa da cuta daga masu kula da lafiya, wanda ya nuna cewa ana iya kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an sanya dokar hana fita a birnin Wuhan kuma an dakatar da duk jigilar kayayyakin jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, marasa lafiya 21 ne kawai suka tuntubi kasuwar abincin teku ta Wuhan wanda aka ɗauka a matsayin wurin da aka fara kamuwa da cutar daga asalin dabbobi da ba a san su ba.
A ranar 30 ga watan Janairu, WHO ta ayyana cutar a matsayin gaggawa ta kiwon lafiya ta duniya.
A lokacin da aka rubuta wannan rahoton, cutar ta riga ta faɗaɗa dukan ƙasar Sin da kuma kusan ƙasashe 50 a faɗin duniya.
Yayin da yanayin yake ci gaba da sauri, an riga an kafa ƙarshen annobar da kuma yadda za ta yi muni.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyin da ke tattare da marasa lafiya 8,866, wanda ya shafi marasa lafiya 4,021 da suka kamu da cutar COVID-19, ya gabatar da bayanan da suka dace game da annobar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana kamuwa da mutane a kowane zamani, amma musamman a cikin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun fi shekaru 50 da haihuwa, kaɗan ne kawai suka kai shekara 20, kuma mutane 14 ne kawai suka kamu da cutar suka kai shekara 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 yana yaduwa cikin rukuni, musamman a cikin da kuma kusa da Hubei.
COVID-19 yana ɗaukar kimanin kwanaki 5 (2-9) daga ganowa zuwa ganewar asali.
Matsakaicin lokacin yin incuba shi ne kwana 4.8 (3.0-7.2).
Matsakaicin lokaci daga haihuwa zuwa mutuwa ya kai kwanaki 9.5 (4,8-13).
Ƙididdigar haihuwa (R0) ita ce 3.77 (95% CI: 3.51-4.05) da kuma R0 daidai da 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin jigilar kaya kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1.44% (95% CI: 1.10-1.86%) da kuma mutuwar da aka yi wa dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Babban abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60), da kuma mummunan cutar huhu.
CoV babban nau'in kwayar cuta ne wanda ke dauke da guda ɗaya na RNA.
Ana iya rarraba CoV zuwa jinsuna hudu, alpha, beta, gamma, da delta, tare da alpha- da beta-CoVs da aka sani suna kamuwa da mutane.
Glycoprotein na spike (S) yana ɗaure da mai karɓar kwayoyinsa, angiotensin 2 (ACE 2) mai canzawa da kuma peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, sannan kuma membrane fusion ya faru.
An saki kwayoyin RNA na kwayar cutar zuwa cikin cytoplasm; bayan kwayar kwayoyin cutar, RNA na kwayoyin halitta tare da glycoproteins da furotin nucleocapsids suna samar da vesicles dauke da virions, wanda daga baya ya haɗu da membrane plasma don sakin kwayar cutar.
An fara samun jerin kwayoyin halitta na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 sabon nau'in beta-CoV ne wanda ya fi dacewa da kwayoyin halitta sama da kashi 99.98% a cikin samfuran 10 da aka samu; an samo samfurin daga wurin da cutar ta fito, wato Kasuwar Abincin Ruwa ta Huanan a Wuhan.
A cikin kwayoyin halitta, SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscopy na lantarki, an gano SARS-CoV-2 a cikin wani ɓangare na epithelium na hanyar numfashi mai matukar bakin ciki.
An gano cewa ACE2 na mutum yana karɓar SARS-CoV-2 kamar SARS-CoV.
Duk da haka, SARS-CoV-2 S protein yana da rauni a cikin mutum ACE2 fiye da S SARS-CoV protein, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya mai tsanani na SARS-CoV a cikin marasa lafiya.
SARS-CoV-2 na iya samar da sabon gajeren furotin wanda aka ɓoye shi da kalmar sirri orf3b da kuma furotin da aka ɓoye shi da kalmar sirri orf8.
SARS-CoV-2 orf3b protein na iya taka rawa wajen cutar cutarwa da hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani sanannen aiki ko motsi.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton cikakken tsarin mutum na cryo-EM ACE2 a ƙuduri 2.9 Å a cikin tsari tare da mai jigilar amino acid B0AT1.
Sun gano cewa, wannan fili, wanda yake da tsari na bude da rufewa, yana da dimer da kuma ACE2-B0AT1 zai iya ɗaure sunadarai biyu na S, wanda ya zama shaida ga ganowa da kamuwa da cutar CoV.
Ana iya amfani da B0AT1 a matsayin maganin maganin maganin maganin cutar SARS-CoV-2.
Uwar gida da kuma matsakaici
SARS-CoV da MERS-CoV an san su ne daga bats kuma an watsa su ga mutane ta hanyar foxes da raƙuma.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, ana ɗaukar bats a matsayin ainihin mai karɓar SARS-CoV-2 saboda sabon cutar ta kasance 96% daidai da CoVs biyu masu kama da SARS daga bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san ko wane ne yake taimaka wa ƙwayoyin cuta su ƙetare ƙwayoyin cuta ba, kuma ba a bayyana hanyar da za a iya kai su ga mutane ba.
Ji, et al. sun ba da shawarar macizai su zama masu ɗaukar kwayar cutar daga bats zuwa mutane wanda ya shafi sake haɗuwa da homologs a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun ba da shawarar cewa furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen furen.
Duk da haka, bambancin kashi 1 cikin 100 da ke cikin dukan jinsunan mutane yana da girma; saboda haka, ba a samu sakamako mai kyau ba a matsayin hujja mai kyau.
Yawancin halittu na SARS-CoV-2 ba a san su ba.
A cikin in vitro, SARS-CoV da MERS-CoV na iya rayuwa har tsawon awanni 48 a cikin yanayin bushe kuma har zuwa kwanaki 5 a 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan hali.
An ruwaito cewa SARS-CoV-2 yana da ƙarancin haske da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, disinfectants wanda ya ƙunshi chlorine, acetate acid, chloroform, da sauran fatty solvents, amma ba chlorhexidin ba, yana da tasiri wajen kashe cutar.
Gabaɗaya, dukkanin mutanen duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da wannan sabon kwayar cutar.
A halin yanzu, babu wani cikakken bincike da ya ba da rahoton amsawar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya komawa ga wasu binciken da aka yi game da cutar ta CoV a baya, musamman SARS-CoV da MERS-CoV (Fabrairu 4).
A gaba ɗaya, bayan sun mamaye mai masauki, ƙwayar cuta ta gane ta hanyar tsarin rigakafi ta hanyar tsarin ganewa (PRR), wanda ya haɗa da C-type lectin-like receptor, Toll-like receptor (TLR), NOD-like receptor (NLR), da RIG-I-like receptor (RLR).
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtuka, ƙwayoyin dendritic cell maturation, da kuma haɗuwa da interferon type I (IFN) wanda ke iyakance yaduwar kwayar cutar da hanzarta fagositosis na maganin cutar ta hanyar macrophage.
Duk da haka, furotin N a SARS-CoV na iya taimakawa ƙwayoyin cuta su kauce wa amsawar rigakafi.
Ba da daɗewa ba, tsarin rigakafi na daidaitawa ya shiga cikin yaƙi da wannan kwayar.
T lymphocytes, wanda ya ƙunshi CD4+ da CD8+ ƙwayoyin halitta, suna taka muhimmiyar rawa a wannan tsaron.
CD4+ T-cell yana motsa B-cell don samar da ƙwayoyin antibodies na musamman ga ƙwayoyin cuta, kuma CD8+ T-cell yana kashe ƙwayoyin da suka kamu da cutar kai tsaye.
Kwayoyin T masu taimako suna samar da cytokines masu kare cututtukan don taimakawa wajen kare sel.
Duk da haka, CoV zai iya hana T cell aiki ta hanyar haifar da apoptosis na T cell.
Humilar rigakafi, wanda ya ƙunshi ƙarin, kamar C3a da C5a, da kuma rigakafi suna da mahimmanci wajen yaki da kamuwa da cutar.
Alal misali, rigakafin da aka yi wa marasa lafiya da suka warke ya hana rigakafin MERS-CoV.
A wani ɓangare kuma, yawan ayyukan da tsarin garkuwar mutum yake yi yana haifar da yawan radicals a cikin gida, wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma, a mafi munin yanayin, rashin lafiyar gabobin jiki har ma da mutuwa.
Cutar SARS-CoV-2, wadda ta ƙunshi ƙwayoyin cuta, ta fi rinjaye ga tsofaffi da ke fama da cutar da ke tattare da cutar da kuma mata masu juna biyu.
A yawancin lokaci, mutanen da suka kamu da cutar ko kuma waɗanda ke fama da matsalar rigakafi suna da mafi yawan haɗarin kamuwa da ita fiye da sauran mutane.
Matsakaicin lokacin incuba na SARS-CoV-2 ya kasance kwanaki 1-14, mafi yawa kwanaki 3-7 bisa ga nazarin da aka yi akan 425 na farko a Wuhan.
Duk da haka, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa matsakaicin lokacin yin ciki kwana uku ne kuma yana daga kwana 0 zuwa 24.
Wani sabon bincike, kamar yadda aka bayyana a sama, ya nuna cewa lokacin yin incuba ya kai kwanaki 4.8 (3.0-7.2) bisa ga alƙaluma 8,866 na shari'o'i.
Yana da muhimmanci hukumomin kiwon lafiya su daidaita lokacin killacewa da kyau bisa ga lokacin da aka fi dacewa don hana mutane da suka kamu da cutar, amma ba su da wata alama, watsa cutar ga wasu.
A cikin al'ada, ana bukatar a yi wa mutanen da suka kamu da cutar ko kuma suka kamu da cutar killace su na kwanaki 14.
Shin, za a kara tsawon lokacin killacewa zuwa kwanaki 24?
Sau da yawa zazzabi shine babban bayyanar COVID-19 da farkon bayyanar, tare da ko ba tare da wasu alamun ba kamar tari, numfashi mai ƙyama, ciwon tsoka, ciwon hanci, ciwon wuya, rhinorrhea, ciwon kirji, diarrhea, nausea, da kuma zubar da jini.
Wasu marasa lafiya suna fama da rashin numfashi da kuma/ ko hypoxia mako guda bayan sun kamu da cutar.
A cikin matsanancin yanayi, ciwon yana ci gaba da sauri zuwa cututtukan numfashi na gaggawa, ƙwayar ƙwayar cuta, ƙwayar cuta, da kuma coagulopathy.
Marasa lafiya da ke fama da zazzabi da kuma/ ko alamun numfashi da kuma zazzabi mai tsanani, ko da ba su da wata cuta ta daukar hoto, ya kamata a yi musu maganin cutar don ganewar asali.
Nazarin demographic a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cututtuka ya kai kashi 98% don zazzabi, 76% don tari, 55% don dyspnea, da 3% don diarrhea; 8% na marasa lafiya suna buƙatar goyon bayan iska.
An samu irin wannan binciken a cikin bincike guda biyu da suka yi kwanan nan, wato, a cikin wani bincike da aka yi a kan iyali da kuma a kan wani rukuni da aka yi amfani da shi wajen canja wurin mutane daga mutum zuwa mutum.
A kwatanci, binciken binciken mutane a shekarar 2012 ya nuna cewa marasa lafiya da ke fama da cutar MERS-CoV sun kamu da zazzabi (98%), tari mai bushe (47%), da kuma dysphnea (55%) a matsayin manyan alamun cututtukan.
Koyaya, kashi 80% na marasa lafiya suna buƙatar taimakon iska, fiye da marasa lafiya na COVID-19 kuma suna da daidaituwa tare da mafi girman mutuwar MERS fiye da COVID-19.
Ana kuma lura da ciwon ciki (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), da ciwon wuya (13-25%) an nuna su a matsayin manyan alamomi kuma ana buƙatar goyon bayan iska don kimanin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kasance kashi 2 cikin dari tare da tabbatar da shari'o'in zuwa 66,576 a duk duniya.
A wannan yanayin, mutuwar SARS a watan Nuwamba na 2002 ya kai kashi 10% na 8,096 da aka tabbatar.
A cikin binciken da aka yi a watan Yuni na 2012, an tabbatar da mutuwar mutane 37 bisa dari daga cikin 2,494 da aka kamu da cutar.
Wani binciken da aka yi a baya ya ruwaito cewa R0 SARS-CoV-2 ya kai 6.47 tare da 95% amintacce (CI) na 5.71-7.23, yayin da R0 SARS-CoV ya kasance kawai a cikin 2 zuwa 4.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da bayyanar cututtuka, mutuwa, da kuma R0 a cikin Table 1.
Wadannan kididdigar sun nuna cewa SARS-CoV-2 na da karfin yadawa fiye da MERS-CoV da SARS-CoV, amma ba ya kama MERS-CoV da SARS-CoV.
Saboda haka, kalubalen da ake fuskanta wajen sarrafa cutar SARS-CoV-2 ya fi na cutar MERS-CoV da SARS-CoV girma.
Ana yawan samun ƙuƙwalwa a cikin iyali ɗaya ko kuma a cikin ƙungiya ɗaya ko kuma a cikin mota kamar jirgin ruwa.
Sau da yawa, marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa ko kuma sun tuntubi mutane da suka kamu da cutar ko marasa lafiya a cikin makonni biyu kafin a fara aiki.
Amma, an ruwaito cewa mutane na iya ɗaukar cutar ba tare da nuna alamun cutar ba har tsawon makonni biyu kuma marasa lafiya da aka dawo daga asibiti na iya ɗaukar cutar kuma.
A farkon lokaci, marasa lafiya suna da ƙwayoyin fari na jini (musamman lymphocytes) na yau da kullum ko kuma sun ragu.
Alal misali, an gano limfopenia da yawan fararen hawan jini < 4×109/L, wanda ya hada da yawan lymphocytes < 1×109/L, da kuma karuwar aspartate aminotransferase da kuma viremia a cikin marasa lafiya 1,099 na COVID-19.
Ƙarfi na hanta da ƙwayar tsoka da kuma ƙwayoyin cuta na mioglobin a cikin jinin marasa lafiya da yawa, da kuma ƙaruwa a cikin furotin C-reactive da kuma yawan jini a yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, yawan D-dimer ya ƙaru, wato, ƙwayoyin da ke cikin jini suna ƙaruwa, kuma yawan ƙwayar lymphocyte ya ragu.
Ana samun rashin lafiyar hoto na thorax a cikin yawancin marasa lafiya na COVID-19 kuma ana nuna shi da inuwa mai launin fata ko ƙarancin gilashin gilashi a cikin huhu.
A yawancin lokaci, marasa lafiya suna fama da cutar pneumonia, da kuma cutar huhu mai tsanani.
Sa'ad da ARDS ta taso, kumburi da kuma tarin ruwa da kuma ci gaba da ciwon fibrosis suna ƙara ɓata yanayin gas.
Rashin aikin huhu na nau'i na I da na II ya rage yawan surfactants kuma ya kara matsa lamba ta farfajiya wanda ya rage karfin huhu don bunkasa kuma ya kara hadarin fashewar huhu.
Saboda haka, mafi munin binciken da aka samu a hotunan ƙwanƙolin ƙanƙara sau da yawa yana daidai da mafi munin yanayin rashin lafiya.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ƙwayoyin cuta na huhu, samar da membranes na hialin, da kuma shigar da lymphocytes na interstitial, da kuma ƙwayoyin sinadarai masu yawa a cikin huhu na marasa lafiya da suka mutu saboda cutar, daidai da yanayin kamuwa da cutar cutar da ARDS da kuma kama da nazarin cututtukan marasa lafiya na SARS da MERS.
Ana amfani da gano RNA na SARS-CoV-2 ta hanyar jujjuyawar layin polymerase transcriptase (RT-PCR) a matsayin babban ma'auni don ganewar asali na COVID-19.
Duk da haka, saboda yawan adadin ƙwayoyin cuta na karya, wanda zai iya hanzarta annobar, an fara amfani da bayyanar cututtuka na asibiti don ganewa (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Hakazalika, ana samun irin wannan yanayin a cikin binciken SARS.
Saboda haka, haɗuwa da tarihin rashin lafiya, bayyanar cututtuka, gwaje-gwaje na dakin gwaje-gwaje, da kuma binciken radiology yana da muhimmanci kuma yana da muhimmanci wajen yin bincike mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniyar amfani da fasaha ta SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kofe a kowace microlitre na shigarwa) ta amfani da sandar ƙugiya a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan wannan sabuwar fasaha za ta iya inganta ƙwarewarmu da kuma saukinmu idan aka tabbatar da shi a cikin gwajin gwaji.
Saboda rashin kwarewa da sabon CoV, likitoci suna ba da kulawa mai goyan baya ga marasa lafiya na COVID-19, yayin da suke gwada magunguna daban-daban da aka yi amfani da su ko kuma aka ba da shawarar a baya don maganin sauran CoV, kamar SARS-CoV, MERS-CoV, da sauran cututtukan kwayar cuta (Table 2).
Wannan magani ya ƙunshi maganin da ake da shi a yanzu da kuma maganin da zai yiwu tare da maganin rigakafi, maganin rigakafi, steroids, plasma na marasa lafiya da suka warke, maganin gargajiya na kasar Sin, da kuma taimakon tunani.
An ba da shawarar yin amfani da jini na marasa lafiya da suka warke don yin magani.
Kamfanonin sayar da magunguna suna gaggauta wajen samar da rigakafi da allurar rigakafi don cutar.
A farkon matakin, SARS-CoV-2 ya fi yawa a cikin huhu kuma yana iya kai hari ga sauran gabobin da ke nuna ACE2 a ƙananan matakan, kamar gastrointestinal system da koda.
Amma, rashin aiki da kuma rashin numfashi suna da muhimmanci ga marasa lafiya kuma suna da sanadin mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci don sauƙaƙa alamun cututtuka da kuma ceton rayuka, wanda ya haɗa da maganin oxygen na yau da kullum, oxygen mai yawa, iska mai ba da izini, da kuma iska mai ba da izini, dangane da irin mummunan yanayin cutar.
Dole ne a tallafa wa marasa lafiya da ke fama da mawuyacin hali na numfashi ta hanyar oxygenation na extracorporeal membrane (ECMO), wata fasaha ce ta cututtuka na cututtuka na zuciya da na huhu da ake amfani da ita don magance rashin ciwon zuciya ko kuma numfashi mai haɗari.
Bugu da ƙari, kula da daidaiton electrolyte, hanawa da kula da cututtuka na biyu da na septic shock, da kuma kare aikin gabobin jiki na musamman suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa yawan magungunan rigakafi na jiki suna haifar da hadari na cytokines a cikin marasa lafiya na SARS da MERS.
Cytocin storm shine nau'in tsarin inflammatory response wanda aka nuna ta hanyar sakin jerin cytokines, wanda ya hada da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan kwayoyin suna sa ƙwayoyin jikin mutum su saki babban adadin ƙwayoyin da ke sa ARDS ya yi tsanani kuma su sa gabobin jiki su kasa.
Maganin rigakafi yana da muhimmanci wajen magance hadari na cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da Tocilizumab, wanda yake da maganin anti-IL6 na monoclonal antibodies, don magance hadari na cytokines.
Sauran maganin rigakafi don hadari na cytokine sun hada da daidaitaccen amsawar rigakafin T; toshe IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; siginar siginar cytokine 4; da kuma hana HDAC.
Ana amfani da steroids, a matsayin masu hana rigakafi, a cikin maganin SARS don rage mummunan lalacewar kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga mummunan rauni a cikin marasa lafiya na SARS da COVID-19.
A akasin haka, steroids na iya haifar da mummunan sakamako masu illa, musamman osteonecrosis, wanda ke shafar hangen nesa.
Duk da haka, an ba da shawarar yin amfani da ƙananan sassan na cortisosteroid a hankali ga marasa lafiya masu cutar COVID-19.
A lokacin da nake rubuta wannan bita, babu wata maganin rigakafi mai inganci da aka tabbatar.
Duk da haka, an gano cewa maganin remdesivir na intravenous, wanda yake kama da nucleotide, yana da amfani ga wani mai cutar COVID-19 daga Amirka.
Remdesivir sabon maganin rigakafi ne da Gilead ta yi, wanda aka fara amfani da shi wajen magance cututtukan da Ebola da kuma Marlburg suka jawo.
Daga baya, remdesivir ya kuma nuna hana wasu kwayoyin RNA guda ɗaya, wanda ya haɗa da MERS da SARS.
A bisa wannan, Gilead ta ba da wannan fili ga kasar Sin don gudanar da jerin gwaje-gwaje a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma sakamakon yana jiran sosai.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ ritonavir, da ribavirin an ba da shawarar su zama magani mai yiwuwa ga marasa lafiya da ke fama da cututtukan numfashi.
Ana iya samun ciwon ciki, nausea, vomiting, ciwon hanta, da kuma wasu sakamako masu illa bayan an yi maganin hade da lopinavir/ ritonavir.
Dole ne a lura da yadda wannan magani yake shafar sauran magunguna da marasa lafiya suke amfani da su.
Plasma daga marasa lafiya da suka warke da kuma samar da rigakafi
Akwai tarihi mai tsawo na tattara jini daga marasa lafiya da suka warke daga cututtuka masu yaduwa don magance wasu marasa lafiya da ke fama da irin wannan cuta ko kuma don hana mutane lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da yawan adadin rigakafi a cikin jininsu.
Antibodies sune immunoglobulin (Ig) da ake samarwa daga kwayoyin halitta na B don yaƙi da wasu ƙwayoyin cuta da kuma wasu abubuwa masu ƙyama, ya gane kwayoyin da suka bambanta da na ƙwayoyin cuta, kuma ya hana su kai tsaye.
Bisa ga wannan, an tattara jini daga cikin jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allura zuwa ga marasa lafiya 10 da suka kamu da cutar.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma sun rage ciwon da ke tattare da ƙwayar cuta da kuma ƙara yawan iskar oxygen a cikin jini.
Duk da haka, ana bukatar a yi bincike da kuma bayani game da yadda za a yi amfani da wannan hanyar a kan babban sikelin kafin a yi amfani da wata magani ta musamman.
Bugu da ƙari, ban da maganin da yake da shi, akwai wasu abubuwan da suka shafi jini da ya kamata a yi la'akari da su sosai.
Alal misali, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Yawan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Ƙirƙirar ƙwayoyin rigakafi da sauri don magance annoba ta duniya ba shi da sauƙi.
Saboda haka, yana da muhimmanci sosai a ware B-cell daga marasa lafiya da suka warke kuma a gano ainihin asalin kwayoyin da ke nuna cewa suna da tasiri sosai a kan ƙwayar cuta ko kuma su yi amfani da maganin rigakafi don su tace sunadarai da ke da muhimmanci ga ƙwayar cuta.
Ta wannan hanyar, za mu iya ƙara yawan samar da rigakafi.
An yi amfani da TCM wajen magance cututtuka a kasar Sin na shekaru dubbai.
Duk da haka, yawancin sakamako ya dogara da haɗuwa da abubuwa daban-daban a cikin tsarin.
Yawancin abubuwa masu tasiri har yanzu ba a san su ba ko kuma ba a bayyana su ba saboda yana da wuya a cire ko tabbatar da waɗannan abubuwa ko kuma haɗuwa da su.
A halin yanzu, saboda babu wani magani mai inganci da takamaiman maganin COVID-19, TCM ya zama ɗayan manyan magungunan madadin ga marasa lafiya masu sauƙi zuwa matsakaici ko kuma ga mutanen da ke murmurewa daga mummunan cutar.
Alal misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules sun kasance masu amfani ga maganin COVID-19.
An lura da mafi yawan farfadowa a cikin maganin marasa lafiya na COVID-19 a wasu lardunan China da ke amfani da TCM a cikin kashi 87% na marasa lafiya, wanda ya haɗa da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin farfadowa (13%).
Amma, wannan kwatancen yana da wuya sosai saboda wasu dalilai masu tasiri, kamar yawan marasa lafiya da kuma tsanani, dole ne a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokansa sun wallafa wani bincike da ya kwatanta maganin maganin yamma (WM) da maganin hada-hadar WM da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, kawar da bayyanar cututtuka, da kuma shiga asibiti ya yi ƙasa da na WM+TCM idan aka kwatanta da na WM kadai.
Abin sha'awa, yawan bayyanar cututtuka (daga mai sauƙi zuwa mai tsanani) ya fi ƙasa da na WM+TCM (kashi 7.4 bisa dari) da kuma na mutuwa a cikin WM+TCM (kashi 8.8 bisa dari) da kuma na WM+TCM (kashi 39.%).
Duk da haka, inganci da tsaro na TCM suna jiran gwaji mafi kyau a kan sikelin da kuma cibiyoyin bincike da yawa.
Wani abin da ya fi ban sha'awa shi ne gano yadda ake yin aiki da kuma bayyana ainihin abubuwan da ke cikin maganin TCM ko kuma a hade su, idan ya yiwu.
Yawancin marasa lafiya da ake zaton ko kuma suka tabbatar da COVID-19 suna jin tsoron wannan cuta mai saurin kamuwa da ita har ma da kisa, kuma mutanen da ke keɓewa suna jin haushi, kadaici, da fushi.
Bugu da ƙari, alamun cututtuka kamar zazzabi, hypoxia, da kuma tari da kuma sakamako masu illa na magani kamar rashin barci da ake samu daga corticosteroids na iya haifar da damuwa da kuma damuwa.
A farkon fasalin SARS, an yi rahoton ciwon hauka na tunanin mutum, wanda ya shafi baƙin ciki, damuwa, tashin hankali, rikice-rikice na motsi, alamun psychotic, delirium, har ma da rashin lafiyar jiki.
Kula da tarihin hulɗa da kuma yin ƙauracewar ƙauracewar, a matsayin ɓangare na amsawar lafiyar jama'a ga annobar COVID-19, na iya sa mutane su ƙara damuwa da jin laifi game da tasirin kamuwa da cuta, ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙauracewar ƙa ƙauracewar ƙa ƙa ƙa ƙauracewar ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa
Saboda haka, dole ne a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, wadanda ake zargi, da wadanda suka tuntube su, da kuma al'umma da ke bukatar hakan.
Taimakon tunani ya kamata ya haɗa da kafa ƙungiyoyin kula da lafiyar hankali, sadarwa mai kyau tare da daidaitaccen sabuntawa game da cutar SARS-CoV-2, da kuma shirin magani da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don guje wa kusanci da juna.
Yin amfani da allurar rigakafi mai tasiri yana da muhimmanci wajen kawar da sarkar watsawa daga cikin adadi na dabbobi da mutane masu kamuwa da cutar zuwa ga masu karɓa kuma sau da yawa yana ba da maganin rigakafi don sarrafa annobar da cutar ke haifarwa.
An yi ƙoƙari don samar da allurar rigakafi ta S-protein, wanda zai iya yin amfani da shi sosai a cikin dogon lokaci don samar da antibodies masu tsattsauran ra'ayi da / ko rigakafi don karewa daga SARS-CoV.
A SARS, an gwada rigakafin da aka kashe a kan dabbobi.
Duk da haka, ana bukatar a ƙayyade yadda wannan maganin zai yi aiki a cikin tsofaffi da kuma yadda za a iya hana shi kamuwa da cutar zoonotic kafin a fara binciken asibiti.
Wannan na iya faruwa ne domin SARS ta ragu shekaru 17 da suka gabata kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
A maimakon haka, ana ci gaba da samun cututtuka na MERS a Gabas ta Tsakiya da kuma yaɗuwa zuwa wasu yankuna saboda ci gaba da samun tushen zoonotic a yankunan da suka rage.
An kirkiro dabarun yin allurar rigakafi don cutar ta MERS ta amfani da ƙwayoyin cuta da aka kashe, plasmids na DNA, masu ɗaukar hoto na cutar, nanoparticles, ƙwayoyin cuta masu kama da cutar, da kuma subunits na furotin na sake haɗuwa kuma an gwada su a cikin dabbobi.
Ci gaban allurar rigakafi mai aminci da inganci ga mutanen da ba su da lafiya ga SARS-CoV-2 aiki ne mai gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Amma, wannan wahalar ba ta da sauƙi saboda tsawon lokacin da za a yi amfani da shi wajen samar da allurar rigakafi (kimanin watanni 18) da kuma bambancin CoV mai ƙarfi.
A matsayin sabon cuta, COVID-19 ya fara nuna cikakken tafiyarta ta asibiti ga dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya warkewa ba tare da wani abu ba.
Duk da haka, kamar SARS da MERS, COVID-19 kuma an danganta shi da yawan kamuwa da cuta da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, samar da tsarin tsara cututtukan cututtuka yana da muhimmanci ga hukumomin kiwon lafiya don ba da fifiko ga ayyukan su, musamman a yankunan da ke da iyakantaccen albarkatu.
Bisa ga binciken asibiti da aka ruwaito zuwa yanzu, waɗannan dalilai na iya tasiri ko danganta su da hangen nesa na marasa lafiya na COVID-19 (Table 3):
Shekaru: Shekaru shine mafi mahimmancin sanarwa ga SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya fi faruwa a cikin shekaru 30 zuwa 65 tare da kashi 47.7% na marasa lafiya a cikin shekaru 50 da haihuwa a cikin binciken da ya ƙunshi shari'o'i 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa mai tsanani suna da haɗari da haɗari da kuma rikitarwa kuma suna da shekaru masu yawa fiye da marasa lafiya da ba su buƙatar kulawa mai tsanani (mai matsakaici shekaru 66 fiye da shekaru 51), wanda ke nuna cewa shekaru sune abubuwan da ke haifar da sakamakon ƙarshe na marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 fiye da 0.27/100,000), kamar yadda aka bayyana a sama.
Haɗuwa da cututtuka: Marasa lafiya da ke bukatar kulawa mai tsanani na COVID-19 suna da mafi yawan haɗarin ciwon zuciya da arrhythmia.
Har ila yau, cututtukan zuciya ne ke haifar da mutuwar mutane da ke fama da cutar SARS.
An ruwaito cewa SARS-CoV-2 na iya haɗuwa da colangiocytes masu kyau na ACE2, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya na COVID-19.
Ya kamata mu lura cewa shekaru da kuma cututtukan da ke tattare da su suna da alaƙa sosai kuma suna iya shafan juna.
Abubuwan da aka gano a cikin dakin gwaje-gwaje: Yawan C-reactive protein (CRP) a cikin jini yana nuna cewa ƙwayar cuta ko rauni na ƙwayoyin cuta yana da tsanani kuma an ba da shawarar cewa yana da tasiri ga yanayin rashin lafiya, amsa ga magani, da kuma farfadowa.
An kuma gabatar da wani dangantaka tsakanin matakan CRP da kuma mummunan cutar da kuma hangen nesa na COVID-19.
Bugu da ƙari, ƙara yawan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatinine kinase (CK) na iya taimakawa wajen hango ko hasashen sakamakon ƙarshe.
Waɗannan enzymes suna bayyana sosai a gabobin jiki, musamman a zuciya da kuma zuciya, kuma suna fitowa daga jikin mutum yayin da ake lalata kayan.
Saboda haka, waɗannan enzymes sun zama alamun gargajiya na rashin aikin zuciya da hanta.
Babban alamun asibiti: Dole ne a yi la'akari da hotunan thorax da ci gaban alamun asibiti na lokaci tare da sauran abubuwa don hango ƙarshen sakamakon da rikitarwa na COVID-19.
Amfani da Steroids: Kamar yadda aka bayyana a sama, steroids suna da iko da rigakafi da ake amfani da su sosai a matsayin magani mai taimako don cututtukan cututtuka don rage mummunan lalacewar kumburi.
Saboda ana amfani da corticosteroids masu yawa a cikin marasa lafiya masu tsanani na SARS, mutane da yawa da suka tsira daga wannan cuta sun ƙare da shan wahala daga osteonecrosis avascular tare da nakasa ta rayuwa da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsin hankali: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa saboda sun shiga cikin dogon lokaci na keɓewa da matsanancin rashin tabbas da kuma mutuwar dangi da abokan marasa lafiya.
Dole ne a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don taimaka wa wannan mutumin ya warke daga damuwa kuma ya koma rayuwa ta al'ada.
Bisa ga binciken alƙaluma da aka yi zuwa yanzu, COVID-19 ya bayyana yana da bambanci na cutar da SARS.
Baya ga sake fasalinsa a cikin ƙananan numfashi, SARS-CoV-2 na iya sake fasalinsa cikin inganci a cikin ƙananan numfashi kuma yana haifar da bayyanar cututtuka mai sauƙi ko ba tare da bayyanar cututtuka ba a farkon farkon kamuwa da cuta, kamar sauran CoVs da ke haifar da mura.
Saboda haka, a farkon lokaci ko lokacin kamuwa da cutar, marasa lafiya da suka kamu da cutar suna iya samar da ƙwayoyin cuta da yawa a yayin ayyukan yau da kullum, wanda ke haifar da wahalar sarrafa cutar.
Koyaya, ana gaskata cewa watsa SARS-CoV yana faruwa ne lokacin da mai haƙuri ya kamu da mummunan cutar kuma galibi ba ya faruwa a farkon matakin.
Saboda haka, annobar COVID-19 ta yanzu ta fi muni da kuma wahalar sarrafawa fiye da annobar SARS.
A halin yanzu, ana yin babban ƙoƙari a China, wanda ya haɗa da killace yankin Wuhan da garuruwan da ke kusa da shi da kuma ci gaba da killace kusan dukkanin yawan jama'a da fatan dakatar da watsa SARS-CoV-2.
Duk da cewa wannan ya yi mummunan lahani ga tattalin arziki da sauran bangarorin kasar, adadin sabbin marasa lafiya ya ragu, wanda ke nuna jinkirin annobar.
Mafi kyawun kimantawa ya nuna cewa annobar za ta ƙare a watan Maris kuma za a rage raguwa na tsawon watanni 3-4.
Amma, wasu masana ba su da irin wannan ra'ayin.
Paul Hunter et al. sun kiyasta cewa COVID-19, wanda ya fi SARS yawa, ba zai ƙare ba a shekara ta 2020.
Ira Longini, et al. sun kirkiro wani samfurin don hango ko hasashen sakamakon cutar ta ƙarshe kuma sun bayyana cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wani rukuni na masu bincike na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin tsokoki na tsakiyar kwakwalwa da kuma wuyan marasa lafiya waɗanda suka warke kuma suka dawo daga asibiti makonni 2 da suka gabata. Wannan yana nuna cewa kwayar cutar da aka gano ta iya zama maimaitawa, kamar cutar mura.
Duk da haka, a kasar Sin akwai alamun da za su nuna cewa akwai yiwuwar samun sakamako mai kyau, idan aka duba ƙarancin adadin sababbin cututtuka, wanda ya nuna cewa dabarun da ake amfani da su a yanzu suna iya yin nasara.
An yi hasashen cewa cutar Ebola za ta kai ga mutum miliyan ɗaya da kuma rabin mutuwarsu.
Amma, da keɓewa da kuma keɓewa, an yi nasara wajen sarrafa cutar.
Hakanan, kamar SARS-CoV, SARS-CoV-2 yana iya rage ikon kamuwa da cutar kuma ya ɓace ko kuma ya zama ƙarancin ƙwayar cuta wanda zai iya zama tare da mutane.
Ana ba da kwatancen cutar COVID-19 da cutar SARS da MERS a ƙasa (Fabrairu 5).
SARS-CoV-2 yana da sauƙin watsawa ta hanyar tari ko kumburi, kuma yana iya kasancewa ta hanyar kai tsaye zuwa kayan da cutar ta kamu da su.
An gano wannan kwayar a cikin hanji kuma hakan ya haifar da yiwuwar sabon watsa, wato, ƙwayar cuta ta hanyar baki.
Wani bincike da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41 cikin 100 na waɗannan cututtuka na iya faruwa ne daga kamuwa da cutar nosocomial, wanda ya shafi marasa lafiya 17 da suka kamu da wasu cututtuka na baya da kuma masu kula da lafiya 40.
Saboda haka, dole ne a yi amfani da matakan tsaro don a kāre mutane, musamman ma masu kula da lafiya, da kuma ma'aikatan jin daɗin jama'a, da kuma waɗanda suke cikin iyali da abokan aiki, har ma da waɗanda suka haɗu da marasa lafiya ko kuma waɗanda suka kamu da cutar.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce ta amfani da abin rufe fuska, duka biyu na tiyata da na numfashi N95 (numar jerin shekarun 1860s) don taimakawa wajen hana yaduwar cutar.
Masks na tiyata suna kāre ƙarancin iska daga waɗanda suke da cutar ko kuma su manne wa farfajiyar da za a iya ba da ƙarancin iska.
Duk da haka, kawai N95 masks (number na 1860s) na iya karewa daga inhalation na virion da ƙananan girman 10 zuwa 80 nm, tare da kawai 5% na virion na iya shiga cikin cikakkiyar; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman, duka suna da girman kusan 85 nm.
Tun da ƙwayoyin za su iya shiga cikin masks biyar da aka yi a cikin wani, masu kula da lafiya da ke tuntuɓar marasa lafiya kai tsaye suna bukatar su saka N95 (lambar lamba ta 1860s) maimakon masks.
Baya ga abin rufe fuska, masu kula da lafiya suna bukatar su saka rigar rigakafi don su rage haɗuwa da cutar.
Hakanan, ƙwayoyin cuta suna iya kamuwa da mutum ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya sa abin rufe fuska na N95; ƙwayoyin cuta na iya shiga jikinsa ta hanyar kumburi na ido.
Saboda haka, masu kula da lafiya suna bukatar su saka rigar fuska ko tabarau masu gani yayin da suke aiki da marasa lafiya.
Ga jama'a a yankunan da aka yi wa cuta ko kuma waɗanda za su iya yi wa cuta, yana da kyau kowa ya wanke hannunsa da sabulu mai tsabta fiye da yadda ya saba, ya yi ƙoƙari ya zauna a gida don yin keɓewa, kuma ya guji yin hulɗa da waɗanda za su iya kamuwa da cutar.
An yi imani cewa kafa uku ne kawai za su iya nisantar da mutum daga wurinsa.
Waɗannan matakan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 sabon kwayar cuta ce ga ɗan adam, babban homology da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama babban gargadi ga China da ke da manyan abubuwan tunawa game da barkewar cutar SARS ta 2003.
Duk da haka, a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin jama'a ta hanyar cewa sabon kwayar cutar tana da ƙananan halaye na yaduwa da iyakanceccen damar haifuwa daga mutum zuwa mutum kuma hanawa da kuma hana cutar ba matsala bane.
Wannan sakon ya kwantar da hankalin jama'a, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara, don haka wannan lokaci mai mahimmanci ya wuce don hana cutar da ke ƙarancin ƙarancin Wuhan.
Hukumar da ke kula da cututtuka a ƙasar Sin za ta koya daga wannan kuma ta yi gyara mai girma a nan gaba.
Alal misali, ya kamata hukumar ta (1) yi hankali sosai wajen yin sanarwa a fili domin kowane kalma tana sa mutane su lura kuma tana iya canja halayensu da shawarwarinsu; (2) ta fi mai da hankali da kuma yin amfani da bayanai na yau da kullum daga asibitoci fiye da ta jira a ba da rahoto na likita ko kuma jami'in da ke da iko; (3) ta fi yin iyakacin iko don hana yiwuwar annobar a farkon lokaci, maimakon ƙoƙarin ta kwantar da hankalin jama'a; da kuma (4) ta fi yin amfani da darussa masu kyau da za su taimaka wa jama'a su san game da annobar cutar da kuma gwada da kuma inganta tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 ta haifar da sabon kwayar cutar SARS-CoV-2 wanda ya fara yaduwa a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, annobar ta bazu ko'ina cikin Sin da kuma fiye da ƙasashe 50 a duniya a lokacin da nake rubuta wannan bita.
Saboda wannan kwayar cutar tana kama da SARS-CoV kuma alamun COVID-19 da SARS suna kama da juna, annobar COVID-19 ta haifar da irin wannan fasalin SARS na maimaitawa.
Duk da haka, akwai wasu bambance-bambance a tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana cutar da kuma magance marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa kuma ya fi rinjayar maza fiye da mata, kuma yawan mutuwar tsofaffi ya fi na matasa.
Mutuwar SARS ta fi na COVID-19 girma (10,91% da 1,44%).
Masu fama da cutar COVID-19 suna watsa kwayar cutar ko da ba su da wata alama, yayin da masu fama da cutar SARS ke watsa kwayar cutar lokacin da suke cikin mummunan rashin lafiya. Wannan ya haifar da matsala mafi girma wajen hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wasu dalilan da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya fi SARS-CoV yawa.
Aikace-aikacen RNA na yau da kullum don bincika SARS-CoV-2 na iya haifar da sakamako mara kyau ga wasu marasa lafiya na COVID-19.
A wani ɓangare kuma, marasa lafiya da suka warke za su iya sake samun sakamako mai kyau a gwajin ƙwayoyin cuta.
Wannan binciken ya kara hadarin yaduwar cutar.
Da yake ci gaban bincike na COVID-19 yana da sauri, akwai wasu muhimman batutuwa da za a warware, wato:
Daga ina SARS-CoV-2 ya fito?
Duk da cewa an gano kashi 96 cikin dari na kwayoyin halitta tsakanin SARS-CoV-2 da CoVs guda biyu masu kama da SARS a bats, har yanzu ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga bats ba.
Waɗanne dabbobi ne suke yin aiki na tsakiya don canja wurin kwayar daga mahaifinsu, wato, barawon, zuwa mutane?
Idan ba mu san amsoshin farko da na biyu ba, ba za mu iya kashe watsawar ba kuma annobar za ta iya sake yaduwa a kowane lokaci.
Ko da yake ƙwayoyin halitta da kuma asalin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da ƙarin canje-canje na pathological?
Shin kwayar cutar tana da alaƙa da ƙwayoyin da ke bayyana ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshin waɗannan tambayoyin, ba za mu iya samun ganewar asali da sauri da kuma magani mai kyau ba.
Har yaushe za a ci gaba da wannan annoba?
Ta yaya kwayoyin halitta suka ci gaba a lokacin da ake watsa su tsakanin mutane?
Shin annobar za ta zama annoba a duniya, ta ƙare kamar SARS, ko kuma ta sake faruwa a kai a kai kamar mura?
Amsar wannan tambayar da kuma wasu maganganu da yawa suna da muhimmanci sosai, amma za a iya ɗaukar lokaci kafin a samu.
Duk da haka, ko da yaya farashin ya kasance, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri don mu koma ga rayuwarmu ta yau da kullum.
Tushen zoonotic na kwayar cutar korona ta mutum
A cikin dubban shekaru, canji da kuma daidaitawa sun motsa co-juyin hali na kwayar cutar korona (CoV) da kuma mai masaukin ta, ciki har da mutane.
Kafin 2003, an san cewa mutum biyu na CoV (HCoV) suna haifar da ƙananan cututtuka, kamar cutar sankara.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Fitowar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ta sake haskaka cutar ta CoV kuma ta ba mu mamaki da yawan watsawa, amma tare da ƙananan cututtuka fiye da ɗan'uwanta, SARS-CoV.
HCoVs suna kama da cutar dabbobi, saboda haka fahimtar asalin dabbobi na HCoV zai taimaka mana.
Yawancin HCoVs sun fito ne daga bats. A cikin wadannan dabbobi, ba su da cutar.
An kuma san wasu HCoVs a cikin matsakaiciyar ajiyar ruwa.
Idan aka gano wani dabba mai gida, hakan yana da tasiri sosai a hana mutum kamuwa da cututtuka.
Binciken da aka yi game da yadda CoV-injin ke shafar dabbobi zai iya ba da muhimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan bita, mun gabatar da cikakken bayani game da ilimin da ake samu game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin su da kuma watsa su tsakanin jinsuna.
Abu mai muhimmanci shi ne, mun gwada da kuma kwatanta HCoVs daga juyin halitta da kuma sake haɗuwa da kwayoyin halitta.
Ana tattauna cutar COVID-19 a cikin wannan mahallin.
Bugu da ƙari, an kuma nuna muhimmancin nasarar canja wurin mai karɓar baƙi da kuma tasirin juyin juya halin ƙwayar cuta a kan rashin lafiyar cutar.
Kwayar cutar korona (CoV) ta fito ne daga dangin Coronaviridae, wanda ya ƙunshi rukuni na kwayoyin RNA masu ɓoye, masu niyya, da kuma guda.
Wannan kwayar tana da mafi girma a cikin kwayoyin halitta, mai girma daga 26 zuwa 32 kilobases, daga cikin kwayoyin RNA da ake kira "CoV", saboda yanayin da ke kama da kambi a ƙarƙashin microscope na lantarki.
Bisa ga tsarinsa, CoV yana da wasu kwayoyin halitta da ba a rarraba su ba da suke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta sun ƙunshi manyan manyan sassan karatu guda biyu (ORF1a da ORF1b) da suka haɗu da juna.
Ana ci gaba da sarrafa polyprotein don samar da furotin 16 na ba-sarrafawa, wanda ake kira nsp1~16.
Sauran kwayoyin halitta sun ƙunshi tsarin karantawa na budewa (ORF) don furotin na tsarin, wanda ya haɗa da ƙugiya ko ƙugiya (S), ƙugiya ko envelope (E), membrane (M), da nucleoprotein (N).
Ƙananan furotin masu ƙunshe da ke da ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun ƙyadaddun.
Bisa ga bambancin da ke cikin jerin sunayen sunadarai, CoVs an rarraba su zuwa nau'i hudu (alfa-CoV, beta-CoV, gamma-CoV, da delta-CoV); daga cikin waɗannan nau'i hudu, nau'in beta-CoVs suna da mafi yawan HCoVs kuma an sake rarraba su zuwa zuriya huɗu (A, B, C, da D).
Shaidar filogenetik ta nuna cewa bats da rodents sune tushen tushen asalin mafi yawan alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune manyan wuraren ajiyar gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs sun ci gaba da ƙetare ƙuntatawa na nau'in, kuma wasu CoVs sun zama manyan cututtuka a cikin mutane.
A halin yanzu, an san mutum bakwai da suka kamu da cutar korona.
Daga cikin waɗannan ƙwayoyin guda bakwai, HCoV-229E da HCoV-NL63 sune alpha-CoV.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar korona ta rikicin numfashi mai tsanani (SARS-CoV), cutar korona ta rikicin numfashi na Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63 yawanci suna haifar da bayyanar cututtuka masu sauƙi, kamar mura da/ko fitsari.
A akasin haka, SARS-CoV, MERS-CoV, da SARS-CoV-2 suna da cututtuka masu yawa, suna haifar da cututtukan ƙananan huhu a cikin marasa lafiya da yawa kuma suna da mafi girma damar ci gaba da cutar ta rashin numfashi (ARDS) da bayyanar cututtukan huhu.
An ware nau'in HCoV-229E na farko, B814, daga cikin marasa lafiya masu cutar a tsakiyar shekarun 1960.
Tun daga lokacin, an sami ƙarin ilimi ta hanyar zurfin nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da bayyanar cututtuka da kansu.
A gaskiya ma, an yarda da wannan ra'ayi cewa kamuwa da cutar HCoV ba ta da haɗari, har sai an sami barkewar cutar SARS.
Cutar SARS da ta auku a shekara ta 2003 na ɗaya daga cikin cututtukan da suka fi halakarwa a tarihin zamani, wanda ya shafi mutane fiye da 8,000 tare da yawan mutuwar kusan 10%.
Shekaru goma bayan haka, annobar cutar ta cutar ta Middle East respiratory syndrome (MERS) ta haifar da ci gaba da yaduwar cutar a yankin Larabawa tare da yaduwar cutar zuwa sauran sassan duniya.
Sabon HCoV 2019 (2019-nCoV), wanda aka sake kira SARS-CoV-2, shine mai haifar da cutar cutar coronavirus ta 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi gargadi kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai na zoonotic ne daga bats, beraye, ko dabbobi.
Akwai hujjoji da yawa da suka nuna cewa dukkanin HCoVs sun samo asali ne daga bats. A bats, CoVs suna daidaitawa sosai kuma ba su da cututtuka, amma suna nuna bambancin kwayoyin halitta mai yawa.
Cutar COVID-19 ta kawo gagarumin kalubale na kiwon lafiya, kimiyya, zamantakewa, da kuma ɗabi'a ga kasar Sin da sauran duniya.
Bin diddigin asalin HCoV na zoonotic yana ba da tsarin fahimtar tarihin halitta, motsi, da kuma ƙuntataccen abubuwan da ke haifar da yaduwar tsakanin jinsuna.
Wannan binciken na iya jagorantar ko sauƙaƙe binciken masu karɓar bakuncin, masu matsakaici, da kuma haɓaka SARS-CoV-2, wanda ke da mahimman bayanai game da hana yaduwar nan gaba.
A cikin wannan bita, mun ba da cikakken bayani game da asalin dabbobi, watsa tsakanin jinsuna, da kuma kamuwa da cutar HCoV.
Mun yi magana musamman game da batun da ke faruwa a yau cewa cutar HCoV ba ta da cutar a cikin adanawa na halitta, amma ta zama mai cutarwa bayan an watsa ta tsakanin nau'ikan zuwa sabon mai masaukin.
Mun kuma lura da yanayin juyin halitta na HCoV cewa karuwar iyawar watsawa sau da yawa yana tattare da raguwar kamuwa da cutar.
An kuma tattauna sakamakon cutar SARS-CoV-2 a wannan mahallin.
An san dabba ta CoV tun daga ƙarshen shekarun 1930.
Kafin a ware nau'in HCoV-229E na farko na nau'in B814 daga cikin masu cutar sankara, an ware nau'ikan CoVs daga dabbobi daban-daban da suka kamu da cutar, wanda ya haɗa da turkeys, beraye, shanu, alade, cats, da karnuka.
A cikin shekaru da dama da suka gabata, an gano HCoVs bakwai.
A takaice taƙaitaccen tarihin gano HCoV a cikin jerin jerin abubuwa (Table 1) yana da bayani.
An fara ware nau'in HCoV-229E daga cikin numfashi na marasa lafiya da ke fama da cutar ta sama a shekara ta 1966, wanda aka yi amfani da shi don girma a cikin WI-38 cell line.
Marasa lafiya da ke dauke da cutar HCoV-229E sun nuna alamun cutar ta tsatsa, wanda ya hada da ciwon kai, kumburi, kumburi, da kuma ciwon wuya, tare da zazzabi da tari wanda ya bayyana a 10~20% na lokuta.
Daga baya a 1967, an ware HCoV-OC43 daga al'adun kwayoyin halitta da kuma jerin hanyoyin a cikin kwakwalwar da ke shan nono.
Bayanan asibiti na kamuwa da cutar HCoV-OC43 ya yi kama da kamuwa da cutar da HCoV-229E ke haifarwa, wanda ba a iya bambanta shi da sauran cututtukan huhu kamar cutar mura ta A da rhinovirus ba.
HCoV-229E da HCoV-OC43 sun bazu ko'ina cikin duniya kuma suna iya kamuwa da su a lokacin hunturu a yankuna masu matsakaicin yanayi.
Yawancin lokaci, waɗannan ƙwayoyin cuta biyu suna da tsawon lokaci na ƙasa da mako guda, kuma suna da tsawon lokaci na rashin lafiya na kusan makonni biyu.
Bisa ga binciken da aka yi na masu aikin sa kai a kan mutane, mutane masu lafiya da suka kamu da cutar HCoV-229E sun kamu da cutar taƙama mai sauƙi.
Mutane da yawa ba su da lafiya sosai, amma suna da tsarin rigakafi da ya raunana.
SARS, wanda aka fi sani da "pneumonia atipis", shine farkon cutar ta HCoV da aka rubuta sosai a tarihin ɗan adam kuma wakili na etiological shine SARS-CoV, wanda shine HCoV na uku da aka gano.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong, China.
Cutar SARS ta haifar da shari'o'i 8,096 da aka ruwaito tare da mutuwar 774, wanda ya bazu a ƙasashe da nahiyoyi da yawa.
Ba tare da an yi amfani da su ba, ana kiyasta cewa kowace cuta za ta iya haifar da wasu cututtuka na biyu, tare da lokacin yin amfani da kwanaki 4 zuwa 7 da kuma ganin ƙwayar cuta a ranar 10 na kamuwa da cutar.
Marasa lafiya da suka kamu da SARS-CoV sun fara fama da cutar ta myalgia, ciwon kai, zazzabi, rashin ƙarfi, da kuma yin rawar jiki, wanda aka bi da shi da dyspnea, tari, da kuma rashin numfashi a matsayin ci gaba da bayyanar cututtuka.
Lymphopenia, gwajin hanta da kuma karuwa a cikin creatine kinase, wani abu ne da ake yawan gani a cikin SARS.
Ana kuma lura da lalacewar alveolar diffusion, yaduwar epithelial cells, da kuma karuwa a cikin macrophage a cikin marasa lafiya na SARS.
Bayan haka, kashi 20-30 cikin ɗari na marasa lafiya suna bukatar kulawa mai tsanani da kuma iska mai iska.
Ban da ƙananan hanyoyin numfashi, wasu gabobin da suka shafi gastrointestinal tract, hanta, da koda suna iya kamuwa da cutar a cikin matsanancin yanayi, yawanci tare da hadari na cytokine, wanda zai iya zama mai mutuwa, musamman a cikin marasa lafiya da ke da rauni.
An fara ware kwayar daga wani kwayar cutar da aka yi wa wani mutum a cikin huhu wanda ya zo Hong Kong daga birnin Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai don nazarin HCoV.
An killace HCoV-NL63 daga yara masu watanni 7 daga Netherlands a ƙarshen 2004.
A farko, wannan ƙwayar tana da yawa a cikin yara, tsofaffi, da kuma marasa lafiya da ke fama da cututtukan numfashi.
Ana samun cututtukan coryza, conjunctivitis, zazzabi, da bronchiolitis a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike na musamman ya bayyana cewa an ware wannan kwayar daga nasal na wani dan shekara takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma a gaskiya, cutar ta bazu ko'ina cikin duniya.
An kiyasta cewa HCoV-NL63 yana wakiltar kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma yana da ƙaruwa a farkon bazara, bazara, da hunturu.
HCoV-NL63 yana da alaƙa da laryngitis na hanawa, wanda ake kira kuma croup.
A wannan shekarar, an killace HCoV-HKU1 daga wani mutum mai shekaru 71 da aka yi masa asibiti saboda cutar huhu da bronchiolitis a Hong Kong.
Baya ga cutar pneumonia da bronchiolitis na al'umma, an ruwaito HCoV-HKU1 yana da alaƙa da cutar asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 an samo shi a duk duniya, yana haifar da rashin lafiyar numfashi mai sauƙi.
Wadannan HCoVs hudu na al'umma sun dace da mutane kuma suna da ƙananan yiwuwar canzawa zuwa cututtuka masu cutarwa. Duk da haka, lokuta masu ban mamaki sun faru ne saboda dalilai da ba a sani ba, kamar yadda a cikin yanayin HCoV-NL63 na virulent wanda aka ruwaito kwanan nan yana haifar da kamuwa da cutar huhu mai nauyi a China.
A yawancin lokaci, idan mutum ya sami damar yin tafiya yadda ya kamata kuma ya ci gaba da kasancewa a cikin mutum, cutar ta rage kuma cutar ta rage.
An fara ware MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da haihuwa da ke fama da cutar huhu da kuma rashin lafiyar koda a Saudiyya.
Ko da yake yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ruwaito cewa an shigo da wasu lokuta na shigo da su daga ƙasashen Turai da Tunisia.
Wani annoba na biyu ya faru a Koriya ta Kudu a shekara ta 2015 inda aka tabbatar da cewa an kamu da cutar 186 a kasar.
Halin da ake nunawa a asibiti na MERS ya yi kama da na SARS, wanda ake kira ci gaba da kamuwa da cutar huhu.
Ba kamar SARS ba, yawancin marasa lafiya na MERS suna fama da rashin lafiyar koda mai tsanani, wanda ya zuwa yanzu ya kasance kawai a cikin MERS daga cikin cututtukan da HCoV ke haifar.
Fiye da kashi 30 cikin dari na marasa lafiya suna nuna alamun gastrointestinal, kamar fitsari da kumburi.
Har zuwa 14 ga Fabrairu, 2020, an sami karin lambobi 2500 da aka tabbatar da su a dakin gwaje-gwaje tare da mutuwar mutane da yawa, wato kashi 34.4%, wanda ya sa MERS-CoV ya zama ɗayan mafi munin ƙwayoyin cuta da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin marasa lafiya na cutar huhu da ke da alaƙa da cutar SARS-CoV-2 a Wuhan, Hubei Province, China.
Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa annobar cutar huhu ta kasa da ta haifar da SARS-CoV-2 a matsayin Gaggawa ta Lafiya ta Duniya kuma ta sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, tare da yawan mutuwar mutum 3.4%.
Ya kamata a lura, mutuwar mutum a Hubei, China, ta kai kashi 4.2%, yayin da mutuwar mutum a wajen Hubei ta kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV tare da bayyanar zazzabi, tari, da kuma numfashi.
Ana kuma samun ciwon daji a wasu marasa lafiya.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya zama ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda babban homologue na nucleotide, da kashi 82%, dukansu sun haɗu cikin rassan bishiyoyi daban-daban.
Ana iya gano cewa cutar ta SARS-CoV-2 ta fi ƙasa, amma tana da yawa fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton cewa an kamu da cutar SARS-CoV-2 ba tare da bayyanar cututtuka ba kuma yana iya taimakawa wajen saurin yaduwar SARS-CoV-2 a duniya.
Kwatanta da bambance-bambance tsakanin SARS-CoV-2 da sauran HCoV shida ya nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin kamuwa da cutar HCoV da tsawon lokacin da cutar ke tafiya suna kama da juna.
A wannan yanayin, SARS-CoV-2 ya bi al'amuran sauran HCoVs shida.
Na biyu, mummunan COVID-19 yana tsakanin SARS-CoV da sauran HCoVs na al'umma guda huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 ya nuna wani hoto na kowa da ake gani na kamuwa da cutar HCoV ta Community, wanda ya haɗa da hoto na bayyanar cututtuka marasa ƙayyadaddun bayyanar cututtuka ko ma ba tare da bayyanar cututtuka ba.
A gefe guda kuma, ƙananan ƙananan cututtukan COVID-19 na iya zama kamar cutar SARS-CoV ko da yake a cikin ƙananan rabo.
Na uku, watsa SARS-CoV-2 yana nuna halaye masu ban sha'awa na tsari, yana da kamanceceniya da HCoV na al'umma da SARS-CoV.
A gefe guda, damar watsa SARS-CoV-2 tana da sama da HCoV na al'umma.
A gefe guda kuma, rashin yiwuwar watsa SARS-CoV-2 ya ragu bayan wasu hanyoyi a cikin mutane har yanzu suna buƙatar tabbatarwa, kamar yadda lamarin SARS-CoV da MERS-CoV ya kasance.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 daga samfurin ƙwayoyin cuta.
"Ko watsa SARS-CoV-2 ta hanyar magungunan magunguna yana da mahimmanci, kamar yadda yake a cikin SARS-CoV, aƙalla a cikin wasu yanayi, har yanzu ana buƙatar bayyana shi ta hanyar nazarin gaba".
Abu mai mahimmanci a sani shi ne ko SARS-CoV-2 na yanayi ne kamar yadda yake a cikin HCoV na al'umma.
Ko ta yaya, bayanin SARS-CoV-2, wanda ya haɗa da iyawar watsawa, kamuwa da cuta, da ci gaba da yaduwa a cikin hanyoyi da yawa a cikin mutane, zai yi tasiri sosai kan ƙarshen barkewar COVID-19 da ke gudana.
HCoVs huɗu na al'umma da ke haifar da bayyanar cututtuka masu sauƙi sun daidaita da mutane.
Idan aka duba shi daga wani ra'ayi, za a iya cewa mutane sun saba da HCoVs guda huɗu.
A wasu kalmomi, HCoV da kuma mutane na iya zama masu tsira daga cutar HCoV na zamanin d ̄ a.
HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutanen da ke fama da cutar HCoVs sun hallaka.
Don haka, HCoVs dole ne su yi yawa a cikin mutane don su iya samun karuwar juyin halitta mai dacewa don magance ƙuntatawa na mai masaukin.
Saboda haka, da zarar cutar ta SARS-CoV-2 ta daɗe kuma mutane da yawa sun kamu da cutar, zai yiwu cewa cutar ta dace da mutane.
Idan ƙwayoyin cuta sun daidaita da kyau, zai yi wuya a dakatar da watsa su ga mutane ta hanyar killace su ko wasu matakan hana kamuwa da cuta.
A cikin shekaru da yawa, cututtukan CoV guda hudu sun bazu cikin yawan mutane kuma sun haifar da tashin hankali a cikin mutanen da ke da rashin ƙarfi.
Wannan kwayar cutar ba ta bukatar wani tanadi na dabbobi.
A akasin haka, SARS-CoV da MERS-CoV masu cutar ba su daidaita da mutane ba kuma ba za a iya jurewa ba.
Dole ne su kāre kansu kuma su yi haifuwa a cikin adadi mai yawa na dabbobi kuma su nemi damar da za su iya kaiwa ga mutane masu rauni, wataƙila ta hanyar ɗaya ko fiye na masu karɓar baƙi da kuma amplifiers.
SARS-CoV-2 yana da kwatancen kwatankwacin SARS-CoV/MERS-CoV da HCoVs huɗu na al'umma.
SARS-CoV-2 yana da sauƙin watsawa kamar HCoV na al'umma, aƙalla a yanzu.
Koyaya, SARS-CoV-2 ya fi cutarwa fiye da HCoV na al'umma kuma ba ya da cutar SARS-CoV ko MERS-CoV.
Har yanzu ana bukatar a lura ko SARS-CoV-2 zai iya daidaitawa da mutane kuma ya yi aiki a cikin mutane ba tare da wani mai masaukin baki ko mai matsakaici ba.
Kafin mu tattauna asalin dabbobi na HCoV, muna bukatar mu tattauna ma'anar da kuma halaye na halitta, na halitta, na tanadi, na matsakaici, da kuma na karfafa HCoV.
Dabbobin suna aiki a matsayin masu karɓar HCoV na juyin halitta idan suna da dangi na dangi kuma suna da babban homology a cikin matakan nucleotide.
Aikin da aka yi na wannan gidan yana da kyau sosai kuma ba shi da cutar.
Hakazalika, masu karɓar ruwa suna ɗaukar HCoV a kai a kai kuma suna yin hakan na dogon lokaci.
A cikin waɗannan lokuta biyu, mai watsa shiri yana da kamuwa da cutar ta halitta kuma shi ne mai watsa shiri na HCoV ko kuma ƙwayar cuta.
A akasin haka, idan HCoVs sun shiga cikin mahalarta na matsakaici daidai kafin ko a kusa da lokacin da cutar ta shiga cikin mutane, cutar ba ta daidaita da sabon mahalarta ba kuma sau da yawa tana da cututtuka.
Wannan matsakaiciyar mahaifa na iya zama tushen zoonotic na kamuwa da cutar mutum kuma ta zama mai karfafawa ta hanyar ba da damar kwayar cutar ta ɗan lokaci, sannan ta watsa ta ga mutane don karfafawa a sikelin kamuwa da cutar mutum.
HCoV na iya kamuwa da cutar ta kamuwa da cutar idan ba zai iya ci gaba da watsawa a cikin mahaifar ba.
A akasin haka, HCoVs na iya daidaitawa da masu karɓar baƙi na matsakaici kuma har ma suna haifar da ƙarshen lokaci.
A wannan yanayin, mai karɓar bakuncin ya zama mai karɓar tanadi na halitta.
Bayanai na cututtuka sun nuna a baya cewa babu wani mutum da ya kamu da cutar SARS da ya taɓa yin hulɗa da dabbobi masu farauta.
Binciken seroprevalence na gaba ya nuna cewa masu sayar da dabbobi suna da mafi girma IgG prevalence na anti-SARS-CoV idan aka kwatanta da yawan jama'a.
Gashin wata (Paguma larvata) da kuma karnuka masu rai a cikin kasuwar dabbobi masu rai sune farkon waɗanda aka gano suna dauke da kwayar cutar SARS-CoV mai kama da kusan daidai da SARS-CoV.
Ba da daɗewa ba, an tabbatar da hakan ne domin babu wani rahoton SARS da aka samu tun lokacin da aka kashe dukan tsuntsaye a kasuwa.
Duk da haka, an ruwaito cewa wata mace daga daji ko gonaki da ba a fallasa su zuwa kasuwar dabbobi masu rai ba sun ba da mummunan sakamako ga SARS-CoV. Wannan yana nuna cewa wata mace na iya zama kawai mai ba da tallafi na matsakaici, amma ba mai ba da damar SARS-CoV ba.
Ya kamata a lura, saboda kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da antibodies na anti-SARS-CoV, ba za a iya ƙin cewa mai yiwuwa ƙananan nau'ikan dabbobi masu shayarwa suna aiki a matsayin masu karɓar karuwar SARS-CoV ba.
Dukkanin waɗannan masu karɓar sun zama masu karɓar SARS-CoV.
Binciken dabbobi masu gida na SARS-CoV ya bayyana wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Wannan ƙanƙara ya ba da tabbataccen gwajin antibodies na SARS-CoV da kuma SARSr-Rh-BatCoV HKU3 genomic sequences.
Wannan CoV da sauran CoV na bats suna da daidaituwa na 88-92% na nucleotide sequence tare da SARS-CoV.
Wannan binciken ya kafa tushen wani sabon ra'ayi cewa bats ne mai karɓar bakuncin sabon mutum pathogen.
An gano wasu CoVs masu kama da SARS (SL-CoV) daga bats, amma guda ɗaya ne kawai, wanda aka sanya masa suna WIV1, za a iya ware shi a matsayin kwayar rai.
An san wani abu mai kama da angiotensin 2 (ACE2) mai karɓar SARS-CoV.
WIV1 wanda aka samo daga samfurin fats na bats an nuna yana amfani da ACE2 a bats, foxes, da kuma mutane a matsayin mai karɓa don shiga cikin kwayoyin.
Abin sha'awa, ƙwayar cutar SARS mai warkewa na iya hana cutar ta WIV1.
Ya zuwa yanzu, WIV1 na wakiltar wani abu mafi kusa da SARS-CoV a cikin bats, tare da 95% na homology na nucleotide sequence.
Duk da cewa wannan nau'i na homologous ne tsakanin waɗannan ƙwayoyin cuta biyu, ana ganin cewa WIV1 ba kwayar cutar SARS-CoV ba ce kuma bats ba su da gidan ajiyar SARS-CoV.
Nazarin filogenetic ya sanya MERS-CoV cikin rukuni ɗaya da CoV-HKU4 bats da CoV-HKU5 bats.
Cutar CoV-HKU4 da MERS-CoV suna amfani da wannan mai karɓar mai karɓar, wanda shine peptidase 4 (DPP4), a matsayin hanyar shiga cikin kwayar.
MERS-CoV RNA-related RNA polymerase sequences suna da kusancin filogenetic da juna a cikin beta-CoV na bats da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a sami wani MERS-CoV mai rai a cikin bats ba.
MERS-CoV da kuma CoV-HKU25 sun yi daidai da kashi 87 cikin 100 na tsarin nucleotide.
Saboda haka, bats bazai iya zama mai karɓar bakunan ruwa na MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa sun ba da sakamako mai kyau ga takamaiman rigakafin da ke hana MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suka yi a wasu ƙasashen Afirka.
An ware wani kwayar cutar MERS-CoV mai rai wanda ya yi kama da wanda aka samu a cikin mutane daga cikin hanci na raƙuman Arabiya. Wannan ya ƙara nuna cewa raƙuma ita ce ainihin mai karɓar ruwa na MERS-CoV.
Yana da mahimmanci a lura cewa an lura da lalacewar ƙwayar cuta mai yawa tare da bayyanar cututtuka masu sauƙi a cikin raƙuman gwaji da aka kamu da MERS-CoV.
Ya kamata a lura cewa raƙuman da suka kamu da cutar suna turawa ba kawai ta hanyar numfashi ba, har ma ta hanyar ƙwayoyin ƙwayoyin cuta, wanda kuma shi ne babban hanyar ɓarna daga cikin bats.
Duk da haka, har yanzu ba a amsa tambayoyin ba saboda yawancin shari'o'in MERS da aka tabbatar ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, yiwuwar sakamakon mutum-zuwa-mutum watsa ko hanyar watsa da ba a sani ba wanda ya shafi nau'in dabbobi da ba a san su ba da ke dauke da MERS-CoV.
SARS-CoV-2 ya raba homologous nucleotide 96.2% tare da CoV RaTG13 wanda aka keɓe daga Rhinolophus affinis bat.
Kamar yadda yake a SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don tabbatar da alaƙar mahaifa.
A wasu kalmomi, bats bazai iya zama mai karɓar bakunan kai tsaye na SARS-CoV-2 ba, sai dai idan an gano CoV na bat mai kama da juna a wani lokaci.
Ana iya samun karuwar SARS-CoV-2 a cikin jinsunan da ake sayar da su a cikin kasuwar sayar da kayayyakin abinci ta teku ta Huanan. Yawancin farkon shari'o'in COVID-19 suna da alaƙa da wannan kasuwar, wanda ke nuna yiwuwar watsawar dabba zuwa mutum.
Wasu binciken da aka yi kwanan nan bisa ga jerin metagenomics sun nuna cewa rukuni na ƙananan dabbobi masu shayarwa, da aka sani da trenggiling (Manis javanica), na iya ɗaukar beta-CoV na asali wanda yake da alaƙa da SARS-CoV-2.
Wannan sabon nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Koyaya, CoV yana da alaƙa da RaTG13 da kusan 90% na daidaito a cikin matakan jerin nucleotides.
An rarraba su cikin ƙananan ƙananan ƙananan kwayoyin cutar SARS-CoV-2 a cikin bishiyoyin filogenetic, ɗayan yana da alaƙa da yankin haɗin mai karɓa (RBD) wanda ya fi kama da SARS-CoV-2, tare da 97.4% kamanceceniya na amino acid sequence.
Abin mamaki, SARS-CoV-2 da RaTG13 RBD sun bambanta sosai, ko da yake matakin homologing na dukan kwayoyin halitta ya fi girma.
Wani binciken da aka yi a kan cutar ta cutar ta ciwo ya kuma nuna cewa an gano kwayar cutar daga samfurin huhu, wanda ya bayyana cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tsarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta na ɓangare wanda ya ƙunshi kusan kashi 86.3% na cikakken kwayoyin halitta.
Ba za mu iya ware yiwuwar cewa cranberries suna cikin masu karɓar bakuncin SARS-CoV-2 ba.
Duk da haka, a halin yanzu babu wata hujja da ta goyi bayan SARS-CoV-2 ya fito ne daga gangamin saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoV-SARS-CoV-2 gangamin.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi kusa da nesa tsakanin SARS-CoV-2 da beta-CoV-SARS-CoV-2.
Har yanzu ba a gano hanyar juyin halitta na SARS-CoV-2 a cikin bats, garuruwa, da sauran masu shayarwa ba.
Ko da yake an gano mafi girman homologs a cikin RBD tsakanin SARS-CoV-2 da kuma beta-CoV-SARS-CoV-2 a cikin kwayoyin halitta, SARS-CoV-2 da RaTG13 suna da mafi girma homologs a cikin matakin sequencing na dukan kwayoyin halitta.
An yi zato cewa irin wannan kamanceceniya tsakanin SARS-CoV-2 da SARS-CoV-2 na RBD beta-CoV mai dangantaka yana da nasaba da juyin halitta mai daidaitaccen zaɓi.
Gidauniyar ta yi amfani da shi wajen yin amfani da nau'in beta-CoV na SARS-CoV-2 da RaTG13 a cikin jinsin dabbobi na uku.
A matsayin mai motsa juyin halitta, ana samun karin haɗuwa tsakanin beta-CoVs.
Har yanzu masu bincike ba su iya yanke hukunci game da asalin SARS-CoV-2 ba.
Baya ga HCoV mai cutar, an kuma bincika asalin HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar filogenetik ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoV na bats, yayin da aka gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An bayar da rahoton cewa cutar ta bat da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin kwayar cutar ta Arewacin Amurka mai launin fata uku ta nuna dangantaka ta kusa da HCoV-NL63.
A gefe guda kuma, HCoV-229E yana da nasaba da wani nau'in CoV na bats, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, tare da Camelidae ana zargin shi ma mai masaukin baki ne.
Don ƙarin bayani, an taƙaita iliminmu na yanzu game da asalin HCoV a cikin Hotuna 1 da kuma Table 2.
Nazarin filogenetik ya ba da tabbacin cewa HCoVs sun kasance a cikin tarihin.
A shekara ta 1890, lokacin da HCoV-OC43 ya wuce jinsunan dabbobi don ya kamu da mutum, an lura da annobar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano wani alpha-CoV na bats da ke da nasaba da HCoV-229E.
A tsakanin su, akwai alpha-CoV mai cutar alpaka.
Akwai wasu shaidu da suka nuna cewa cutar tana gudana kai tsaye daga bats zuwa mutane.
Na farko, mutane ne, ba alpacas ba, wanda zai iya yin hulɗa da bats a cikin yanayin da ke cikin yanayin.
A maimakon haka, mutane suna da dangantaka ta kud da kud da alkalis.
Na biyu, alpha-CoV na bats da ke da alaƙa da HCoV-229E suna da bambanci da ba su da cutar a bats, yayin da alpha-CoV na alpaka ke haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a sami alpha-CoV a cikin dabbobi masu daji ba.
Saboda haka, ba za a iya ƙin yiwuwar alkalas su sami alpha-CoV-HCoV-229E daga mutane ba.
A gaskiya ma, bats ne tushen kai tsaye na cututtukan mutum, wanda ya haɗa da ƙwayar cutar rabies, Ebola, Nipah, da Hendra.
Saboda haka, ba abin mamaki ba ne cewa bats na iya kai tsaye watsa HCoV-229E zuwa mutane.
Wataƙila, yayin da alpha-CoV na bats ke aiki a matsayin ɓoye na HCoV-229E, alpacas da raƙuma na Arabiya na iya aiki a matsayin masu watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen zuwa mutane, kamar yadda lamarin MERS-CoV yake.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bats zuwa raƙuma na Arabiya da kuma daga raƙuma na Arabiya zuwa mutum.
An gano asalin MERS-CoV na halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar
A bayyane yake cewa bats suna da wadataccen ƙwayar cuta don musayar kwayoyin halitta tsakanin jinsuna da kuma watsa su.
Tsawon shekarunsu, da kuma ƙawancen da suke yi, da kuma yadda suke hulɗa da mutane sosai, da kuma yadda suke tashi sosai, suna taimaka wa bats su zama masu yaduwa.
A gefe guda, MERS-CoV ya shiga cikin raƙuman Larabawa na shekaru da yawa.
Wannan kwayar ta saba da raƙuma da suka canja daga mahaifar matsakaici zuwa mahaifar da ke cikin tankuna.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙananan ƙananan mutations a cikin waɗannan dabbobi.
Ana iya watsa shi zuwa mutane ta hanyar haɗari kuma mutane sun kasance masu karɓar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsa shi ba.
Ba kamar yadda raƙuma ke taka rawa wajen watsa MERS-CoV ba, rawar da albasa ke takawa, idan akwai, wajen watsa SARS-CoV-2 ta bambanta.
A cikin al'ada, beta-CoV na al'ada yana da matukar cutarwa a cikin al'ada.
Gashin daji na iya zama mai karɓar bakuncin beta-CoV na SARS-CoV-2, kamar yadda tsutsa take a cikin SARS-CoV.
A cikin nazarin da za a yi a nan gaba, za a yi la'akari da yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabba zuwa mutum ko kuma a ware.
Na farko, bats na iya zama mai karɓar bakunan don SARS-CoV-2 wanda yake da nasaba da SARS-CoV-2.
Mutane za su iya raba yanayin da ake ciki da bats ta hanyar yin hadaya ko kuma yin hakar ma'adinai.
Na biyu, ƙwayoyin cuta na iya zama ɗaya daga cikin masu karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar
Mutane suna kamuwa da cutar ta hanyar cin nama da kuma cin nama.
Da alama, dabbobi masu shayarwa da yawa, ciki har da dabbobi, suna da saukin kamuwa da SARS-CoV-2.
Ana bukatar a yi gwajin rigakafi a dabbobi da kuma dabbobi masu daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ya yi hulɗa da bats da kuma cranberries.
Ana ci gaba da bincike kan asalin SARS-CoV-2.
Ba tare da la'akari da nau'ikan dabbobi ba, manyan abubuwa uku na ɓangaren ƙwayar cuta suna da mahimmanci don sauƙaƙa CoV ta hanyar ƙuntatawa na nau'in.
Na farko, yana da saurin juyawa a cikin RNA.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya ɗaukar ƙididdigar ƙimar juyin halitta na CoV a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
CoV yana da exoribonuclease mai gyara, wanda ke haifar da babban canji, ragewa, ko ma rashin rayuwa.
Abin sha'awa, an san cewa Remdesivir yana hana CoV ta hanyar hana wannan exoribunuclease da RNA polymerase-dependent RNA.
Remdesivir yana daya daga cikin masu bada shawara na anti-SARS-CoV-2 da za a gwada a cikin gwaji na asibiti.
Amma, CoV ya yi juyin halitta sau miliyan ɗaya fiye da mai masaukinsa.
Bugu da ƙari, sau da yawa, yanayin canjin yana da girma idan CoV ba ta daidaita da mai masaukin ba.
Idan aka kwatanta da SARS-CoV da ke da yawan canjin, SARS-CoV-2 a zahiri ya fi ƙanƙanta, yana nuna cewa an daidaita shi da mutane.
Zai yiwu, SARS-CoV-2 ya dace da wasu masu masaukin da ke da dangantaka ta kusa da mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV wanda ya dace da raƙuman Arabiya.
A ka'idar, akwai yiwuwar cewa ƙwayar halitta ba za ta iya yin amfani da allurar rigakafi da kuma maganin rigakafi ba don cutar SARS-CoV-2.
Na biyu, manyan kwayoyin RNA a cikin CoV suna ba da ƙarin sassauci a cikin gyare-gyaren kwayoyin halitta, don juyawa da sake haɗuwa, don haka yana ƙara yiwuwar juyin halitta tsakanin jinsuna, wanda ke ba da fa'ida ga bayyanar sabon CoV a yanayin da ya dace.
Wannan yana da nasaba da yawan tsarin karantawa na musamman da kuma aikin furotin da aka rubuta zuwa ƙarshen 3′ na genom.
Na uku, CoVs sukan canza samfurori a bazuwar yayin da suke yin kwafin RNA ta hanyar tsarin zaɓin kwafin musamman.
A cikin masu karɓar da ke aiki a matsayin masu haɗuwa, sauye-sauyen igiyoyi suna faruwa a yayin rubutun RNA na CoV.
Cikakken RNA da kuma ƙananan kwayoyin halitta masu kama da juna suna iya sake haɗuwa don samar da sabon CoV.
An gano hujja ta phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoV na dabba kamar SL-CoV da CoV-HKU9 a cikin bats.
Hadin gwiwar kwayoyin cuta da ke tattare da watsawa
Baya ga waɗannan abubuwa uku na cutar da aka ambata a sama, hulɗar ƙwayar cuta da masu karɓar baƙo wani babban abu ne da ke shafar watsa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na musamman, wanda kuma ya nuna tabbataccen zaɓi na zaɓi yayin da ake watsawa tsakanin nau'ikan.
Bisa ga bincike na kwatanta tsakanin mutum da ƙwayar cuta na SARS-CoV, ana zargin SARS-CoV ya yi saurin daidaitawa a cikin masu karɓar baƙi daban-daban, musamman tare da mutations a cikin RBD na furotin S.
A yawancin lokaci, furotin RBD S CoV yana hulɗa da masu karɓar sel kuma yana da mahimmanci a matsayin mai ba da amsa ga maganin rigakafi.
A cikin SARS-CoV, RBD shine amino acid na 318 zuwa 510 a cikin sashin S1, wanda ke ɗaure da ACE2 na mutum da kuma masu karɓar sa a matsayin hanyar shiga kwayar.
SARS-CoV na RBD yana da ikon gane masu karɓar ACE2 na dabbobi daban-daban, wanda ya haɗa da bats, foxes, ratsan, da karnuka raccoons, don haka yana ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya, an lura da amino acid guda shida kawai da suka bambanta tsakanin kwayoyin cutar mutum da na fuka-fuki a RBD kuma hudu daga cikinsu suna cikin motsin haɗin mai karɓa don hulɗa da mai karɓar ACE2.
SARS-CoV na fuka-fuki yana da mutations K479N da S487T a cikin RBD, wanda zai iya haɓaka haɗakarwa da hulɗar furotin tare da masu karɓar ACE2 na mutum.
A wasu kalmomi, maye gurbin amino acid guda biyu na iya zama da muhimmanci wajen daidaita kwayar cutar zuwa mutum.
Ya kamata a lura cewa SARS-CoV-2 yana da masu karɓar kwayoyin halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S1 sun nuna cewa dangantaka ta S da ACE2 na mutum na iya canzawa.
A gaskiya ma, wani binciken cryo-EM ya nuna cewa dangantaka tsakanin mutum da ACE2 da kuma SARS-CoV-2 S sun fi girma sau 10 zuwa 20 fiye da dangantaka tsakanin mutum da ACE2 da kuma SARS-CoV S.
Abu mai mahimmanci a sani shi ne ko akwai wasu masu karɓar da za a iya buƙata don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 ma yana da alaƙa da ACE2, amma tare da wani ɓangare daban-daban na S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da 9-O-thrasethylation sialic acid don HCoV-OC43.
Waɗannan masu karɓa na iya taimakawa wajen nasarar daidaita wannan CoV a cikin mutane bayan an watsa shi tsakanin jinsuna daga mahaifinsu.
Baya ga masu karɓar kwayoyin halitta, sakamakon ƙarshe na watsa HCoV tsakanin jinsuna kuma yana ƙarƙashin sauran abubuwan dogaro da ƙuntatawa na mai masauki.
Wannan bambancin da ke tsakanin masu karɓar baƙi da kuma masu karɓar ruwa na halitta, kamar su bats, raƙuma na Arabiya, da kuma dabbobi masu rarrafe na iya zama ƙalubale ga watsa tsakanin jinsuna.
HCoVs dole ne su ɗauki nauyin masu karɓar su kuma su karya ƙuntatawa na masu karɓar su don su yi nasara a watsawa tsakanin jinsuna.
A wannan yanayin, ana bukatar a gano kuma a gano waɗannan ƙwayoyin ƙwayoyin ƙwayoyin a cikin wannan muhimmin yanayin na hulɗar ƙwayoyin cuta.
Yin amfani da dukkanin kwayoyin halitta ba tare da nuna bambanci ba don ganin abubuwan dogaro da ƙuntatawa na SARS-CoV-2 mai karɓar baƙi ta amfani da fasahar CRISPR mai ci gaba na iya zama da amfani.
Tashin sabon HCoV: komawar cutar
Yawan bambancin CoV na bats yana ba da babbar dama ga sabon HCoV.
A wannan yanayin, CoV na bats yana aiki ne a matsayin ɓoye na HCoV.
Bugu da ƙari, saurin juyawa da kuma sake haɗuwa da kwayoyin halitta suna motsa juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko rasa sabon furotin mai ƙonewa zai iya canja yanayin ƙwayar cuta sosai.
Daga cikin masu amfani da SARS-CoV, ana zargin cewa ORF8 yana da muhimmiyar rawa wajen daidaitawa ga mutane saboda an gano cewa kwayar cutar SARS-CoV ta kwayar cutar ta kwayar cutar tana da nauyin kwayoyin ORF8.
SARS-CoV tare da halaye na kawar da nucleotides 29 an samo su a cikin nau'in da aka keɓance a farkon annobar mutum.
Wannan kawar ta raba ORF8 zuwa ORF8a da ORF8b kuma ana zaton shi ne juyin halitta mai dacewa wanda ke tallafawa sauyawar mai masaukin baki.
Bugu da ƙari, SARS-CoV na iya samun tarihin sake haɗuwa da zuriyar alpha-CoV da gamma-CoV, tare da ƙananan yankunan sake haɗuwa da aka gano a cikin RNA polymerase wanda ya dogara da RNA.
An kuma gano wuraren da aka sake yin amfani da su a nsp9, mafi yawan nsp10, da kuma wasu nsp14.
Hakazalika, an nuna cewa an yi rikibin tsakanin zuriyar da ke faruwa a cikin annobar MERS-CoV, wanda ya faru a cikin raƙuman Arabiya a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na sake haɗuwa a cikin sauran HCoVs inda HCoV ke sake haɗuwa da CoV na sauran dabbobi a cikin gene ɗin su na ba da tsari.
Ya kamata kuma a lura cewa zaɓa na mutum zai iya haifar da canje-canje a cikin kwayoyin halitta na kwayar cuta, wanda zai iya faruwa ne ta hanyar sakin kwayar daga matsin zaɓa, kamar na tsarin rigakafi na mahaifar.
Misali na wannan sakamako shine cikakken ɓacewar ORF4 a cikin nau'in HCoV-229E na farko sakamakon kawar da nucleotides biyu.
Duk da yake ana iya lura da ORF4 cikakke a cikin kwayoyin cutar bats da raƙuma da ke da alaƙa da HCoV-229E, alpha-CoV alpaka ya nuna shigar da nucleotide guda ɗaya wanda ya haifar da sauya tsarin.
A ƙarshe, juyin halitta na HCoVs na zamani an kuma motsa shi ta hanyar matsin lamba na zaɓa a cikin mai masaukinsa.
Ana iya gano bayyanar cututtuka masu sauƙi ko marasa bayyanar cututtuka a lokacin da ake kamuwa da CoV, wanda ke nuna daidaitawar CoV da bats.
Da alama bats sun daidaita da CoV sosai a fannin jikinsu da na jiki.
Alal misali, rashin kunnawar maganin rigakafi a cikin bats zai rage cututtukan da CoV ke haifarwa.
Bugu da ƙari, an hana aikin kwayoyin halitta na kisan kai a cikin bats saboda karuwar tsarin karɓar kwayoyin halitta na NKG2/CD94 inhibitor da ƙananan matakan bayyanawar kwayoyin halitta na ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan.
Bugu da ƙari, yawan adadin oxygen mai aiki (ROS) na kwayoyin halitta na kwayoyin cuta na iya hana CoV ta sake juyawa kuma yana rinjayar gyaran exoribonuclease don haka yana ba da matsin lamba ga zaɓin don yin kwayar cutar da ke da cututtuka sosai lokacin da ta shiga cikin sabon mai masaukin.
Ƙari ga haka, ƙwayoyin CoV masu cutarwa suna iya tasowa ta hanyar sake haɗuwa, wanda ke haifar da samun sabon furotin ko kuma sabon fasalin furotin don daidaitawar mai masaukin.
Saboda haka, ba zato ba tsammani ne cewa HCoVs guda uku sun bayyana a cikin shekaru goma da suka gabata.
CoV ba shi da cututtuka ko kuma yana haifar da bayyanar cututtuka a cikin masu karɓar bakinsa, kamar su bats da raƙuma.
CoV yana yin aiki sosai ba tare da ya haifar da amsa mai ƙarfi ba.
Wannan shi ne ainihin abin da ke sa a san cewa akwai masu dauke da cutar ba tare da wata alama ba kuma hakan yana jawo mummunan kamuwa da cutar a cikin mutane.
Abubuwan da ke faruwa suna da tsanani musamman domin an yi amfani da maganin rigakafi mai tsanani da kuma hadari na cytokines, kuma ana samun mummunan lalacewar huhu idan an yi amfani da maganin rigakafi mai ƙarfi.
A wani ɓangare kuma, a cikin masu ba da alamun cutar, maganin rigakafi ya kasance ba tare da karɓar kwayar cutar ba.
Irin wannan dabarun don yanke shawarar alaƙar amsawar rigakafi na iya zama da amfani a maganin anti-SARS-CoV-2.
Maganin interferon yana da ƙarfi sosai a cikin bats.
Saboda haka, ba da interferon nau'in I, aƙalla a farkon farkon cutar SARS-CoV-2 a cikin mutane, ya kamata ya kasance mai amfani.
Bugu da ƙari, ƙwayar NLRP3 a cikin bats tana da lahani.
Saboda haka, hana NLRP3 mai kumburi tare da MCC950 na iya zama da amfani wajen magance COVID-19.
SARS-CoV-2 ya biyo bayan al'ada na SARS-CoV da MERS-CoV.
Yayin da aka gano beta-CoV na bats wanda ke da kashi 95% na homologous nucleotide tare da SARS-CoV, akwai CoV na bats wanda ke da kashi 96% na homologous nucleotide tare da SARS-CoV-2.
Ko da yake an gano cewa kunkuru da sauran dabbobi a cikin kasuwar suna dauke da kwayar cutar da ta dace da SARS-CoV, ba a gano mai ba da izinin kai tsaye ga SARS-CoV-2 ba.
An gano nau'in beta-CoV na cranberry wanda yake da kamanceceniya da SARS-CoV-2, wanda ya nuna cewa cranberry na iya zama ɗayan masu karɓar bakuncin ko kuma cranberry beta-CoV na iya ba da gudummawar ɓangarorin gene a cikin ƙarshen SARS-CoV-2.
Duk da cewa har yanzu ana tambayarsa, babu wata hujja cewa SARS-CoV-2 na mutum ne ko dai da gangan ko kuma ba da gangan ba.
CoV ya sake zama babban abin lura saboda barkewar SARS-CoV-2 kwanan nan.
Binciken CoV a cikin bats da sauran dabbobi ya canza tunaninmu game da muhimmancin asalin dabbobi da kuma tanadin dabbobi don HCoV a cikin watsawar mutum.
Akwai shaidu da yawa da suka nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun fito ne daga bats kuma an watsa su zuwa mutane ta hanyar masu karɓar bakuncin.
Idan aka yi la'akari da cewa kamuwa da cutar SARS-CoV ya fito ne daga tuntuɓar mutane da fararen fata a cikin kasuwar ruwa, ƙila rufe kasuwar ruwa da kashe duk fararen fata a ciki zai kawo ƙarshen annobar SARS.
Saboda wannan dalili, ya kamata a cire cranberries daga kasuwannin ruwa don hana watsawar zoonotic, saboda an gano wasu zuriyar beta-CoV na cranberries da ke da alaƙa da SARS-CoV-2.
Duk da haka, gaskiyar da kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar dabbobi masu rarrafe da sauran dabbobi masu shayarwa har yanzu suna da tsabta a cikin bincike na gaba.
A gefe guda, MERS-CoV ya daɗe yana cikin raƙuman Larabawa.
Wannan motar tana aiki ne a matsayin muhimmin hanyar sufuri da kuma tushen nama, madara, fata, da kuma kayan wool don al'ummar yankin.
An yi amfani da 'yan Arab a dukan Gabas ta Tsakiya da Afirka.
Saboda haka, ba za mu iya kashe dukan raƙuman don hana cutar ta MERS ba, kamar yadda aka yi a kasuwar dabbobin daji a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da cutar ta MERS, dole ne a yi cikakken tsarin samar da allurar rigakafi ga raƙuma wanda ke da tasiri ga MERS-CoV kuma ya haɗu da sauran matakan sarrafa kamuwa da cuta.
Kafin mu kawar da cutar, sabon nau'i na kwayoyin zai iya bayyana kuma ya haifar da annoba.
Akwai wasu nau'o'in cutar CoV da ke yaduwa a cikin daji.
Musamman, cutar CoV a cikin bats tana da bambancin gaske.
Akwai yiwuwar cewa waɗannan ƙwayoyin cuta na dabbobi za su iya tasowa kuma su sake haɗuwa, wanda zai haifar da fitowar sabon ƙwayoyin cuta wanda zai iya zama da sauƙi a watsa shi kuma/ko kuma ya fi mutuwa ga mutane a nan gaba.
Al'adun cin dabbobi a wasu wurare a kasar Sin ya kamata a bar su domin rage rashin bukatar mutane da dabbobi.
Da yake an samu mummunan labari game da SARS, MERS, da COVID-19, an bukaci a yi shiri da kuma tsara yadda za a magance cutar.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniyar nan tun zamanin dā.
Waɗannan ƙwayoyin cuta suna cikin ajiyarsu har sai sun sami damar yaduwa.
Ko da yake bats suna da halaye masu yawa da ke tallafawa yaduwar cutar, ana iya rage damar da mutane suke da shi na tuntuɓar bats da sauran jinsunan daji idan aka ba mutane damar guje wa dabbobi.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don samun fahimtar yanayin halittu na CoV da kuma mahaifarsa na halitta, wanda zai tabbatar da cewa yana da amfani wajen hana yaduwar dabba zuwa mutum da cututtuka masu zuwa.
A ƙarshe, hanya mafi inganci don hana cutar ta zoonosis ita ce mutum ya nisanta kansa daga yanayin halittu na yanayin yanayin da ake tattare da cutar.
Ba a gano wasu sassan da suka shafi asalin SARS-CoV-2 ba.
Na farko, idan bats suna watsa cutar SARS-CoV-2 zuwa kwayar cutar, yanayin da kwayar cutar da kwayar cutar ke raba yanayin halittu yana da muhimmanci a sani.
Na biyu, idan bats suna da matsayi na musamman wajen watsawa ga mutane, dole ne a ƙayyade yadda mutane suke hulɗa da bats.
Na uku, idan akwai wata dabba ta uku da take zama ainihin mai ba da gudummawa, dole ne a bayyana yadda ta ke hulɗa da wasu jinsuna, wato, mutane, bats, da kuma tururuwa.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, ciki har da dabbobi masu iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a yi bincike da bincike.
Ko dai kwayar cutar, ko kuma wasu dabbobi masu shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kusan irin wannan ƙwayar cutar za a iya gano ta a cikin mahaifarta a nan gaba.
Ci gaba da bincike a cikin wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman tasirin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin bincike na COVID-19 don tabbatar da cutar.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewa da kuma magance sabon kamuwa da cutar coronavirus 2019 (2019-nCoV). Wannan jagorar ya dogara da kwarewarmu kuma ya zama kyakkyawan tunani don magance cutar a duniya.
Duk da haka, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma sanarwa da iliminmu suna ƙaruwa bisa ga binciken da ake yi da kuma kwarewar asibiti; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magance su.
A cikin wannan wasiƙar, mun amsa ɗaya daga cikin maganganun da ke cikin jagorarmu kuma mun samar da sabbin ƙa'idodin bincike na asali don haƙuri da haƙuri bisa ga Jagorar Gano da Kula da COVID-19 (sarrafa ta bakwai) da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta fitar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda a halin yanzu ana kiransa cutar coronavirus ta 2019 (COVID-19) kuma an sanya wa cutar coronavirus mai tsanani na cutar ta 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawara mai sauri kuma an buga jagorar ta kan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Wannan littafin ya jawo hankali sosai tun lokacin da aka wallafa shi.
Duk da haka, ya kamata a lura cewa COVID-19 sabon cuta ne, kuma sanarwa da iliminmu suna ƙaruwa bisa ga binciken da ake yi da kuma kwarewar asibiti; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magance su.
Misali, Jagorar Bincike da Magana don COVID-19 da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta fitar (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, hukumar ta fitar da jimlar bugu bakwai tare da wasu abubuwan da aka canza sosai.
Jagorarmu ta karɓi tsokaci daga Zhou et al., sun gabatar da shawarwari masu sauƙi na ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙwararru bisa ga kwarewarsu ta asibiti.
Sakamakon aikin su ya kara da cewa akwai sabon hujja a cikin jagorarmu kuma ya zama muhimmin abin da za a yi amfani da shi wajen magance wannan annoba a duniya.
Muna goyon bayan irin wannan aikin da suka yi kuma muna nuna godiya.
Duk da haka, sakamakon aikin su na bukatar sabuntawa bisa ga sabuwar Jagorar Bincike da Gudanarwa don COVID-19 (sarrafa na bakwai) da kuma sabon binciken.
Bisa ga fitowar ta bakwai (3 ga Maris, 2020), don tabbatar da yiwuwar kamuwa da cutar, ya zama dole a haɗa ɗaya daga cikin bayanan tarihin cututtukan cututtuka tare da bayyanar cututtuka biyu don yin cikakken bincike, ko kuma ya zama dole a cika bayyanar cututtuka uku idan babu bayyanar cututtuka:
Tarihin cututtuka: (1) tarihin tafiya ko zama a birnin Wuhan da yankunan da ke kewaye da shi, ko wasu al'ummomin da aka ruwaito shari'ar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin tuntuɓar wani mutum da ya kamu da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar wani mai fama da zazzabi ko alamun numfashi daga birnin Wuhan da kewaye da shi, ko wasu al'ummomin da aka ruwaito wani mutum da ya kamu da COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin tuntuɓar wani rukuni na mutane da aka tabbatar da cutar (≥ 2 lokuta da zazzabi da/ko alamun numfashi da suka faru a cikin makonni 2 a cikin ƙananan wurare, kamar gidaje, ofis, aji na makaranta, da sauransu).
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) siffofin daukar hoto na kamuwa da cutar COVID-19; (3) jimlar adadin fararen kwayar jini ya nuna yawan kwayoyin halitta na yau da kullum, sun ragu, ko sun ragu a farkon matakin daukar ciki.
Gano wani sanannen labari ya kamata ya dogara da wani sanannen labari tare da wata hujja ta hanyar cututtuka ko kuma na serological kamar haka: (1) gwajin PCR na ainihi mai kyau ga SARS-CoV-2; (2) jerin kwayoyin cuta na dukkanin kwayoyin cuta sun nuna babban homogeneity ga sabon coronavirus da aka sani; (3) tabbatacce ga takamaiman IgM antibodies da IgG antibodies ga SARS-CoV-2 a cikin gwajin serum; ko canji na musamman IgG antibodies-SARS-CoV-2 daga mummunan zuwa tabbatacce, ko kuma titers ya karu ≥4 sau a lokacin dawowa a kan matakan a cikin mataki na gaggawa.
Mun ga cewa an ƙara gwajin PCR na ainihin lokacin nucleic acid a cikin samfurin numfashi ko jini a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara da cewa an gano cututtukan a cikin jinin a fitowar na hudu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020); sannan kuma an kara da cewa an kara da cewa an samu tabbacin cutar a fitowar na bakwai.
Wannan gyare-gyare ya dogara ne akan ci gaba da bincike na masu bincike don neman kayan gano nucleic acid mafi kyau don ganewar asali mai sauri, da kuma samfurin numfashi wanda ya haɗa da karɓar jini, wanda ya kara wadatar samfurori daban-daban, kuma ya goyi bayan shigar da sakamakon sakamako na musamman na antibodies cikin ingantattun ka'idoji.
Bugu da ƙari, akwai ƙarin tabbaci da ke gargaɗe mu mu yi hankali da marasa lafiya da ba su da alamun bayyanar cututtuka.
Saboda haka, ya kamata a sabunta jadawalin Zhou et al. domin sun ƙayyade mutanen da ba su da alamun asibiti a matsayin masu haɗari.
Za a kuma bukaci a tabbatar da tsarin a cikin ayyuka da kuma nazarin asibiti na nan gaba.
A ƙarshe, muna fata cewa za a sami ƙarin hujja kai tsaye kuma mu nemi masu karatu su ba da amsa.
Don ganewar asali na mutum da aka tabbatar, muna ba da shawarar bin kuma bi sabon jagororin da ke cikin ƙasarmu.
Ƙungiyarmu za ta sabunta jagororinmu a kai a kai don taimaka mana.
Bangladesh ta samu sabbin mutum biyar da suka mutu sakamakon COVID-19, wanda ya kai matsakaicin adadin mutuwar yau da kullum
Jiya, Bangladesh ta tabbatar da wasu mutane biyar da suka mutu sakamakon COVID-19 a wannan rana.
Wannan shi ne adadin mutuwar da aka samu a rana daya sakamakon cutar.
Har zuwa jiya, Cibiyar Epidemiology, Control da Research na Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin adadin adadin kamuwa da cutar da aka samu, wanda ya haɗa da mutane 114 da suka kamu da cutar da kuma mutane 33 da suka warke daga cutar da ke cikin gida.
An yi sanadiyar mutuwar mutane 17.
A wani labari na kan layi, darektan IEDCR, Dokta Meerjady Sabrina Flora, ta ce mutuwar ta shafi maza hudu da mace guda.
A cewar Dr Meerjady, mutane biyu sun kai shekara 60, wasu biyu sun kai shekaru 51 zuwa 60, kuma wani ya kai shekaru 41 zuwa 50.
Ya kuma ce wasu daga cikin wadanda suka mutu sun fito ne daga birnin Dhaka.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Wani jami'in asibitin ya shaida wa Anadolu Agency, wata ofishin yada labarai na gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani bidiyo na yanar gizo, Ministan Sufuri da Hanyoyin Hanyar Hanya, Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
Wannan dakatarwar ta fara ne a ranar 26 ga watan Maris kuma an shirya ta ta ƙare a ranar Asabar, 4 ga Afrilu.
Ana iya kawo kayayyakin da ake bukata, kamar su magani da man fetur da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga watan Maris, a cikin mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu.
A ranar 19 ga Maris, waɗannan mutane uku sun warke.
Cutar SARS-CoV-2 ta wuce miliyan daya a duniya
A ranar Alhamis, jimlar adadin mutane da suka kamu da cutar korona ta SARS-CoV-2 ta wuce miliyan daya a duniya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutuwar dubu 52 na mutane ne ke da alaƙa da COVID-19, cutar da ke haifar da kwayar cutar korona.
Wannan ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko da kuma Zambia ta fara mutuwa sakamakon cutar korona.
Koriya ta Arewa ta ce, a ranar Alhamis, ita ce daya daga cikin 'yan kasashen da suka tsira daga kamuwa da cutar korona.
Har zuwa jiya, Hukumar Lafiya ta Duniya (WHO) ta ba da rahoton mutane 1,051,635 da aka tabbatar da cutar, ciki har da mutane 79,332 a cikin awanni ashirin da hudu tun daga karfe 10 na safe na Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu fiye da 244,000 na kamuwa da cutar korona, wanda ya haifar da mutuwar akalla 5,900.
Ofishin yada labarai na CBS ya ruwaito, wanda ya yi amfani da bayanan jami'ar Johns Hopkins, cewa akwai mutuwar sama da 1,000 a Amurka sakamakon kamuwa da cutar korona.
A faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cututtuka.
A ranar Alhamis, magajin birnin Moscow, Sergei Sobyanin, ya tsawaita dokar hana fita ta yankin har zuwa ranar 1 ga Mayu.
A kasa, Shugaba Vladimir Putin ya bayyana cewa za a biya 'yan Rasha ba tare da su je aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta yi kuri'a don tsawaita dokar ta baci ta kasa har tsawon kwanaki 15; an yi ta ne da kuri'u 215 a baya, goma a baya, kuma guda a baya.
Saudiyya ta tsawaita sa'o'in dare a cikin biranen Makka da Madina har zuwa rana; a baya, sa'o'in dare suna aiki ne kawai tsakanin 3 na yamma da 6 na safe.
Thailand na shirin yin amfani da sa'o'i na dare tsakanin 10 na dare da 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun rage yawan sayen tawul a kowace ma'amala
A ranar Lahadi da kuma ranar Asabar da yamma, cibiyoyin kantunan Australiya Woolworth da Coles sun rage yawan sayen tawul zuwa biyu da kuma fakiti daya a kowace ma'amala a duk shagunan da ke cikin ƙasa.
ALDI ta kuma kafa dokar hana yin amfani da kayan kwalliya guda daya a ranar Litinin.
An sanar da wannan takunkumin a matsayin sako a cikin akwatin ajiya da kuma shafin Facebook na cibiyar sadarwa.
An ruwaito masu sayen suna tara kayayyaki saboda tsoron COVID-19 idan jama'a za su yi zaman kansu.
A ranar Laraba, kamfanin Woolworths ya kuma ƙuntata sayan tawul ɗin gida don jigilar kaya zuwa fakiti ɗaya a kowane tsari.
Wannan canjin ya biyo bayan takunkumin da aka yi wa Woolworths da Coles a ranar 4 da 5 ga Maris.
A wata sanarwa da ta fitar a ranar 8 ga watan Maris, Coles ya ruwaito cewa, da aka yi wa takunkumin takunkumin guda hudu, "manyan shagunan har yanzu suna cike da kaya cikin sa'a daya daga ranar da aka kawo su", kuma ya ce wannan bukatar "ba ta taba faruwa ba", yayin da ALDI, a wani sakon Facebook a ranar Talata, ya kira shi "ba zato ba tsammani".
Wani mai magana da yawun kamfanin Woolworths ya ce, tallace-tallace sun ƙaru sosai a makon da ya shige.
Costco store a Canberra kuma ya takaita adadin da aka ba da izinin zuwa fakiti biyu a makon da ya gabata.
Don kauce wa ƙarancin, Coles ya ba da umarni ga manyan fakitoci daga masu samarwa kuma ya haɓaka yawan aikawa, Woolworths ya ba da umarni ga ƙarin kaya, yayin da ALDI ta ba da kayan aiki don ayyukan gabatarwa na musamman na Laraba a wuri.
Russell Zimmerman, shugaban ƙungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna ƙoƙari su ƙara yawan kayayyaki, amma ƙuntatawa na hukumomin gida game da lokacin jigilar kaya yana sa ya yi wuya.
Ya yi hasashen cewa farashin samarwa zai ƙaru, yayin da masu samarwa ke ƙoƙarin biyan bukatar, kuma ba za a yi wasu tallace-tallace na musamman ba.
A ranar Talata, ALDI ta sanar da cewa saboda ta saki kayayyakin da wuri, wasu shagunan ba za su iya yin ranar Laraba ta musamman ba.
A wani rahoto da aka wallafa a News.com.au, Dokta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce, shaguna suna cike da kayayyaki a kowace dare.
Ya ce, kayan wanka suna da yawa sosai don haka yawan kayayyakin da ake samu ba su da yawa kuma idan aka sayar da su, suna sa a yi amfani da su sosai don a ƙara samun kayayyaki da yawa.
Coles da Woolworths sun yi jayayya cewa idan akwai abubuwa da yawa a kan ɗakunan ajiya, idan ana iya sayen kayayyaki kamar tawul da kayan wanka, kuma ana iya samun su a adadi mai yawa, za a iya rage tsoro, in ji Russel Zimmerman ta ABC News.
Mai kera kayan wanka mai amfani da kayan wanka wanda ke ba da kayan wanka ya ce a ranar Laraba da ta gabata cewa sun rasa kayayyakin.
Kimberly-Clark, wanda ya yi Kleenex Toilet Fabric, da Solaris Paper, wanda ya yi Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye kayayyakin, in ji rahoton News.com.au.
Domain.com, wani shafin yanar gizon gidaje, ya ruwaito cewa wasu masu sayar da dukiya suna ba da tawul na gida kyauta ga masu yin hayar farko a Melbourne, yayin da aka yi wasu ƙananan gwanjo saboda masu sayen suna yin hutu don dogon karshen mako na ranar aiki.
Labarin ranar Alhamis na NT News, wata jarida da ake buga a Darwin, ya ƙunshi shafuffuka takwas na abin da ake sakawa da ake so a yanka su kuma yi amfani da su a matsayin tawul.
A cewar wani rahoto da aka bayar a ranar 3 ga Maris, ABC ta Australia, shagunan sun ƙi yin amfani da wannan dokar, sun ce ba su da niyyar yin amfani da wannan dokar.
Russell Zimmerman ya ƙara da cewa wasu kayayyakin suna da girma a bukatar, ciki har da masks, kayan shafawa, abinci mai bushewa, sabulu na wanke hannu, da kuma gari.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma, an lura cewa wani babban kanti na Ocado a Burtaniya ya ƙuntata sayen tawul ɗin Andres zuwa fakiti biyu da ke ɗauke da abubuwa 12.
Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar cutar COVID-19 da ke faruwa a matsayin cuta ta coronavirus SARS-CoV-2 a matsayin annoba.
Ko da yake kalmar "zazzabin cuta" tana nufin yadda cutar ta yadu, ba yadda cutar ta yi muni ba, WHO ta lura da bukatar ƙarfafa gwamnatoci su yi aiki:
Dukkanin kasashe na iya canza yanayin annobar.
Idan jihohi suka gano, suka gwada, suka magance, suka ware, kuma suka yi wa al'ummarsu aiki a matsayin martani, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Mun yi hattara sosai saboda yawan yaduwar da kuma mummunan halin da ake ciki da kuma rashin jinkirin da ake ciki.
A cewar Dr. Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka a Amirka, wannan annoba "ba ta taɓa faruwa ba".
A wani rahoto da CNN ta wallafa a watan Fabrairu, ta ce, "ba a taɓa bin diddigin wani kwayar cutar da ta shafi numfashi ba, banda cutar influenza, daga lokacin da ta fara zuwa ci gaba da yaduwar ta duniya".
Ghebreyesus ya yi irin wannan furucin, yana cewa "ba mu taɓa ganin annobar coronavirus ba".
Ya ci gaba da cewa, "kuma ba mu taɓa ganin annobar da za a iya sarrafawa a lokaci guda ba".
Sabuwar annobar ta biyo bayan wani hukunci na WHO a watan Janairu wanda ya bayyana cutar a matsayin wata matsala ta lafiyar jama'a da ke damun duniya.
Dokta Anthony Fauci, shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasar Amirka, ya ce game da annobar, "ainihin, za ta yi muni".
A ranar Alhamis, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar mutane sama da 4,600.
Cutar coronavirus ta 2019-2020 annobar cutar coronavirus ta 2019 (COVID-19) ce da ke gudana kuma ana haifar da cutar coronavirus ta cutar ta 2 (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disambar 2019, an bayyana ta a matsayin Rikicin Lafiya na Jama'a wanda ya shafi Duniya a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya haifar da mutuwar kusan 97,000.
An warkar da mutane 364,000.
An kiyasta yawan mutuwar mutane da kashi 4 cikin 100 a kasar Sin, yayin da a duniya yawan mutuwar mutane ya kai kashi 13.04 cikin 100 zuwa 0.08 cikin 100 a New Zealand.
Alamun da ake nunawa a yau sun ƙunshi zazzabi, tari, da kuma rashin numfashi.
Abubuwan da za su iya sa mutum ya yi rashin lafiya sun haɗa da cutar pneumonia da kuma ciwon hanta na numfashi.
Lokaci daga bayyanar zuwa bayyanar cututtuka yana da kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu wani magani ko maganin rigakafi da aka sani.
Ana ba da shawarar yin amfani da maganin hanawa da kuma maganin hanawa, wato, wanke hannu, rufe baki sa'ad da kake tari, ka nisanta kanka daga mutane, da kuma kula da waɗanda ake zargi da kamuwa da cutar.
Hukumomi a faɗin duniya sun amsa da kafa takunkumi na tafiya, killace mutane, sa'o'i na dare, hana haɗarin aiki, da kuma rufe wuraren aiki.
Wannan annoba ta haifar da mummunan rikice-rikice na zamantakewar tattalin arziki na duniya, jinkirta ko soke ayyukan al'adu, siyasa, addini, wasanni, da kuma yawan karancin kayayyaki da aka kara da yawa ta hanyar sayayya mai tsananin tsoro.
Makarantu da jami'o'i sun rufe a ƙasashe da ƙasashe 193, wanda ke shafar kashi 99.4 cikin ɗari na yawan ɗaliban duniya.
Rashin fahimta game da cutar ta bazu a kan layi kuma akwai wasu lamuran rashin jin daɗin jama'a da nuna bambanci ga Sinawa, mutanen da ke fitowa daga gabashin Asiya da kudu maso gabashin Asiya da kuma mutanen da ke fitowa daga yankunan da ke da alamun cutar.
Saboda rage tafiye-tafiye da kuma rufe manyan masana'antu, gurɓataccen iska da kuma iskar carbon sun ragu.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei), sun ruwaito wani rukuni na cututtukan huhu da ba a san dalilin ba a ranar 31 ga Disamba, 2019 kuma an gudanar da bincike a farkon watan Janairu, 2020.
Yawancin lokuta suna da alaƙa da babbar kasuwar Huanan Seafood da kuma saboda haka ana zargin cewa cutar tana da asalin zoonotic.
An kira cutar da ta haifar da annobar SARS-CoV-2, sabon kwayar cutar da ke da alaƙa da kwayar cutar bat, kwayar cutar coronavirus, da SARS-CoV. Mutumin da ya fara kamuwa da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da wata alama ta ruwa da aka ambata a baya.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku na wadanda aka samu suna da alaƙa da kasuwar.
A ranar 13 ga watan Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya kiyasta cewa wani mutum mai shekaru 55 daga lardin Hubei, wanda za a iya ganowa zuwa 17 ga watan Nuwamba, 2019, zai iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ruwaito cewa, tare da sabon adadin da aka ruwaito ya ragu a China, amma ya karu a Italiya, Iran, da Koriya ta Kudu, adadin sabbin cututtuka a waje da China ya zarce adadin sabbin cututtuka a cikin China a karon farko.
Akwai yiwuwar cewa akwai wasu mutane da yawa da ba a ba da rahoto ba, musamman ma a cikin mutanen da suka fi rashin lafiyarsu.
Har zuwa 26 ga Fabrairu, ƙananan adadin lokuta ne aka ruwaito tsakanin matasa, tare da mutanen da ke ƙasa da shekaru 19 suna yin kashi 2.4% na lokuta a duk duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya suna buƙatar kamuwa da cutar kafin rigakafin rukuni ya isa.
Wannan ya shafi adadin mutanen da suka gwada COVID-19 kuma an tabbatar da sakamakon gwajin a cikin tsarin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawanta, kuma ƙasashe da yawa sun kafa manufofin da ba za su gwada mutane da ƙananan alamun ba, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga Maris ya gano cewa a kasar Sin, har zuwa 23 ga Janairu, an kiyasta cewa kashi 86 cikin 100 na kamuwa da cutar COVID-19 ba a gano ta ba, kuma wannan kamuwa da cutar da ba a rubuta ba ita ce tushen kamuwa da cutar ga kashi 79 cikin 100 na kamuwa da cutar da aka rubuta.
Wani bincike na kididdiga da aka wallafa a ranar 30 ga Maris ya nuna cewa adadin kamuwa da cuta a Italiya ya fi yawan wadanda aka ruwaito.
Kwanan farko na yawan haihuwa (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa hakan zai iya zama 5.7.
Yawancin mutanen da ke fama da cutar COVID-19 sun warke.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14.
Tun daga ranar 10 ga Afrilu, 2020, an yi kusan mutuwar 97,000 da ke da alaƙa da COVID-19.
A kasar Sin, har zuwa 5 ga Fabrairu, kimanin kashi 80% na mutuwar sun faru ne a cikin mutanen da suka wuce shekaru 60 kuma kashi 75% suna da cututtukan kiwon lafiya na baya, wanda ya haɗa da cututtukan zuciya da ciwon sukari.
Adadin mutuwar da ake samu daga COVID-19 na iya zama mafi girma, tun da ba a haɗa da waɗanda suka mutu ba tare da an gwada su ba, misali, a gida, a cikin gidajen kulawa, da sauransu.
Bayanai na Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar COVID na hukuma da kashi 4-5 na yawan.
Wata mai magana da yawun cibiyar kula da cututtuka ta Amurka ta amince, "Mun san [ƙididdigar mutuwar da aka sanar] ta fi ƙarancin adadin", sanarwa da aka karfafa ta da rahotanni na rashin ilimin kimiyya game da ƙididdigar ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga Fabrairu, a wajen ƙasar Sin, an yi fiye da goma sha biyu da suka mutu a Iran, Koriya ta Kudu, da kuma Italiya.
A ranar 13 ga Maris, fiye da kasashe arba'in da yankuna sun ba da rahoton mutuwar, a kowace nahiya, sai dai Antarctica.
Wannan adadi ya bambanta bisa ga yankuna da kuma tsawon lokaci, kuma yana shafar yawan gwaji, ingancin tsarin kula da lafiya, zaɓin kulawa, lokacin da aka fara barkewar cutar, da kuma yanayin yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane zuwa shari'o'i a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan ya bambanta daga yanki zuwa yanki.
A kasar Sin, an kiyasta cewa adadin mutuwar mutane a cikin cutar ya ragu daga kashi 17.3 cikin dari (ga mutanen da ke da cututtukan cututtuka na 1-10 ga Janairu 2020) zuwa kashi 0.7 cikin dari (ga mutanen da ke da cututtuka na tsawon lokaci bayan 1 ga Fabrairu 2020). Sauran ma'auni sun haɗa da adadin mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu saboda wata cuta, da kuma adadin mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da ke da cutar (masu gano da marasa gano) waɗanda suka mutu saboda wata cuta.
Wannan ƙididdigar ba ta da iyaka a kan lokaci kuma tana bin wani yanki na al'umma daga kamuwa da cuta zuwa warwarewar hali.
Wasu masana kimiyya sun yi kokarin lissafa wadannan lambobi ga wasu al'ummomi.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cuta a cikin annobar ta kasance tsakanin kashi 0.1 zuwa 0.39%.
Wannan iyaka ta sama ta jitu da sakamakon gwajin farko na COVID-19 a Jamus da kuma binciken kididdiga wanda ya bincika tasirin gwajin akan kimantawar CFR.
WHO ta tabbatar da cewa za a iya sarrafa cutar.
Ba a san lokacin da cutar za ta kai ba kuma za ta iya bambanta daga wuri zuwa wuri.
Maciej Boni daga Jami'ar Penn State ya ce: "Ba tare da a sarrafa shi ba, annoba tana saukowa a hankali kuma tana raguwa sa'ad da mai watsa shiri ya ƙare.
Amma, ba zai yiwu a yi hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhong Nanshan, ya yi jayayya cewa "za a iya kawo karshen annobar a watan Yuni" idan an yi wa dukan kasar ta ja-gora don bin shawarar WHO game da matakan da za a dauka don hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Lafiya ta London ya bayyana cewa SRS-CoV-2 "zai ci gaba da yaduwa, mai yiwuwa har zuwa shekara guda ko biyu".
A cewar wani bincike da aka yi a Kwalejin Imperial da Neil Ferguson ya gudanar, za a bukaci a yi wasu ƙuntatawa na jiki da kuma wasu matakai "har sai an samu allurar (mai yiwuwa watanni 18 ko fiye)".
William Schaffner daga Jami'ar Vanderbilt ya ce: "Ina ganin cewa akwai yiwuwar cewa cutar coronavirus, saboda tana da sauƙin kamuwa da ita, za ta iya ɓacewa gaba ɗaya" kuma wannan cuta "zai iya zama wata cuta ta yanayi, wadda za ta dawo kowace shekara".
Ana iya ganin cewa cutar ta sake faruwa ne bisa ga tsarin rigakafin da ke tsakanin mutanen da suka kamu da cutar da kuma yadda suka samu bambancin da ke tsakanin su.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma waɗanda suka kamu da cutar ba su da alamun cutar.
Abubuwa biyu da suka fi kowa a cikin mutane sun fi kowa a cikin mutane yawanci za su iya sa su ji zazzabi (88%) da kuma tari (68%).
Alamun da ba a saba gani ba sun haɗa da gajiya, samar da sputum na numfashi (flegma), rashin numfashi, numfashi, ciwon gwiwa da na tsoka, ciwon wuya, ciwon kai, yin rawar jiki, zubar da jini, diarrhea, ko cyanosis. WHO ta ce mutum ɗaya cikin shida yana fama da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) na Amirka sun lissafa alamun gaggawa da suka shafi numfashi mai wuya, damuwa ko ciwon kirji na kwance, rikicewar taƙaice, wahalar tafiya, da kuma launin shuɗi a fuska da lebe; ana ba da shawarar gaggawa idan waɗannan alamun sun bayyana. Ƙarin ci gaban cutar zai iya zama mummunan cutar huhu, acute respiratory syndrome, sepsis, septic shock, da mutuwa.
Wasu mutane da suka kamu da cutar za su iya zama marasa lafiya, wato ba su da alamun asibiti, amma idan an gwada su da suka tabbatar da cewa suna da cutar, masu bincike sun ba da shawarar cewa a saka idanu sosai ga waɗanda suka yi kusa da waɗanda suka kamu da cutar kuma a bincika su don tabbatar da cewa ba su da cutar.
Masana Sin sun kiyasta cewa asymptomatic rabo ya kasance daga wasu zuwa 44%.
Lokacin kamuwa da cuta (lokacin da ke tsakanin kamuwa da cuta da kuma bayyanar cututtuka) yawanci yana tsakanin kwanaki 1 zuwa 14, yawanci kwanaki 5. Alal misali, rashin tabbas, ƙididdigar yawan mutanen da ke fama da cutar COVID-19 da suka rasa numfashi da farko ya kai 30%, sannan ya ragu zuwa 15%.
Ana ci gaba da nazarin yadda wannan cuta take yaduwa.
An yi imanin cewa yaduwar COVID-19 tana faruwa ne a lokacin da aka yi kusa da shi kuma ta hanyar ƙananan digo da aka samar yayin da yake tari, yin kumburi, ko magana; kusanci shine lamba a cikin mita 1 zuwa 2 (3 zuwa 6 feet).
Wani bincike ya gano cewa, coughing da ba a rufe shi ba zai iya sa a tura ruwa da ya kai mita 15 zuwa mita 8.2.
Wasu masu bincike sun yi zaton cewa ƙwayoyin cuta na iya zama karamin saukad da ke cikin iska wanda ke wucewa tsawon lokaci kuma ana samar da shi lokacin magana. Ƙwayoyin numfashi na iya zama lokacin numfashi, ciki har da lokacin magana, ko da yake ba a yawan watsa su ta iska.
Sa'ad da aka yi amfani da ruwa, zai iya shiga cikin bakinsa ko hancin mutumin da ke kusa da shi ko kuma ya shiga cikin huhu.
Wasu hanyoyin magani, kamar su intubation da kuma sake numfashi na zuciya (RJP), suna iya sa numfashi ya zama aerosol kuma ya bazu ta iska.
Ƙari ga haka, za a iya samun yaduwar idan mutum ya taɓa wani abu da ya kamu da cutar, har da fata, ya kuma taɓa idanunsa da hanci da kuma bakinsa.
Duk da cewa akwai damuwa cewa cutar za ta iya yaduwa ta hanyar fitsari, ana ganin wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar maganin mahaifa. Virusi ya fi kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin ci gaba da cutar.
Mutane sun ba da sakamako mai kyau har kwana uku kafin bayyanar cututtuka, wanda ke nuna cewa za a iya samun yaduwar kafin bayyanar cututtuka.
Rahotanni kaɗan ne kawai na asymptomatic da aka tabbatar da su a cikin dakin gwaje-gwaje, amma an gano asymptomatic transmission ta wasu ƙasashe a lokacin binciken binciken tuntuɓar.
Cibiyoyin Turai don Rigakafin Cututtuka da Kulawa (ECDC) sun bayyana cewa ko da yake ba a san yadda cutar ta iya yaduwa ba, mutum ɗaya yana kamuwa da mutane biyu zuwa uku.
Musamman, an gano cewa ana iya gano cutar har zuwa kwana uku a kan filastik (polypropylene) da kuma bakin karfe 304, kwana ɗaya a kan kwali, da kuma fiye da sa'o'i huɗu a kan tagulla.
Amma, wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun gwada COVID-19 mai kyau.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, ko da yake hukumomin Birtaniya sun ba da shawarar wanke hannuwan bayan sun haɗu da dabba, kamar bayan sun haɗu da farfajiya da wataƙila ta taɓa mutumin da ke da cutar.
Cutar coronavirus ta cutar ta 2 (SARS-CoV-2) sabon kwayar cuta ce, wacce aka fara warewa daga cikin mutane uku da ke fama da cutar huhu da ke da alaƙa da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin siffofin SARS-CoV-2 na sabon kwayar cutar suna da alaƙa da coronavirus a cikin yanayi. A waje da jikin mutum, cutar tana iya lalacewa idan aka yi amfani da sabulu na gida, wanda ke warware ambulaf ɗin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
An yi imanin cewa kwayar cutar ta zoonotic ne.
Binciken kwayoyin halitta ya nuna cewa coronavirus ya kasance a cikin kwayoyin halitta tare da nau'in Betacoronavirus, a cikin subgenus Sarbecovirus (layin zuriya B) tare da nau'i biyu na zuriyar bats.
Wannan kwayar cutar tana da daidaituwa 96% a cikin dukkanin kwayoyin halitta tare da sauran samfurori na kwayar cutar bat (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a wasu sassan tsarin genomic tsakanin kwayar cutar tangerine da kwayar cutar mutum.
Har zuwa yanzu, kwatancen dukkanin kwayoyin halitta ya gano cewa akwai kusan 92% na kamanceceniya tsakanin kwayar cutar coronavirus da SARS-CoV-2, ba isa ya tabbatar da cewa kwayar ita ce mai karɓar bakuncin SARS-CoV-2 ba.
Ana iya gano kamuwa da cutar ta ɗan lokaci bisa ga bayyanar cututtuka, amma a ƙarshe ana tabbatar da ita ta hanyar jujjuyawar tsarin polymerase na jujjuyawar (rRT-PCR) a cikin asirin da aka kamu da shi ko kuma ta hanyar yin CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT tana da matukar damuwa fiye da PCR, amma ba ta da ƙayyadaddun bayanai, tare da siffofin daukar hoto da yawa da ke hade da cutar pneumonia da sauran cututtukan cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amirka ta ba da shawarar "Kada a yi amfani da CT don tacewa ko a matsayin gwajin farko a cikin gano COVID-19".
WHO ta wallafa wasu takardun shaida na gwajin RNA don SARS-CoV-2, wanda aka fara rarraba a ranar 17 ga Janairu.
Gwajin yana amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR).
Ana iya gwada shi a kan samfurori na numfashi ko kuma jini.
Ana samun sakamako a cikin sa'o'i ko kwanaki.
Ana yin wannan gwajin ne a kan nasopharyngeal swab, amma ana iya yin amfani da su a kan hanci.
A ranar 6 ga Afrilu, 2020, babu wani daga cikin waɗannan gwaje-gwajen da aka tabbatar da cewa sun isa su zama daidai don a amince da su a cikin amfani da su.
A Amirka, gwajin da Cellex ta yi na gaggawa ya amince da shi don gaggawa, amma gwaje-gwaje ne kawai suka amince da shi.
Halin da ake nunawa na daukar hoto na radiography da kuma daukar hoto na computed tomography (CT) a cikin mutane masu bayyanar cututtuka ya hada da rashin daidaituwa na gefen gefen gilashin da ba a yi wa pleura ba.
Kungiyar Radiological ta Italiya tana tattara bayanai na kan layi na duniya don gano hotunan da aka tabbatar da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, hotunan hoto ba tare da tabbacin PCR ba yana da iyakantaccen ƙayyadaddun bayanai game da gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa duk da cewa bai dace da kamuwa da cuta ba, daukar hoto ya fi sauri kuma ya fi dacewa don haka an ba da shawarar yin la'akari da shi azaman kayan tacewa a yankin annobar.
An yi amfani da fasaha ta wucin gadi wajen gano siffofin hoto na cutar ta hanyar daukar hoto da kuma CT.
Hanyoyi na hana kamuwa da cutar sun haɗa da tsabtace mutum sosai, wanke hannu, guje wa taɓa idanu, hanci, ko baki kafin wanke hannu, kuma yin amfani da tawul a lokacin tari ko kumburi da kuma jefa tawul a shara.
Ana ba da shawarar cewa waɗanda suka kamu da cutar su saka abin rufe fuska a wuraren da jama'a suke.
Gwamnatoci a yankuna da dama sun iyakance ko kuma sun bukaci a dakatar da duk wani tafiya mara mahimmanci zuwa da kuma daga ƙasashe da yankunan da cutar ta shafa.
Amma, cutar ta riga ta kai matakin da ta shafi yawancin al'ummomi a yawancin yankunan duniya.
Wannan yana nufin cewa cutar ta riga ta bazu cikin al'umma, kuma wasu 'yan al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar cewa masu ba da kula da lafiya da ke kula da mutanen da za su iya kamuwa da cutar su ɗauki matakan kariya na yau da kullun, matakan kariya daga tuntuɓar, da kuma kariya daga ido. Kula da tuntuɓar yana da muhimmanci ga hukumomin kiwon lafiya don gano tushen kamuwa da cuta da hana ci gaba da yaduwa.
Amfani da gwamnati da bayanan wuri daga wayoyin salula don wannan dalili ya haifar da matsalolin sirri, tare da fitowar sanarwa daga Amnesty International da fiye da kungiyoyi 100 da ke kira ga iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu daban-daban ko kuma an ba da shawarar yin amfani da su a kan sadaukarwa, kuma a ranar 7 ga Afrilu, 2020, fiye da rukuni na masana sun yi aiki kan hanyoyin da ke da alaƙa da tsare sirri, kamar amfani da Bluetooth don yin rikodin yadda mai amfani yake kusa da sauran wayoyin hannu.
Bayan haka, masu amfani za su karɓi saƙo idan sun kasance kusa da wani wanda ya gwada tabbatacce ga COVID-19. Akwai rashin fahimta game da yadda za a hana kamuwa da cuta; misali, wanke hanci da kuma yin wanka da maganin wanka ba shi da tasiri.
Babu allurar rigakafin COVID-19 a yanzu, duk da cewa kungiyoyi da dama suna aiki don bunkasa ta.
Ana ba da shawarar yin wanka a hannu don hana yaduwar cututtuka.
Hukumar kula da lafiyar jiki ta ce a riƙa wanke hannuwanmu da sabulu da ruwa na tsawon sa'o'i ashirin ko fiye, musamman bayan sun fita daga gidan wanka ko kuma sun yi wanka; kafin su ci abinci; da kuma bayan sun shiga cikin hanci, sun yi tari ko sun yi kumburi.
Wannan shi ne dalilin da ya sa, a waje da jikin mutum, sabulu na gida ke kashe kwayar cutar kuma yana lalata jikinta.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da maganin hana shan giya na hannu da ya ƙunshi aƙalla kashi 60 cikin ɗari na giya bisa ga ƙarar lokacin da sabulu da ruwa ba su da.
Hukumar Lafiya ta Duniya ta ce kada mutum ya taɓa idanunsa ko hanci ko bakinsa kafin ya wanke hannu.
Ana iya lalata farfajiya ta amfani da wasu magunguna (a cikin minti daya na lalata lalatawar farfajiya don farfajiyar bakin karfe), ciki har da ethanol 6271%, isopropanol 50100%, sodium hypochlorite 0.1%, hydrogen peroxide 0.5%, da povidone-iodine 0.27.5%.
Sauran maganin, kamar benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai.
Hukumar ta bayar da shawarar cewa idan akwai wasu lokuta da aka samu ko kuma an tabbatar da cutar COVID a wuraren jama'a, kamar ofisoshin ko wuraren kula da yara, a yi amfani da maganin rigakafi a duk wuraren da ake amfani da su kamar su ofisoshin, dakunan wanka, wuraren da ake amfani da su, da kuma na'urorin lantarki kamar kwamfutar hannu, allon tabawa, keyboard, na'urorin sarrafawa na nesa, da na'urorin ATM da masu cutar ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa a rufe bakinsu da hancinsu da ƙuƙwalwa ko kuma a yi amfani da takalma a lokacin da suke tari ko kuma suna zubar da takalma, kuma a yi watsi da takalma nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga mutanen da suka kamu da cutar domin yin amfani da shi zai iya rage yawan jini da kuma nisan da za a iya samu daga hawan numfashi yayin magana, yin kumburi, da kuma tari.
Hukumar lafiya ta duniya ta fitar da umarnin a kan lokacin da za a yi amfani da abin rufe fuska.
Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, ya ce: "Samun abin rufe fuska zai iya rage yawan mutanen da suke taɓa fuskarsu da hannayensu marasa tsabta, wanda shi ne tushen kamuwa da cutar".
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska ga mutane masu lafiya kawai idan suna da haɗari, kamar waɗanda ke kula da masu cutar COVID-19, kodayake WHO ta kuma yarda cewa yin amfani da abin rufe fuska na iya taimakawa wajen hana mutane taɓa fuskarsu.
Wasu ƙasashe sun fara ƙarfafa amfani da abin rufe fuska ga 'yan ƙasa.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likita wanda ba a yi shi da masana'anta ba. China ta ba da shawarar yin amfani da abin rufe fuska na likita na musamman ga jama'a masu lafiya, musamman idan suna kusa da (1 mita (3 feet) ko ƙasa da haka) da wasu.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata a lokacin amfani da sufuri na jama'a ko kuma lokacin da kake zama a wurin da mutane suke yawa.
Jami'an lafiya a Thailand sun ƙarfafa mutane su yi wa kansu masks a gida kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun hana jama'arta fita a wuraren da ba su da masks ko rufe hanci da bakinsu.
A ranar 16 ga Maris, Vietnam ta bukaci dukan 'yan kasar ta su saka abin rufe fuska a lokacin da suke zuwa wuraren da jama'a ke zuwa don kare kansu da kuma wasu.
Gwamnatin Austriya ta bukaci duk wanda ya shiga cikin gidan ajiye motoci ya saka abin rufe fuska.
Isra'ila ta bukaci dukan 'yan kasar ta su saka abin rufe fuska a wuraren da jama'a suke.
Taiwan, wadda ta samar da masks miliyan 10 a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas na gari-garden su saka masks na fuska daga ranar 1 ga Afrilu.
Panama ta tilasta yin amfani da abin rufe fuska a duk lokacin da kake waje, kuma ta ba da shawarar yin na'urar rufe fuska ta gida ga waɗanda ba za su iya saya abin rufe fuska ba.
Ana amfani da masks a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Ƙuntatawa ta zamantakewa (wanda ake kira ƙuntatawa ta jiki) wani mataki ne na sarrafa kamuwa da cuta wanda aka yi niyya don rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin hana zamantakewa sun haɗa da killacewa; ƙuntata tafiye-tafiye; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko wuraren cin kasuwa.
Mutane za su iya yin amfani da hanyoyin hana su yin tarayya ta wajen kasancewa a gida, yin iyakance a tafiye-tafiye, guje wa wuraren da mutane suke, yin amfani da gaisuwa ba tare da yin magana ba, da kuma nisantar da kai daga mutane.
A yau, gwamnatoci da yawa suna yin amfani da takunkumin hana jama'a yin aiki a yankunan da annoba ta shafa.
Matsakaicin adadin mutanen da gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawarar su halarci taron da sauri ya ragu, daga mutane 250 (idan ba a san cewa akwai yaduwar COVID-19 a wani yanki ba) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta tarurruka a wuraren jama'a da suka shafi mutane fiye da biyu. Tsofaffi da mutanen da ke da yanayin kiwon lafiya na asali kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma tsarin rigakafi da ke da haɗarin cututtuka masu tsanani da rikitarwa sun ba da shawarar CDC su kasance a gida kamar yadda ya kamata a cikin wuraren da cutar ke faruwa a matakin jama'a. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara canza amfani da kalmar "ƙuntatawa ta zamantakewa" zuwa "ƙuntatawa ta jiki", don bayyana cewa manufarsu ita ce rage haɗuwa ta jiki ta hanyar kiyaye alaƙar zamantakewa, ko dai ta hanyar kama-da-wane ko kuma ta nesa.
Amfani da kalmar "ƙuntatawa ta zamantakewa" yana ba da ra'ayi cewa mutane su ware kansu gaba ɗaya daga zamantakewar jama'a kuma kada su ƙarfafa mutane su ci gaba da hulɗa da wasu ta hanyoyin da za su iya amfani da su. Wasu hukumomi sun fitar da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar.
Wannan shawarar ta ƙunshi yin jima'i da mutanen da suke zama tare da kai kawai kuma ba su da ƙwayar cuta ko alamun ƙwayar cuta.
Ana ba da shawarar keɓe kai a gida ga mutanen da aka gano suna da COVID-19 da kuma waɗanda ake zaton suna da cutar.
Hukumomi da yawa sun ba da umarni da yawa game da yin zaman kansu a cikin gida, kuma sun ba da shawarar yin zaman kansu a cikin gida don dukan mutanen da ke zaune a yankunan da aka shafa.
An ba da umarnin yin keɓe kai mafi tsauri ga mutanen da ke cikin rukunin haɗari.
An shawarci mutanen da za su iya fuskantar COVID-19 da kuma waɗanda suka yi tafiya zuwa ƙasashe ko yankuna da ke da yaduwar COVID-19 su yi keɓewa na kwanaki 14 tun lokacin da suka yi wa cutar.
Aikin sarrafa annoba shi ne hana ko kuma kawar da cutar, da kuma rage ta.
Ana yin rigakafin a farkon fasalin annobar kuma ana nufin bin diddigin da keɓe waɗanda ke da cutar da kuma yin wasu matakan sarrafa kamuwa da cuta da yin allurar rigakafi da nufin dakatar da yaduwar cutar zuwa ga dukan jama'a.
Sa'ad da ba za a iya hana yaduwar cutar ba, sai a ci gaba da yin aiki don ragewa: an ɗauki waɗannan matakan don rage yaduwar kuma a rage tasirinsa a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya yin haɗuwa da matakan hanawa da kuma ragewa a lokaci guda.
Suppression na bukatar karin tsauraran matakai don juyar da annobar ta hanyar rage yawan haihuwa zuwa kasa da 1.
Hakan zai rage haɗarin rashin amfani da kiwon lafiya kuma ya ba da lokaci mai yawa don ci gaban alluran rigakafi da magani.
Hanyoyin da ba na magani ba don magance annobar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓewa; matakan da aka yi a matakin jama'a don ƙuntatawa na jiki, kamar rufe makarantu da soke taron taro; shigar jama'a don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da matakan muhalli, kamar tsabtace farfajiyar. Sauran matakan da suka yi niyyar dakile annobar suna faruwa a China yayin da mummunan annobar ke kara bayyana, kamar yin keɓewar birane gaba ɗaya da kuma sanya tsauraran takunkumin tafiye-tafiye.
Sauran ƙasashe ma suna aiwatar da matakai da yawa don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da tsaftace-tsaftace da kuma killace mutane a cikin gida, kuma ta ba da gargadi game da motsi na masu kamuwa da cutar.
Singapore na ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da ke yin keɓewa da kansu kuma tana ɗora wa waɗanda suka kasa yin hakan manyan kudade.
Taiwan ta kara yawan samar da masks na fuska kuma ta hukunta masu tara kayan magani. Simulations ga Burtaniya da Amurka sun nuna cewa ragewa (sanya jinkiri, amma ba ya dakatar da yaduwar cutar) da kuma suppression (sanya ci gaban cutar) suna da manyan kalubale.
Manufofin rage yawan cutar za su iya rage yawan bukatar kiwon lafiya zuwa kashi biyu bisa uku da kuma mutuwar zuwa rabi, amma har yanzu suna haifar da mutuwar dubbai da kuma rashin lafiyar tsarin.
Za a iya zaɓar kawar da cutar, amma ana bukatar a ci gaba da yin hakan muddin cutar tana ci gaba da yaduwa a cikin mutane (ko har sai an sami allurar rigakafi, idan an fara samun ta), domin idan ba haka ba, za a sake samun kamuwa da cutar da sauri idan an rage matakan kawar da ita.
Yin amfani da dogon lokaci don kawar da cutar yana da tasiri a kan zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafi da aka amince da shi don COVID-19, amma ana ci gaba da ci gaba, wanda ya haɗa da gwajin maganin da ke akwai.
Yin amfani da maganin da ake sayar da shi, shan ruwa da yawa, da kuma yin hutu zai iya taimaka wa ka rage alamun.
Dangane da irin yanayin da kake ciki, za ka iya bukatar maganin oxygen, ruwa a cikin intravenous, da kuma taimakon numfashi.
Yin amfani da kwayoyin cuta zai iya sa yanayin mutum ya yi muni.
Wasu sinadarai da aka amince da su a baya don maganin wasu cututtukan kwayar cutar suna cikin binciken don amfani dasu wajen magance COVID-19.
WHO ta kuma bayyana cewa wasu "tuba da magunguna na gida" na iya rage alamun da SARS-CoV-19 ke haifarwa.
WHO ta ce karfafawa da daidaitawa da kula da lafiya ga bukatun marasa lafiya na COVID-19 shine babban mataki a cikin amsawa ga annobar.
ECDC da kuma ofishin WHO na Turai sun fitar da jagororin ga asibitoci da sabis na kiwon lafiya na farko don tura albarkatu a matakai daban-daban, gami da mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, idan ya yiwu a soke hanyoyin zaɓin, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ikon kulawa mai tsanani ta hanyar horar da ma'aikata da haɓaka yawan masu iska da gadaje.
Akwai ra'ayoyi da yawa game da asalin farko (wanda ake kira marasa lafiya).
An gano farkon sabon cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu dauke da cutar korona a Hubei ya karu a hankali.
Wadannan lokuta suna da alaƙa da kasuwar Huanan Seafood wholesale, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ta ce kwayar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wasu kalmomin, kwayar tana da asalin zoonotic. An lura da tarin cutar huhu tare da sanannen sanannen dalili a ranar 26 ga Disamba kuma likitan Zhang Jixian a asibitin lardin Hubei ya kula da shi, wanda ya sanar da CDC Jianghan Wuhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan na tsakiya sun gaya wa abokan aikin su game da "koronavirus kamar SARS".
'Yan sanda sun yi gargadi ga takwas daga cikin likitocin, ciki har da Li Wenliang, don yada jita-jita, kuma wani, Ai Fen, ya yi wa shugabansa horo don yin gargadi.
Hukumar kula da lafiyar birnin Wuhan ta sanar da jama'a a ranar 31 ga watan Disamba kuma ta sanar da WHO.
Mutane da yawa ba su san cutar ta pneumonia ba, an ruwaito su ga hukumomin kiwon lafiya a Wuhan wanda ya fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairu na 2020, cutar ta bazu zuwa sauran lardunan kasar Sin, wanda ke tallafawa hijira a lokacin Sabuwar Shekara ta Imlek kuma saboda Wuhan shine babban cibiyar sufuri da kuma wurin sufuri na jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan sabbin mutane 140 a rana guda, ciki har da mutum biyu a Beijing da kuma mutum daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun kamu da alamun cutar a ranar 20 ga Janairu 2020.A ranar 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin masu kamuwa da cutar a duniya.
Kasashe da yankuna 200 suna da akalla wani hali.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata motsi da kuma sanya dokoki a kan iyakoki.
Amsar kasa ta hada da matakan dakatarwa, kamar killace gida (wanda aka sani da dokar zama a gida, dokar kare kai a gida, ko dokar hana fita ta yanki) da kuma sa'o'i na dare. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna cikin wani nau'in killace yanki a Amurka, fiye da mutane miliyan 50 ke cikin killace yanki a Philippines, kimanin mutane miliyan 59 ke cikin killace yanki a Afirka ta Kudu, da kuma mutane biliyan 1.3 ke cikin killace yanki a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na keɓewa na yanki, wanda ya karu zuwa mutane biliyan 2.6 kwana biyu bayan haka, wato kusan kashi ɗaya bisa uku na yawan duniya.
An gano cewa an fara samun mutum na COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an fara samun mutum a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan huhu da ba a san dalilin ba a ranar 26 ga Disamba; asibitin ya sanar da wannan lura ga CDC Jianghan a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai coronavirus mai kama da SARS.
Hukumar Kula da Lafiya ta birnin Wuhan ta ba da sanarwar a ranar 31 ga watan Disamba.
An sanar da WHO a wannan rana.
A lokacin da aka yi wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan don " yada jita-jita" game da annobar.
Hukumar kula da lafiyar jama'ar kasar Sin ta ce babu "babban shaida" na kamuwa da cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani mummunan yunkuri wanda sakataren jam'iyyar ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" don dakile yaduwar cutar.
A cikin abin da ake kira "babban killace a tarihin 'yan adam", an sanar da dokar hana fita ta hanyar tsaftacewa a ranar 23 ga Janairu don dakatar da zirga-zirga zuwa da kuma fita daga Wuhan, kuma an faɗaɗa shi zuwa jimlar birane 15 a Hubei, wanda ke shafar mutane kusan miliyan 57.
An haramta amfani da motocin sirri a cikin birni.
An soke bikin Sabuwar Shekara ta Imlek (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da cewa za a gina asibitin wucin gadi, asibitin Huoshenshan, wanda za a kammala a cikin kwanaki 10.
An gina wata asibiti kuma bayan haka, wato, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibiti da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyar taron da kuma filin wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta tsara wasu matakan hana barkewar COVID-19, ciki har da fitar da sanarwar lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An rufe dukan jami'o'i da makarantu a ƙasar.
Ƙasar Hong Kong da Macau sun yi amfani da wasu matakai, musamman a batun makarantu da jami'o'i.
Ana amfani da matakan yin aiki daga nesa a wasu yankuna a kasar Sin.
An yi amfani da takunkumin tafiye-tafiye a cikin Hubei da wajenta.
An gyara sufuri na jama'a kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin.
Ana gudanar da ayyukan hana jama'a motsawa a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu ƙuntatawa a waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana "saba" cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar hana fita ta kwanaki 14 ga duk masu yawon bude ido na duniya da suka shiga birnin. A ranar 23 ga Maris, an yi amfani da wata hanyar da ta wuce ta hanyar kasar Sin ta hanyar wata yawon bude ido da ta koma Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ruwaito cewa an toshe yaduwar cutar da aka watsa a cikin gida kuma an sarrafa cutar a kasar Sin.
An sauƙaƙa takunkumin tafiya a ranar guda a Hubei, ban da Wuhan, watanni biyu bayan an sanya dokar hana fita ta yankin. Ma'aikatar Harkokin Wajen Jamhuriyar Jama'ar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shiga masu riƙe da biza ko izinin zama daga ranar 28 ga Maris zuwa gaba, ba tare da wani bayani dalla-dalla game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda yake so ya shiga kasar Sin dole ne ya nemi takardar visa a ofishin jakadancin kasar.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su sake budewa da kuma samar da makircin karfafa kudi ga kamfanoni. Majalisar Dinkin Duniya ta sanar da ranar makoki ta fara da minti uku na shiru a ranar 4 ga watan Afrilu da karfe 10:00, daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta nemi iyalan su yi tabawa ta yanar gizo ta hanyar kula da takunkumin jiki don kauce wa sabon barkewar COVID-19.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa COVID-19 ta bazu zuwa Koriya ta Kudu daga China.
A ranar 20 ga Fabrairu, hukumar kula da lafiyar kasar ta ruwaito wani gagarumin karuwa a cikin adadin wadanda aka tabbatar da cutar, wanda ya fi yawa ne sakamakon taron da aka yi a Daegu na sabon addini, wanda aka sani da Shincheonji Church of Jesus.
Shincheonji da suka ziyarci Daegu daga Wuhan ne ake zargin sun kasance tushen cutar.
A ranar 22 ga watan Fabrairu, daga cikin masu bin cocin 9,336, 1,261 ko kusan 13% sun ba da rahoton alamun cutar. Koriya ta Kudu ta ba da sanarwar mafi girman matakin tsaro a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jiragen sama kuma an canza su. Koriya ta Kudu ta gabatar da wani shiri da ake ganin shi ne mafi girma da kuma mafi kyau a duniya don tace kwayar cutar a cikin yawan jama'a, ware duk wanda ya kamu da cutar, da kuma bin sawun da kuma ware wadanda suka yi hulɗa da su.
Hanyoyin tacewa sun haɗa da wajibi ne ga sababbin masu zuwa daga ƙasashen waje su ba da rahoton bayyanar cututtuka ta hanyar aikace-aikacen hannu, gwajin kwayar cutar a kan layi ko drive-thru tare da sakamakon da ke samuwa a rana mai zuwa, da haɓaka ikon gwaji zuwa fiye da mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na samun nasara wajen hana annobar duk da cewa bai yi wa dukan biranen kariya ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a sallami Shugaba Moon bisa ikirarin da suka yi cewa gwamnati ta yi kuskure wajen magance annobar, ko kuma a akasin haka, ta yaba da yadda shugaba ya amsa.
A ranar 23 ga watan Maris, Koriya ta Kudu ta samu rahoton mafi karancin adadin wadanda suka kamu a cikin kwana daya a cikin makonni hudu.
A ranar 29 ga Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, za a yi wa dukan waɗanda suka zo daga ƙasashen waje killace na mako biyu.
Rahotanni daga kafofin watsa labarai sun ce a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi bukatar taimakon gwajin cutar daga kasashe 121.
Iran ta ruwaito cewa an fara samun kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom kuma, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan rana.
Shawarar da gwamnati ta yi ta farko ta ƙunshi soke bukukuwa da kuma sauran abubuwan al'adu, wasanni, da kuma addu'o'in Juma'a, da kuma rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da dala tiriliyan biyar na kudade don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na keɓe yankunan da cutar ta shafa, mutane ne kawai za a keɓe.
An sanar da shirin rage zirga-zirgar birane a watan Maris, duk da cewa an ci gaba da samun yawan zirga-zirga a cikin birnin kafin Sabuwar Shekara ta Farisa.
Sha'anin addinin Shi'a a Qom ya kasance a bude don yin hajjin har zuwa 16 ga Maris 2020. Bayan China, Iran ta zama cibiyar yaduwar cutar a watan Fabrairu.
A cikin da'awar cewa an rufe adadin annobar a Iran, fiye da kasashe goma sun koma da shari'arsu zuwa Iran a ranar 28 ga Fabrairu, wanda ya nuna cewa yawan annobar na iya zama mafi muni fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, inda aka samu rahoton cewa 23 daga cikin 'yan majalisa 290 sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki 'yan kare hakkin bil adama da ake tsare da su a kan zanga-zangar lumana ba tare da wata takamaiman doka ba, kuma, a wani lokaci, su saki duk fursunonin da suka cancanta.
An ce akwai haɗarin da ya fi girma na yaduwa a cikin cibiyoyin da aka rufe kamar cibiyoyin fursuna, waɗanda kuma ba su da isasshen magani.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda ya fi yawan mutanen da suka mutu a ƙasar tun lokacin da annobar ta fara.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa 12 ko jami'an gwamnati na Iran da suka gabata ko kuma a yanzu sun mutu sakamakon cutar.
A ranar 23 ga watan Maris, Iran ta fuskanci sabbin mutane 50 a kowace awa da kuma sabon mutuwar mutum daya a kowane minti 10 sakamakon cutar coronavirus.
Wani jami'in WHO ya ce, akwai yiwuwar samun adadin mutane biyar da suka kamu da cutar a Iran fiye da yadda aka ruwaito.
An kuma ce takunkumin da Amurka ta dauka kan Iran zai iya shafar yadda kasar ta ke biyan bukatunta a lokacin da cutar ta bulla.
Babban Kwamishinan Majalisar Dinkin Duniya don Hakkokin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta shafa, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da cewa cutar ta bazu zuwa Italiya lokacin da matafiya biyu na kasar Sin suka gwada tabbataccen SARS-CoV-2 a Roma.
An yi gagarumin karuwa a cikin al'amuran da suka sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da kuma zuwa China da kuma bayyana dokar ta baci.
Daga bisani, an gano tarin marasa alaƙa da COVID-19, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon doka don hana annobar, wanda ya shafi killace mutane sama da 50,000 daga birane daban-daban 11 na arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da ake fama da cutar, ba a yarda mutane su fita ba.
An ba da umarnin dakatar da ayyukan aiki da wasanni a yankin". A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar 100.
Duk manyan wasanni, gami da wasannin ƙwallon ƙafa na Serie A, za a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci, sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Makarantar Italiya ta Anesthesia, Analgesia, Resuscitation, and Intensive Care (SIAARTI) ta buga shawarwarin ka'idar likita game da hanyoyin triase da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta ɗauki matsayin China a matsayin ƙasa da ta fi yawan mutuwar coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga annobar.
A ranar 22 ga Maris, Rasha ta aika da jiragen sama tara na soja da ke dauke da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, da yawa daga cikinsu sun faru a yankin Lombardy.
Wani rahoto daga CNN ya ce, wani abu da ya sa mutuwar ta yi yawa a ƙasar Italiya shi ne haɗuwa da yawan tsofaffi da kuma rashin iyawar yin gwajin cutar ga dukan waɗanda suka kamu da ita.
Da farko, amsawar Burtaniya ga cutar ta kasance ɗaya daga cikin mafi kyawun ƙasashe da aka shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani matakin ƙuntatawa na zamantakewa ko keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta karbi zargi saboda ta yi la'akari da rashin amsawa da rashin tsanani a cikin amsa ga damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwar da ke kira ga dakatar da duk tafiye-tafiye da kuma tuntuɓar zamantakewa mara mahimmanci kuma ya ba da shawarar cewa mutane suyi aiki daga gida, idan zai yiwu, da kuma guje wa wurare kamar pubs, gidajen cin abinci, da kuma gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin ta sanar da cewa duk wuraren shakatawa, kamar mashaya da wuraren motsa jiki, dole ne a rufe su da wuri-wuri, kuma ta yi alkawarin biyan har zuwa 80% na albashi na ma'aikata har zuwa iyakar £2,500 a kowane wata don hana rashin aikin yi a cikin rikici. A ranar 23 ga watan Maris, Firayim Minista ya sanar da matakan ƙuntatawa na zamantakewa, wato hana taron mutane fiye da biyu da iyakance tafiye-tafiye da ayyukan waje kawai ga ayyukan da aka ɗauka da mahimmanci.
Ba kamar matakan da aka ɗauka a baya ba, 'yan sanda sun ba da takunkumi da kuma rarraba tarin.
An ba da umarnin rufe yawancin kasuwancin, sai dai waɗanda aka ɗauka "mafi mahimmanci", waɗanda suka haɗa da manyan kantuna, kantuna, bankuna, shagunan kayan aiki, famfunan gas, da kuma ɗakunan karatu.
A ranar 20 ga watan Janairu, an gano mutum na farko da ya kamu da cutar COVID-19 a jihar Washington ta arewa maso yamma, a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa rukunin aikin Korona a fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar ta baci ta kiwon lafiya ta jama'a kuma ta sanya takunkumin shiga ga mutanen da suka zo daga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, wata babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta ci gaba da samar da kayan gwajin kanta.
Duk da haka, Amirka ta yi jinkirin yin gwaji don ta ɓoye ainihin annobar a lokacin.
Gwaje-gwajen sun kasance da rikice-rikice ta hanyar kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta hanyar ilimi, kamfanoni, da asibitoci) har zuwa ƙarshen Fabrairu, da kuma takaddama ta takaddama ga mutanen da suka cancanta don gwajin har zuwa farkon Maris (ana buƙatar umarnin likita bayan haka).
A ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaji kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an yi gwajin da bai kai 14,000 ba.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cututtuka da kuma umarnin likitoci suna jira na sa'o'i ko kwanaki don a gwada su". Bayan an ruwaito mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da dokar ta baci, abin da wasu jihohi suka yi nan da nan.
Makarantun da ke yankin Seattle sun soke karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, an sanar da Amurka game da ƙididdigar tasirin sabon coronavirus a cikin ƙasar ta hanyar ƙungiyar masana ilimin cututtuka a Kwalejin Imperial na London.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Karfafawa da Karfafawa kan Coronavirus, wanda ya samar da dala biliyan 8.3 na kudaden gaggawa ga hukumomin tarayya don amsawa ga annobar.
Kamfanonin sun sa an hana ma'aikatan tafiya, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da cewa za a iya dakatar da tafiye-tafiye na Turai, sai dai na Burtaniya, na tsawon kwanaki 30, wanda zai fara aiki a ranar 13 ga watan Maris.
Washegari, ya faɗaɗa takunkumin zuwa Ingila da Ireland.
A ranar 13 ga Maris, ya sanar da dokar ta baci ta kasa don a samu kudade na tarayya don magance matsalar.
Tun daga ranar 15 ga Maris, an rufe ko kuma rage yawan kasuwancin da ke cikin Amurka don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da kuma a gundumar Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City tana da shari'o'in cutar coronavirus 10,700, wanda ya fi yawan adadin mutanen da ke cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan New York ya ce an yi amfani da takunkumin da ake amfani da su don a sauƙaƙe adadin mutane daga kwana 2.0 zuwa kwana 4.7.
A ranar 28 ga Maris, an sami mutane 32,308 da suka kamu da cutar a New York City, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an ruwaito cewa Amurka ta sami ƙarin mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya.
A cewar rahotanni a cikin kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idodin hana zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, jirgin ruwa mai suna USNS Comfort, wanda ke ɗauke da asibiti mai dakuna 1,000, ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A jihar New York, adadin mutane ya wuce 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda ta raina barazanar da kuma sarrafa saƙon ta hanyar tura jami'an lafiya da masana kimiyya don daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar a ofishin mataimakin shugaban kasar Mike Pence.
A cikin dukan wannan, amincewar Trump game da gudanar da rikicin ya rabu a cikin dukan masu raba gardama.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da muhimman kayan daga China, wanda ya hada da kayayyakin kiwon lafiya masu mahimmanci.
Ana amfani da nazarin yanayin tafiya ta iska don taswirar da kuma hango ko hasashen yanayin yaduwar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 na Ƙungiyar Sufuri ta Duniya, mutane da yawa da suka yi tafiya daga Wuhan sun kasance a Bangkok, Hong Kong, Tokyo, da Taipei.
Dubai, Sydney, da kuma Melbourne sun kuma bayar da rahoton kasancewa sanannun wurare ga mutanen da ke tafiya daga Wuhan.
An ruwaito cewa Bali ta fi kasawa wajen kasancewa cikin shirye-shirye a cikin shahararrun biranen 20 na duniya, yayin da biranen Ostiraliya suka kasance mafi iyawa. Ostiraliya ta saki Tsarin Matsalar Gaggawa don Sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An ce har yanzu akwai abubuwa da yawa da ba a gano ba game da COVID-19, kuma cewa Ostiraliya za ta mai da hankali kan kula da iyaka da sadarwa a cikin amsawa ga annobar.
A ranar 21 ga Maris, Ostiraliya ta bayyana dokar ta baci ta rayuwar 'yan Adam.
Saboda dokar hana fita ta zirga-zirgar jama'a da aka yi a Wuhan da Hubei, wasu ƙasashe suna shirin kwashe 'yan ƙasarsu da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jirgin haya daga ƙasarsu, tare da izinin hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da kuma Thailand sun kasance wasu daga cikin ƙasashe na farko da suka yi shirin kwashe 'yan ƙasar.
Pakistan ta ce ba za ta yi watsi da 'yan kasar ta ba daga kasar Sin.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma dangin 'yan Brazil, da kuma wasu 'yan Poland hudu, da na kasar Sin, da kuma na Indiya.
An kai 'yan ƙasar Poland, China, da Indiyawan ƙasar Poland, inda jirgin ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
'Yan kasar Brazil da suka tafi Wuhan sun yi zaman kansu a wani sansanin soja kusa da Brasília.
A wannan rana, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australiya sun kwashe 'yan kasar su 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da Kurkuku ta tsibirin Kirsimeti, wadda aka mayar da ita cikin wani wuri na killace mutane, inda suka zauna har tsawon kwanaki 14.
Jirgin da aka yi wa tsibirin New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Australia da Pacific) a sansanin soja a Whangaparoa, a arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan Amirkawa da ke cikin jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama da ke dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga watan Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta haya ya dawo da 'yan kasar 112 daga kasar.
An yi bincike kafin a tashi kuma an bar 'yan Afirka ta Kudu hudu da suka nuna alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da aka gwada ba su da kyau ne aka mayar da su.
Bisa ga sakamakon gwajin, an ba da izini ga dukan mutanen Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda, da sojoji da ke aiki a kan manufofin jin kai; a matsayin abin da zai hana su, an saka su a kan hanya kuma an killace su na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu sojojinta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'i daban-daban na Amurka sun shiga cikin kungiyar don aika taimako zuwa yankunan da cutar ta shafa a kasar Sin, tare da kungiyoyin da suka shiga daga yankin birni na Chicago; an ruwaito sun yi nasarar aikawa da masks N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da kyautar dala miliyan 100 ga WHO don tallafawa bincike da kuma gudanar da allurar rigakafi, da kuma kare "ƙungiyoyin da ke fuskantar haɗari a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin kasar Sin ta ba da kyautar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga Fabrairu, kungiyar agaji ta Red Cross ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kyautar fuska miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da fiye da tan 13 na kayayyakin kiwon lafiya ga Wuhan, Malaysia ta ba da sanarwar bayar da kyautar safofin hannu miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya da suka hada da riguna 10,000 na Hazmat, kuma Amurka ta ba da tan 17.8 na kayayyakin kiwon lafiya ga China tare da alkawarin ƙarin dala miliyan 100 a cikin taimakon kudi ga kasashen da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun tura kayayyakin kiwon lafiya da kwararrun mutane don taimakawa Italiya wajen magance annobar coronavirus.
Jack Ma ya tura kayan gwaji miliyan 1.1 da abin rufe fuska miliyan 6 da kuma tufafi 60,000 zuwa Addis Ababa, Habasha, don a rarraba wa Tarayyar Afirka.
Daga baya, ya tura kayan gwaji 5,000, masks 100,000, da kuma na'urori masu iska 5 zuwa Panama.
Ma ta kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada.
Alal misali, Spain ta janye kayan gwajin coronavirus na kasar Sin 58,000 da suka yi daidai da kashi 30% kawai; a halin yanzu, Netherlands ta janye masks na fuska na kasar Sin 600,000 da suka yi lahani.
Belgium ta kuma janye masks 100,000 da ba za a iya amfani da su ba, wanda ake zaton ya fito ne daga China, amma a gaskiya daga Colombia.
A wani bangare kuma, an samu karbar taimakon kasar Sin a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani shiri na gaggawa na tallafawa kasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da gwamnatin kasar Sin ke yi wajen sarrafa cutar.
WHO ta lura da bambanci tsakanin annobar SARS na 2002-2004 lokacin da aka zargi hukumomin China da ɓoye-ɓoye don hana rigakafin da ƙoƙarin hanawa da kuma rikicin da ke faruwa a yanzu tare da gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa firgita a gaban hutun Sabuwar Shekara ta Wuta".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da gwamnatin tarayya ta yanke na sanya dokar hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya ce ko da yake matakin "ba a bayyane yake ba shawarar WHO ba ne", amma matakin kuma "mafi muhimmanci ne ga sadaukar da kai don dakile annobar a wuraren da annobar ta fi yawa" kuma ya kira shi "ba a taɓa faruwa ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da cewa mutum ya kamu da cutar daga mutane a wajen China da kuma karuwar adadin shari'o'i a wasu ƙasashe, WHO ta bayyana cutar a matsayin Cutar Lafiya ta Jama'a da ke Shafan Duniya (PHEIC), PHEIC na shida tun lokacin da aka fara aiwatar da wannan matakin a lokacin annobar cutar mura ta 2009.
Babban darektan WHO Tedros Adhanom ya ce an bayyana PHEIC saboda "hadarin yaduwar duniya, musamman ga ƙasashe masu karamin da matsakaitan kudade waɗanda ba su da ingantaccen tsarin kiwon lafiya.
A cikin martani ga dokar hana tafiye-tafiye, Tedros ya ce "babu wani dalili da zai sa a yi amfani da matakan da ba su da muhimmanci wajen hana tafiye-tafiye da kuma cinikayya ta duniya" kuma "WHO ba ta ba da shawarar hana cinikayya da kuma motsi".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 da za a yi amfani da su wajen tallafa wa shirye-shiryen da ake yi a ƙasashen da ba su da kuɗi, ta kuma nuna gaggawa wajen tallafa wa ƙasashen da "ba su da tsarin gano mutanen da suka kamu da cutar idan annoba ta barke".
Bugu da ƙari, Tedros ya yi bayani cewa "ƙuntataccen ƙarfinmu yana kan ido mafi rauni" kuma ya bukaci al'ummar duniya su "yi zuba jari a yau ko kuma su biya ƙarin a nan gaba".A wani taron manema labarai a ranar 11 ga Fabrairu, WHO ta sanya COVID-19 a matsayin sunan cutar ga cutar.
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya ba da "sakamakon da ke nuna cewa an ba da dukan ikon tsarin Majalisar Dinkin Duniya".
Daga baya, Majalisar Ɗinkin Duniya ta ba da damar Ƙungiyoyin Gudanar da Rikicin don ba da damar daidaita duk ayyukan Majalisar Ɗinkin Duniya, wanda WHO ta ce zai ba su damar "daidaita kansu ga aikin kiwon lafiya, yayin da sauran cibiyoyin za su iya amfani da ƙwarewarsu don magance tasirin annoba a fannoni na zamantakewa, tattalin arziki, da kuma ci gaba".
A ranar 14 ga watan Fabrairu, an kunna tawagar hadin gwiwar China da WHO ta jagoranci; tawagar ta yi niyyar samar da kwararrun masana na duniya da WHO a kasar Sin don taimakawa gudanar da aikin gida da kuma kimanta "matakan cutar ta kamuwa da cuta" ta hanyar gudanar da bita da taro tare da hukumomin da ke da alaƙa da matakin ƙasa da kuma yin ziyara a filin don tantance "mummunan tasirin ayyukan magance cutar a lardin da gundumar, wanda ya shafi tsarin birane da na karkara". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya ta yi aiki mafi yawa don shirya kanta don fuskantar yiwuwar cutar coronavirus" kuma ta ce, kodayake har yanzu yana da wuri don kiran cutar, dole ne kasashe su kasance "a cikin shirye-shiryen".
A ranar 28 ga watan Fabrairu, jami'an WHO sun ce za a kara yawan darajar barazanar coronavirus a duniya daga "babba" zuwa "babba", wanda shine mafi girman matakin tsaro da kimantawa.
A wani jawabi, Mike Ryan, darektan gudanarwa na shirin WHO na kula da lafiyar mutane, ya yi kashedi cewa, "Lokaci ya yi da kowace gwamnati a duniya za ta fuskanci gaskiya: Ku yi tsaro.
Wannan kwayar cutar tana iya zuwa wurinku kuma ya kamata ku kasance a shirye", kuma ya yi kira da cewa matakan da suka dace na magance ta zai iya taimaka wa duniya ta kauce wa "mafi muni".
Ryan ya ci gaba da cewa bayanan da ake samu a yanzu ba sa ba da damar da jami'an kiwon lafiya za su iya bayyana cewa annobar ta zama ta duniya, kuma ya ce irin wannan sanarwar tana nufin "ainihin mun yarda cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin annoba.
Darakta Janar na WHO ya ce WHO "ta damu ƙwarai da yawan yaduwar da kuma mummunan yanayi, da kuma rashin jinkirin yin aiki mai ban tsoro". WHO ta fuskanci mummunan zargi saboda rashin dacewa a cikin magance annobar, wanda ya haɗa da jinkirin bayyana dokar ta baci ta kiwon lafiya ta jama'a da kuma rarraba cutar a matsayin annoba.
Wani mummunan martani ya hada da wata takarda da mutane 733,000 suka sanya hannu a ranar 6 ga watan Afrilu, wanda aka aika wa Daraktan Janar na WHO Tedros Adhanom don ya yi murabus.
A ranar 26 ga Maris, 2020, masana da dama na Majalisar Dinkin Duniya sun jaddada girmamawa ga hakkokin kowane mutum yayin annobar COVID-19.
Ƙungiyar ta ce kowa yana da hakkin ya ceci rayuka kuma gwamnati tana da alhakin hakan.
Ƙungiyar ta nanata cewa rashin albarkatu ko inshorar lafiya ba za a iya amfani da su a matsayin hujja don nuna bambanci ga wasu rukuni ba.
Masana sun nuna cewa kowa yana da hakkin yin amfani da lafiyar jiki, har da nakasassu, ƙalilan, tsofaffi, 'yan gudun hijira, marasa gida, waɗanda suke rayuwa cikin matsanancin talauci, waɗanda suke kurkuku, 'yan gudun hijira, da kuma sauran rukunin da suke bukatar taimakon gwamnati.
Kungiyoyin gwamnatoci na duniya suna ƙoƙari su magance tasirin zamantakewa da tattalin arziki na rikicin COVID-19.
Kungiyar Tattalin Arziki da Ci Gaban ta kaddamar da shirye-shirye don samar da cikakken bayani game da manufofin da ke faruwa a ƙasashe a duniya, tare da ra'ayoyi da shawarwari.
Daga manufofin ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin yin rigakafin yanki da ƙuntatawa na tafiya, cibiyar dijital ta haɗa da Mai Sauraron Manufofin Jiha, kuma tana nufin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe daidaitaccen amsawar duniya game da ƙalubalen coronavirus.
Gwamnatin kasar Sin ta karbi sukar daga Amurka, Ministan ofishin majalisar dattijai na Birtaniya Michael Gove, da kuma dan Shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda ake magance annobar da ta barke a lardin Hubei, kasar Sin.
An dakatar da wasu gwamnoni a matakin lardin jam'iyyar kwaminis ta kasar Sin (CPC) dangane da yadda ake gudanar da kokarin killace mutane a kasar Sin ta tsakiya, wanda ya nuna rashin jin dadin yadda hukumomin siyasa ke amsawa wajen magance annobar a yankin.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta yarda da cewa cutar coronavirus ta fara ne a Wuhan, kuma sun goyi bayan ka'idar da ta nuna cewa COVID-19 ta fito ne daga Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta kira coronavirus "ciwon China" ko "ciwon Wuhan" kuma ta ce "harkokin da kasar Sin ta yi a ɓoye sun ba da ƙarfi ga cutar da ta zama annobar duniya". Wannan furucin ya zama abin da wasu masu sukar suka yi zargi da nuna wariyar launin fata da kuma "karkatar da hankali game da gazawar gwamnatin ta wajen magance cutar korona".
Jaridar Daily Beast ta samu sakon gwamnatin Amurka wanda ya bayyana dabarun sadarwa kuma a bayyane yake daga Majalisar Tsaro ta Kasa, tare da dabarun da aka ambata a matsayin "Duk game da China.
An gaya mana mu yi ƙoƙari mu yi amfani da duk wata hanyar da za mu iya, ta hanyar yin taron manema labarai da kuma nunawa a talabijin". Kafofin watsa labarai kamar su Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa ƙoƙarin da China ta yi na tura taimako ga ƙasashen da suka kamu da cutar wani ɓangare ne na ƙoƙarin da take yi na yada labarai don rinjayar duniya.
Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na geopolitics, wanda ya hada da yaki don samun tasiri ta hanyar jujjuyawar gaskiya da kuma 'yancin siyasa.'"
Borrell ya kuma ce, "Kungiyoyin suna ta da karfi wajen tura saƙon cewa, ba kamar Amurka ba, su abokan tarayya ne masu aminci da kuma abin dogara".
China ta kuma yi kira ga Amurka ta soke takunkumin da ta yi wa Syria, Venezuela, da Iran, kuma an ruwaito ta tura taimakon ga kasashe biyun.
Jack Ma ya ba da kyautar masks 100,000 ga Cuba wanda aka hana ta ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amirka da canja wurin taimakon da aka ba wasu ƙasashe zuwa nasu ƙasashe.
An kuma samu rahotanni daga wasu ƙasashe, kamar Jamus, Austria, da Switzerland; da kuma Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta ɗauki ɗaruruwan na'urori masu sanyaya iska da aka yi amfani da su a ƙasar Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kai na Tarayyar Turai ga Italiya da cutar ta coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce: "Shugaban kasar Sin ne kawai ke amsawa a bangaren biyu.
Hakika, wannan ba alamar haɗin kai na Turai ba ne".
A ranar 22 ga Maris, bayan ya karɓi kiran waya daga Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya tura sojojin Rasha don aika da sojoji, motocin kashe cututtuka, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a san shi ba da ya ce kashi 80 cikin ɗari na taimakon da Rasha ta ba ta "ba da amfani ko kuma ba ta da amfani ga Italiya".
Majiyar ta zargi Rasha da yin "harin siyasa da na diplomasiyya" da ya janyo hankalin mutane.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kuma sun nuna godiyarsu.
Rasha ta kuma tura jiragen da ke dauke da kayayyakin kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce: "Sa'ad da ya ba da taimako ga abokan aikinsa a Amurka, [Putin] ya ɗauka cewa idan masu samar da kayan aikin likita da na Amurka suka samu damar, za su iya ba da taimako idan ya cancanta".
Aikin soja na NATO "Defender 2020" da aka shirya a Jamus, Poland, da kuma kasashen Baltic, shi ne mafi girma NATO warfare horo tun karshen Cold War, za a gudanar a kan karami sikelin.
Sakatare Janar na Kamfen din Hana Makaman Nukiliya Kate Hudson ta soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, wannan aikin ba kawai yana cutar da rayukan sojojin Amurka da kasashen Turai da yawa da ke shiga ba, har ma da mazaunan kasashen da suke aiki". Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa biyu da aka kamu da su da kuma manyan siyasa goma sha biyar a yanzu ko a baya.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta budewa ga shugabannin duniya don neman taimako, yana cewa kasarsa tana fama da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka akan Iran.
Masu nazarin siyasa sun yi zaton hakan zai iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta lalace saboda annobar.
Koriya ta Kudu ta soki "ƙoƙarin hanawar Japan yin amfani da ita" bayan Japan ta sanar da cewa za a sanya duk wanda ya zo daga Koriya ta Kudu a cikin killace na makonni biyu a wuraren da gwamnati ta nada.
Tun da farko, jama'ar Koriya ta Kudu sun rarrabu game da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun, suna kira ga a sallami Moon, bisa ga da'awarsu game da kuskuren gwamnati a cikin magance annobar, da kuma yaba da martani.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya ba gwamnati damar ƙarfafa ikonta.
A Hungary, majalisa ta zabi ta ba da izinin firaminista Viktor Orbán ya yi mulki ta hanyar umarni ba tare da iyakance lokaci ba, ta dakatar da majalisar dokoki da kuma zaben, da kuma hukunta mutanen da ake zaton suna yada ƙarya game da cutar da kuma yadda gwamnati ke magance rikice-rikice.
An zargi annobar coronavirus da rashin wadata, wanda ya fito ne daga karuwar amfani da kayan aiki a duniya don yaƙar annobar, sayayya saboda tsoro, da kuma katsewar ayyukan masana'antu da kayan aiki.
Hukumar Kula da Magunguna da Abinci ta Amirka ta yi gargaɗi game da rashin amfani da magunguna da kuma kayan aikin likita saboda yawan bukatar masu amfani da kuma rashin wadatar masu sayarwa.
Wasu yankuna ma suna samun sayayya domin tsoro da ke jawo rashin abinci, tawul, da ruwan kwalba, da kuma rashin abinci.
Musamman ma, masana'antun fasaha sun yi gargadin cewa za a yi jinkirin aikawa da kayayyakin lantarki.
A cewar darektan WHO Tedros Adhanom, bukatar yin amfani da kayan kariya ta kai sau 100.
Wannan bukatar ta sa farashin ya karu har zuwa sau ashirin na farashin al'ada kuma ta haifar da jinkirin samar da kayayyakin kiwon lafiya na watanni hudu zuwa shida.
Wannan kuma yana jawo rashin kariya a duniya, kuma WHO ta yi gargadin cewa hakan zai yi wa ma'aikatan kiwon lafiya illa.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou don sayar da kayayyakin Ostiraliya a cikin China.
Wannan aikin ya haifar da karancin madara mai gina jiki a wasu manyan kantuna kuma an dakatar da shi daga gwamnatin Ostiraliya. Duk da yawan cututtukan COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban bukatar kayayyakin abinci, waɗannan yankuna biyu sun guje wa rashin abinci.
Matakan da kasar Sin da Italiya suka dauka na yaki da haramtacciyar safarar kayayyaki masu muhimmanci sun yi nasara wajen hana a yi rashin abinci mai yawa a Turai da Amirka ta Arewa.
Arewacin Italiya, da yawan aikin gona, ba ta samu raguwa mai yawa ba, amma farashin zai iya tashi bisa ga wakilcin masana'antu.
An gano shelves na abinci a wani lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin ke cire naman alade don tabbatar da wadatar abinci ga al'umma.
A Italiya ma, akwai irin wannan dokar, wadda ta bukaci masana'antun abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji koma bayan tattalin arzikin duniya a kasar Sin: a cewar wani rahoto da kafofin yada labarai suka fitar a ranar 16 ga watan Maris, tattalin arzikin kasar Sin ya yi matukar rauni a farkon watanni biyu na shekarar 2020 sakamakon matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma tallace-tallace sun fadi da kashi 20.5%.
Tun da kasar Sin ta kasance babbar cibiyar tattalin arziki da masana'antu, ana ganin cewa annobar ta haifar da babbar barazanar rushewar tattalin arzikin duniya.
Agathe Demarais daga kungiyar tattalin arziki ta Economist Intelligence Unit ta yi hasashen cewa kasuwar za ta ci gaba da yin rikici har sai an samu karin haske game da yiwuwar sakamakon karshe.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tasirin tattalin arziki na annobar a kan ci gaban duniya zai iya wuce annobar SARS ta 2002-2004.
Wani ƙididdiga daga jami'ar Washington a St. Louis ya ce annoba ta shafi sarkar samar da kayayyaki ta duniya fiye da dala biliyan 300, wanda zai iya wuce shekaru biyu.
Kungiyar Kasashen da ke Fitar da Man Fetur ta Duniya (OPEC) ta ruwaito cewa "ta yi koma baya" bayan da farashin man fetur ya ragu sosai sakamakon raguwar bukatar kasar Sin.
A ranar 24 ga Fabrairu, kasuwar jari ta duniya ta fadi saboda ƙaruwa mai yawa a cikin adadin COVID-19 a wajen ƙasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da annobar coronavirus, wasu alamun jari na Amurka, waɗanda suka haɗa da NASDAQ-100, S&P 500 Index, da Dow Jones Industrial Average, sun yi rikodin raguwar da ta fi muni tun daga 2008, tare da Dow ya faɗi maki 1,191, wanda shine mafi girma a cikin kwana ɗaya raguwa tun lokacin rikicin kudi na 20072008.
Waɗannan alamun sun rufe makon da suka yi kasa da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar cinikin gwamnatin kasar Sin, amma ta riƙe da mummunan hangen nesa.
Kasuwancin ya sake faɗuwa saboda damuwa game da cutar coronavirus, mafi girma ya faɗi a ranar 16 ga Maris.
Mutane da yawa suna tunanin cewa tattalin arziki zai iya zama mummunar.
Wani masanin tattalin arziki mai suna Mohamed El-Erian ya yaba da matakin gaggawa da bankin tarayya da kuma jihohi suka dauka.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da aka fi shafa saboda hana tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren yawon buɗe ido, da kuma matakan gwamnati da ke hana tafiye-tafiye a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen saboda karancin buƙatu, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin Flybe na Burtaniya ya rushe.
Sakamakon da ake yi a masana'antar jiragen ruwa ya kai ga wani matakin da ba a taɓa gani ba.
An rufe wasu tashoshin jirgin kasa da tashar jiragen ruwa.
Aikin ya yi daidai da lokacin Chunyun, wanda ya fi dacewa da hutun Sabuwar Shekara ta Imlek.
An soke wasu abubuwan da suka shafi mutane da yawa ta hanyar gwamnatoci na tsakiya da na yanki, ciki har da bikin Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan da wuraren yawon shakatawa, kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin abubuwan da ake yi a Sabuwar Shekara ta Laraba da wuraren yawon shakatawa an rufe su don hana taro, ciki har da Taron Hauka a Beijing da kuma bikin haikalin gargajiya.
A cikin 24 daga cikin larduna 31, karamar hukuma, da yankuna na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga Fabrairu kuma sun umurci yawancin wuraren aiki da kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna suna samar da kashi 80 cikin 100 na GDP na ƙasar da kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta kara yawan matakan yaki da cututtukan cututtuka zuwa mafi girma kuma ta sanar da dokar ta baci, ta rufe makarantu har zuwa Maris, kuma ta soke bikin Sabuwar Shekara.
Ziyarar masu sayar da kayayyaki a Turai da Latin Amirka ta ragu da kashi 40 cikin ɗari.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ragu da kashi 50 zuwa 60%.
Wannan kuma ya haifar da raguwar 33-43% na zirga-zirgar masu tafiya zuwa kantin sayar da kayayyaki a watan Maris idan aka kwatanta da Fabrairu.
Masu amfani da cibiyoyin cinikayya a duk faɗin duniya suna aiwatar da ƙarin matakan, kamar inganta tsabtace jiki, shigar da na'urorin bincike na zafi don bincika yanayin zafi na masu siye, da kuma soke taron. Bisa ga kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da annobar ta haifar na iya haifar da mutane a cikin matsanancin talauci a Latin Amurka ya karu tsakanin 14 da 22 miliyan fiye da yanayin da ba a da annobar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi fice a Wuhan, kimanin mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin 'yan gudun hijira miliyan 300 na kasar Sin sun bar gidajensu a lardin Hubei ko kuma sun makale a lardin Hubei. A watan Maris na shekarar 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimar da bankin tarayya na St. Louis, annobar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa 32%. Yankin quarantine a Indiya ya haifar da rashin aikin yi na dubban miliyoyin ma'aikatan Indiya masu ƙaura (wanda aka biya ta hanyar albashi na yau da kullun). Binciken daga Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai a Kanada sun rasa wani nau'in aikin yi. Kusan ma'aikata 900,000 sun rasa aikin su a Spain tun lokacin da aka aiwatar da quarantine na yankin a tsakiyar watan Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi albashi na wucin gadi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi tsarin karbar kudi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun nemi tsarin aiki na gajeren lokaci da gwamnati ta ba ma'aikatansu, wanda ake kira Kurzarbeit.
Faransa da Ingila sun karɓi tsarin biyan kuɗin aiki na ɗan gajeren lokaci na Jamus.
A duk faɗin duniya, masana'antun wasan kwaikwayo da al'adun gargajiya sun sami babban tasiri daga annobar, wanda ya shafi ayyukan ƙungiyoyi da mutane, na aiki da na kai.
Kungiyoyin fasaha da al'adu suna ƙoƙari su ci gaba da aikinsu (wanda galibi ana tallafawa su ta hanyar jama'a) don samar da damar samun al'adun al'adu ga al'umma, kula da lafiyar ma'aikata da al'umma, da tallafawa masu fasaha idan ya yiwu.
A watan Maris na 2020, a duk faɗin duniya da kuma a matakan daban-daban, gidajen tarihi, dakunan karatu, wuraren baje koli, da sauran cibiyoyin al'adu sun rufe ba tare da iyaka ba, tare da an soke ko kuma an dakatar da nune-nunen, abubuwan da suka faru, da kuma nune-nunen.
A sakamakon haka, an yi ƙoƙari sosai don samar da sabis na madadin ta hanyar dandamali na dijital. Wani mummunan sakamako na wannan sabon cuta da ke ci gaba da sauri shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa na kiɗa da kide-kide, tarurrukan fasaha, da kuma kayan ado.
A lokacin da aka soma bikin, an soke bikin da ake yi a Roma na mako mai tsarki, wanda ya kasance a makon ƙarshe na lokacin tuba.
Yawancin bishopi suna ƙarfafa tsofaffin Kiristoci su zauna a gida kuma kada su halarci Mass a ranar Lahadi; wasu majami'u suna ba da sabis na coci ta rediyo, watsa shirye-shirye na kai tsaye ta yanar gizo ko talabijin, yayin da wasu ke ba da sabis na drive-in ko kuma yin taro.
Da aka rufe majami'u da kuma ɗakin sujada da Roman Katolika suka yi da kuma yin watsi da filin tsarkaka na Bitrus daga masu bautar Kirista, sauran addinai sun soke ayyukan kuma sun ƙuntata taron jama'a a coci, masallaci, majami'u, haikali, da gurdwara.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa da rufe wuraren ibada, yayin da Saudiyya ta haramta shigar da baƙi da mazauna su zuwa wuraren ibada a Makka da Madina.
Wannan annoba ta haifar da babbar matsala ga kalandar wasanni a duniya tun lokacin Yaƙin Duniya na Biyu.
Yawancin manyan wasanni na wasanni an soke ko kuma an dakatar da su, ciki har da gasar zakarun Turai ta 2019-2020, gasar Premier ta 2019-2020, gasar zakarun Turai ta 2020, gasar zakarun Turai ta 2019-2020, da gasar zakarun Turai ta 2019-2020.
Wannan annoba ta rushe shirin gasar Olympics ta bazara ta 2020, wanda aka fara shirin fara a karshen watan Yuli; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a "sake shirya taron har zuwa bayan 2020, amma ba za a wuce lokacin bazara na 2021 ba". A duniya, an rufe gidajen caca da sauran wuraren wasan kwaikwayo kuma an dakatar da watsa shirye-shiryen wasan poker ko kuma an soke su.
Wannan ya sa yawancin masu caca suka koma caca ta yanar gizo, yawancin shafukan caca na yanar gizo sun ba da rahoton ƙaruwa mai mahimmanci na sabon rajista.
Gidajen wasan kwaikwayo masu yawa kamar Broadway sun jinkirta duk wasan kwaikwayon.
Masu zane-zane suna gano hanyoyi daban-daban don ci gaba da samarwa da raba aikin ta hanyar intanet a matsayin madadin ga wasan kwaikwayon kai tsaye na gargajiya, kamar wasan kwaikwayo na kai tsaye na kan layi ko ƙirƙirar "ƙoƙarin" yanar gizo don masu zane-zane suyi aiki, yadawa, da kuma tallata ayyukansu.
Yawancin abubuwan da ke faruwa a Intanet game da coronavirus suna yawo a kan layi tare da mutane da yawa da ke juyawa zuwa ban dariya da kuma juyayi a cikin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an lura da karuwar nuna bambanci, ƙiyayya da wariyar launin fata a kan mutanen da ke fitowa daga kasar Sin da Asiya ta Gabas, da kuma mutanen da ke fitowa daga yankunan da cutar ta shafa a Turai, Amurka, da sauran ƙasashe.
An lura da tsoro, shakku, da kuma rashin jituwa a ƙasashe da yawa, musamman a Turai, Gabas ta Asiya, Arewacin Amirka, da kuma Asiya-Pacific.
Rahoton daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ba su da iyaka a China) ya ba da rahoton ra'ayin wariyar launin fata da aka bayyana a cikin kungiyoyi a duk faɗin duniya cewa Sinawa sun cancanci karɓar cutar ko karɓar abin da suke da'awar cewa lada ne mai kyau.
Wasu ƙasashen Afirka ma suna fuskantar ƙaruwar motsin rai game da 'yan ta'adda.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin yankin.
Akwai tallafi ga 'yan kasar Sin, a kan layi da kuma a cikin layi, da kuma ga mutanen da ke yankunan da cutar ta shafa.
Bayan ci gaba da barkewar cutar zuwa sababbin ƙasashe masu zafi, mutanen Italiya, ƙasar farko a Turai da ta fara fuskantar mummunan annobar COVID-19, na iya zama sanadin zargin da kuma ƙiyayya.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a Twitter.
Mutanen China da kuma sauran 'yan Asiya a Birtaniya da Amurka sun ruwaito karuwar yawan zalunci da hare-hare na wariyar launin fata.
An soki shugaban Amurka Donald Trump saboda kiran coronavirus "Cinese Virus", wani lokaci da masu sukar suka yi la'akari da shi a matsayin wariyar launin fata da kuma anti-Tongkok.
Masu zanga-zangar a Ukraine sun kai hari kan bas da ke kaiwa 'yan Ukraine da kuma 'yan kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke kan iyaka da China, da ke karatu a manyan biranen Indiya an ruwaito cewa suna fama da zalunci saboda annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na jihar Bengal ta yamma, Dilip Ghosh, ya ce kasar Sin ta lalata yanayi kuma "saboda haka Allah ya yi musu rashi".
Bayan haka, ofishin jakadancin kasar Sin a Kolkata ya soki wannan sanarwa, yana mai da shi "mara kyau". A kasar Sin, rashin jin dadin jama'a da wariyar launin fata a kan mutanen da ba na Tionghoa ba sun yi muni saboda annobar, tare da baƙi da aka kwatanta da "ƙazanta baƙi" kuma ana nufin "gogewa".
Yawancin jaridu da ke amfani da takunkumin biya sun cire shi don wasu ko duk labaran da suka yi game da coronavirus.
Masu wallafa kimiyya da yawa suna ba da takardun kimiyya game da annobar a buɗe.
Wasu masana kimiyya sun zaɓi su raba sakamakon da sauri a kan sabobin da aka buga, kamar bioRxiv.
Sabuwar cuta mai yaduwa  Sabuwar cuta mai yaduwa, sau da yawa sabon abu ne a cikin annobar ko kuma hanyar watsawa
Duniya da cututtuka - Binciken duniya da kuma yaduwar cututtuka
Jerin annoba da annoba - Jerin mutuwar da aka yi sakamakon cututtuka masu yaduwa
Cin hanci da rashawa da kuma cutar dabbobi - Hadarin kiwon lafiya da ke tattare da cinikin dabbobi masu tasowa
Gwajin dakin gwaje-gwaje na cutar coronavirus 2019 (COVID-19) da cutar SARS-CoV-2 sun haɗa da hanyoyin gano kasancewar cutar da gano antibodies da aka samar a cikin amsa ga kamuwa da cuta.
An tabbatar da kasancewar cutar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwaji na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da wannan gwajin don tabbatar da cewa akwai sabon kamuwa da cuta ko kuma cewa cutar tana aiki.
Ana iya amfani da gano rigakafi (serology) don ganewar asali da kuma kula da yawan jama'a.
Ana gwada rigakafin da ke nuna yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin adadin mutuwar da cutar ta yi a cikin al'umma da kuma matakin rigakafin da aka yi a cikin rukuni daga sakamakon gwajin.
Saboda karancin gwajin, har zuwa watan Maris na shekarar 2020, babu wata ƙasa da ta sami tabbataccen bayanai game da yaduwar cutar a cikin al'ummarta.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambancin gaske a yawan gwaje-gwajen da ƙasashe suka yi.
Wannan bambancin zai iya shafar yawan mutuwar da aka ruwaito, wanda ya fi dacewa a wasu ƙasashe.
Ta amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR), ana iya yin wannan gwajin a kan samfurin numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasopharynx ko samfurin sputum.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya amincewa da gwajin RT-PCR da aka yi a cikin ƙashin ƙuƙwalwa a farkon makon da aka kamu da cutar.
Daga baya, ƙwayoyin cuta za su iya ɓace a cikin ƙashin ƙafarsa yayin da suke ci gaba da yin kwayar a cikin huhu.
A madadin haka, ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, ana iya cire samfurin daga cikin numfashi ta amfani da catheter na numfashi ko kuma ana iya amfani da kayan da aka fitar ta hanyar tari (sputum).
An kirkiro gwajin PCR na farko a Charité, Berlin, a watan Janairun 2020 ta amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR), kuma ya samar da aƙalla kayan gwaji 250,000 don rarraba su ta Hukumar Lafiya ta Duniya (WHO).
Ƙasar Ingila ta kuma ci gaba da gwaji a ranar 23 ga Janairu 2020.Kamfanin Koriya ta Kudu Kogenebiotech ya ci gaba da haɓaka kayan aikin gano SARS-CoV-2 na PCR (PowerChek Coronavirus) wanda ke da nau'i na asibiti a ranar 28 ga Janairu 2020.
A kasar Sin, BGI Group na daya daga cikin kamfanonin farko da suka karbi izinin gaggawa daga Hukumar Kula da Kayayyakin Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin tsofaffin kayan aikin gwaji sun ba da sakamako mai ban sha'awa saboda kuskuren mai aiki, kuma yawan gwaje-gwajen a CDC a Atlanta ya iyakance; wannan ya haifar da matsakaicin samfurori kasa da 100 a kowace rana da aka yi nasarar sarrafawa a cikin Fabrairu 2020.
Ana ganin cewa ba za a iya amincewa da gwajin da aka yi da abubuwa biyu ba har zuwa 28 ga Fabrairu, 2020, kuma ba bayan haka ba ne aka ba da izinin yin gwajin ga jihohi da kuma gidajen gwaji.
Hukumar Kula da Magunguna da Abinci ta Amurka ta amince da gwajin a ƙarƙashin izinin Amfani da Gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da kasancewar gwajin COVID-19 na RT-PCR a matakin ƙasa.
Hakanan, Quest Diagnostics ta ba da damar yin gwajin COVID-19 a cikin ƙasa a ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar; ana bukatar a tattara da kuma sarrafa samfurin bisa ga bukatun CDC.
A Rasha, cibiyar bincike ta Jihar Virology da Biotechnology ta VECTOR ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajista da gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton ci gaba da gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 da babban girma don haka injin guda ɗaya zai iya yin gwajin kusan 4,128 a cikin sa'o'i 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott; FDA ta riga ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma karɓi EUA daga FDA don gwaji wanda ya ɗauki kimanin minti 45.
Hukumar ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification wanda ba PCR ba.
Tun da yake ba a bukatar a yi canje-canje a yanayi, wannan hanyar tana ba da sakamako mai kyau a cikin minti biyar kawai kuma a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na'urori a Amurka kuma Abbott na tsammanin haɓaka samarwa zuwa gwaji 50,000 a kowace rana. Gwaje-gwaje da ke amfani da kwayoyin halitta guda ɗaya waɗanda ke ɗaure ƙwayoyin nucleocapsid (protein N) na sabon coronavirus suna ci gaba a Taiwan, tare da fatan samar da sakamako a cikin mintina 15 zuwa 20 kamar gwajin sauri na mura.
Wani bincike da aka yi a cikin wata littafin da aka wallafa a watan Maris na shekara ta 2020 ya nuna cewa "hotunan na thorax ba su da ƙarancin ƙimar ganewar asali a farkon lokaci, saboda CT [tomography] na iya kasancewa kafin bayyanar cututtuka".
Abubuwan da ke cikin CT sun haɗa da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan.
Ƙarƙashin ƙwayar cuta, da kuma ci gaba da ciwon yana ƙaruwa yayin da cutar ta ci gaba.
A Wuhan, wani bincike da ya kwatanta PCR da CT a lokacin da annoba ta fara ya nuna cewa CT ya fi PCR muhimmanci, ko da yake ba shi da ƙayyadaddun bayanai, tare da fasali da yawa na hoto da ke hade da cutar pneumonia da sauran cututtukan.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar "Kada a yi amfani da CT don tacewa ko a matsayin gwajin farko a cikin gano COVID-19". A watan Maris na 2020, CDC ta ba da shawarar PCR don tacewa na farko.
Wani ɓangare na maganin rigakafi ga kamuwa da cuta shi ne gina rigakafi wanda ya ƙunshi IgM da IgG.
Ana iya amfani da shi don gano kamuwa da cuta a cikin mutum daga kimanin kwanaki 7 bayan bayyanar cututtuka, don ƙayyade rigakafi ga cututtuka, da kuma a cikin kulawar yawan jama'a. Ana iya yin gwaji a cikin dakin gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin kulawa (PoCT).
Aikin kai na atomatik da ya yi nasara sosai a dakunan gwaje-gwaje da yawa zai iya yin wannan binciken, amma kasancewa a wurin zai dogara ne da yawan samar da kowace tsarin.
Don CLT, ana amfani da jini guda ɗaya na jini, ko da yake ana iya amfani da jerin jini don bin tsarin garkuwar jiki.
A cikin PoCT, ana amfani da jini guda ɗaya na jini wanda aka samu ta hanyar safa.
Ba kamar hanyar PCR ba, ba a buƙatar matakan cirewa kafin a bincika su. A ranar 26 ga Maris, 2020, FDA ta ambata hukumomi 29 da suka ba da sanarwar ga hukumomi kamar yadda ake buƙata kuma saboda haka yanzu suna iya rarraba gwajin rigakafin su.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai bisa ga izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su waɗanda zasu iya gano IgG da IgA antibodies ga ƙwayoyin cuta a cikin samfurin jini.
Yana iya gwadawa har zuwa daruruwan samfurori a cikin 'yan sa'o'i, don haka yana da sauri fiye da gwajin PCR na yau da kullum na RNA na kwayar cuta.
A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin da ta saya da zai dace da amfani da ita.
Hong Kong ta tsara tsarin da zai sa marasa lafiya masu sa ran kamuwa da cuta su zauna a gida, "ma'aikatar gaggawa za ta ba da bututun samfurin ga marasa lafiya", su yayyafa a ciki, su aika da su, kuma su sami sakamakon gwajin ba da daɗewa ba. NHS ta Ingila ta sanar da cewa NHS tana yin aikin farko na tsarin gwajin gwajin gwajin gida don kawar da haɗarin marasa lafiya na kamuwa da wasu idan sun zo asibiti ko dole ne su kashe motar asibiti idan an yi amfani da su.
Cibiyar gwajin gwaji ta taimaka wa Koriya ta Kudu ta yi gwaji mafi sauri da kuma mafi girma fiye da kowace ƙasa. A ranar 2 ga Maris, Ƙungiyar Kasuwancin Kasuwancin Kasuwancin Kasuwancin Kasuwanci ta Jamus ta ce Jamus tana da damar gwaji kusan 12,000 a kowace rana a cikin asibitin hanya kuma an yi gwaji 10,700 a makon da ya gabata.
Asusun inshorar lafiya zai biya kuɗin idan likita ya ce a yi gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da ƙarfin gwaji 160,000 a mako.
A ranar 19 ga Maris, za a yi gwaji a wasu manyan birane.
A ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba saboda an ba da rahoton sakamako mai kyau kawai.
Wani binciken farko na dakin gwaje-gwaje ya bayyana cewa, a total, an gwada aƙalla samfura 483,295 har zuwa da kuma hada da makon 12/2020 kuma an gwada samfura 33,491 (6.9%) masu kyau ga SARS-CoV-2.A Isra'ila, masu bincike a asibitin Technion da Rambam sun haɓaka da gwada hanyoyin da za su gwada samfurori daga marasa lafiya 64 a lokaci guda, ta hanyar haɗa samfurori da kuma gwada su kawai idan an sami samfurin haɗin gwiwa mai kyau. A Wuhan, dakin gwaje-gwaje na gaggawa na murabba'in mita 2,000 mai suna "Huo-Yan" (Mandarin: 火 眼, ko "Idan wuta" a cikin Indonesian) ya buɗe a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya aiwatar da samfurori sama da 10,000.
Da kuma gina shi a karkashin kulawar wanda ya kafa BGI Wang Jian kuma ya dauki kwanaki 5, samfurin ya nuna cewa a Hubei, yawan mutane da ke fama da cutar zai iya tashi da kashi 47% kuma farashin da ake kashewa don magance rigakafin zai ninka idan ba a samu damar yin gwaji ba.
Nan da nan, dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai suka bi bayan dakin gwaje-gwaje na Wuhan, a total birane 12 a fadin kasar Sin.
A ranar 4 ga Maris, 2020, ana gudanar da gwajin gwaji na yau da kullum na 50,000 a kowace rana. Tsarin Multiplex na budewa wanda Origami Assays ya saki zai iya gwada samfurori 1,222 na marasa lafiya don COVID-19 ta amfani da gwaji 93 kawai.
A watan Maris, ƙarancin abubuwa da kuma rashin isasshen abubuwa sun hana a yi gwaje-gwaje a ƙasashen Turai da Ingila da kuma Amirka.
Saboda haka, wasu masu bincike sun yi kokarin gano tsarin shirya samfurin wanda ya shafi dumama samfurin a 98 °C (208 °F) na minti 5 don sakin genomes na RNA don ƙarin gwaji. A ranar 31 ga Maris, an ruwaito cewa UAE ta yi gwajin coronavirus da yawa a kowace al'umma fiye da kowace ƙasa, kuma a shirye take ta ƙara girman gwajin don isa ga yawancin jama'a.
An cimma wannan ne ta hanyar hada gwaje-gwaje na lalatari da sayen yawan kwayoyin halitta daga Group 42 da BGI (wanda ya dogara da dakin gwaje-gwaje na gaggawa "Huo-Yan" a kasar Sin).
An gina shi a cikin kwanaki 14, kuma yana iya yin dubban gwaje-gwaje na RT-PCR a kowace rana kuma shi ne dakin gwaje-gwaje na farko da ke da wannan sikelin a wajen kasar Sin.
An yi amfani da wasu magungunan gwaji don gano wasu fannoni na kwayoyin halitta na coronavirus a kasar Sin, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar lafiya ta duniya ta amince da takardar da Jamus ta ba da don samar da kayan gwaji da za a tura wa ƙasashe masu karamin arziki ba tare da albarkatun da za su iya ci gaba da kansu ba.
An buga girke-girke na Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta samuwa har zuwa ranar 28 ga Janairu saboda haka yana rage gwajin da ke akwai a Amurka. A farkon annobar, China da Amurka suna da matsala game da amincin kayan aikin gwaji; waɗannan ƙasashen biyu da Ostiraliya ba za su iya samar da isasshen kayan gwaji don biyan buƙatun gwaji da shawarwarin ƙwararrun likitocin lafiya ba.
Akasin haka, masana sun ce samun gwaji a Koriya ta Kudu yana taimakawa wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta gina wannan dakin gwaje-gwaje a cikin shekaru da yawa, kuma yawancin su na cikin dakunan gwaje-gwaje na masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga karuwar shirye-shiryen gwaji a matsayin hanya mafi kyau don rage hauhawar cutar COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ta haifar da ɗaruruwan dubban gwaji suna jiran aiki a cikin dakunan gwaje-gwaje na Amurka, kuma wadatar kayan aiki da reagents na sinadarai sun zama ƙarancin gaske.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton rashin daidaito a cikin kayan gwajin ta.
A Amurka, kayan aikin gwajin da CDC ta haɓaka suna da "rashin aiki"; gwamnati ta cire ƙuntatawa na aikin hukuma wanda ke hana gwaji ta masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya faruwa ba saboda rashin samun samfurin ko kuma yin amfani da kayan gwaji yadda ya kamata.
Ma'aikatar kasar ta Spain ta ce za ta cire kayan aikin da suka ba da sakamako mara kyau, kuma ta maye gurbin su da wasu kayan aikin gwaji da Shenzhen Bioeasy ta samar.
Firayim Minista Matovič ya ba da shawarar cewa a jefa wannan gwajin a kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" kuma ba su "amfani da su".
Gwaje-gwajen, wanda aka bi da keɓe mutanen da suka gwada tabbatacce da kuma bin diddigin mutanen da suka yi hulɗa da mutanen da suka kamu da cutar SARS-CoV-2, sun ba da kyakkyawan sakamako.
Masu binciken da ke aiki a garin Vò Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun yi gwajin gwaji guda biyu a kan yawan mutane 3,400, a tsakanin kwanaki 10.
Kimanin rabin mutanen da suka samu sakamako mai kyau ba su da wata alama, kuma an killace duk wadanda aka gano.
Ta wajen hana mutane zuwa wannan al'umma, an kawar da sabon kamuwa da cuta.
Tare da bin diddigin lamba mai tsanani, ƙuntatawa na shiga, gwaji, da killacewa, annobar coronavirus ta 2020 a Singapore ta ci gaba da tafiya a hankali fiye da sauran ƙasashe masu tasowa duk da cewa ba tare da ƙuntatawa mai tsanani ba, kamar rufe gidajen cin abinci da kamfanonin sayar da kayayyaki.
An soke taron da yawa, kuma Singapore ta ba da shawarar mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutu a ranar 23 ga Maris.
Wasu ƙasashe kuma sun magance cutar ta hanyar bin diddigin hulɗa mai ƙarfi, ƙuntatawa na shiga, gwaji, da killacewa, amma tare da killace yankuna waɗanda ba su da ƙarfi sosai, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa kasashen da suka yi karin gwaje-gwaje, dangane da yawan mutuwar, sun samu karancin adadin mutuwar, wataƙila saboda sun fi iya gano mutanen da ke da alamun rashin lafiya ko kuma marasa cutar.
WHO ta ba da shawarar cewa kasashen da ba su da damar gwaji, da kuma dakunan gwaje-gwaje na kasa da ke da iyakantaccen kwarewar COVID-19, su aika da samfurori biyar na farko na COVID-19 da kuma samfurori goma na farko na rashin lafiya zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
A cikin wannan jadawalin, "% sakamakon gwajin da ya dace" shafi yana shafar manufofin gwajin na wannan ƙasar.
Kasashe da ke gwada mutanen da ke asibiti ne kawai za su samu sakamako mai kyau fiye da na ƙasashe da ke gwada dukan al'ummarsu, ko suna da alamun cutar ko a'a, tare da wasu dalilai iri ɗaya.
Wanke hannu, ko kuma tsabtace hannu, aikin tsabtace hannu ne da ake yi don kawar da datti, man fetur, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Yin wanka da sabulu a kai a kai a "lokaci mai muhimmanci" na yini yana hana kamuwa da cututtuka da yawa, kamar diarrhea da cholera, da ake samu ta hanyar magungunan.
Mutum zai iya kamuwa da cututtukan numfashi, kamar mura ko mura, idan bai wanke hannayensa ba kafin ya taɓa idanunsa, hanci, ko bakinsa (watau ƙwayar mucosa).
Abubuwa biyar masu muhimmanci da za a yi a kowace rana don wanke hannu da sabulu su ne: kafin da bayan zubar da ciki, bayan an wanke ɗakunan yara ko kuma an canja suturarsu, kafin a yi wa yaro abinci, kafin ya ci abinci da kuma kafin da bayan ya shirya abinci ko ya shirya nama, kifi, ko kuma naman kaza.
Idan babu ruwa da sabulu, za a iya wanke hannuwanku da toka.
Kafin, lokacin, da kuma bayan da aka shirya abinci.
Kafin da kuma bayan ka kula da marasa lafiya.
Bayan an canja tabarma ko kuma an wanke yaran da suka yi amfani da gidan wanka.
Bayan an tsabtace hanci, tari, ko kuma yin kumburi.
Bayan ka taɓa dabba, abinci na dabba, ko kuma naman dabba.
Aikin tsabtace hannu na likita yana nufin yin tsabtace hannu da ke da alaƙa da aikin likita.
Yin wanka kafin ka ba da magani ko kuma ka yi magani zai iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu a likita shi ne ya tsabtace hannayenmu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta) da kuma sunadarai da za su iya haifar da haɗari ko cututtuka.
Wannan yana da muhimmanci musamman ga mutanen da suke kula da abinci ko kuma waɗanda suke aiki a fannin likita, amma kuma yana da muhimmanci ga jama'a.
Yin wanka yana da fa'idodi masu yawa ga lafiyar mutum, ciki har da rage yaduwar cutar influenza, coronavirus, da sauran cututtukan da ke kamuwa da cuta; hana kamuwa da cututtukan da ke haifar da ciwon hanci; rage kamuwa da cututtukan numfashi;
kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa ƙara yawan wanke hannu zai iya sa jarirai su yi girma sosai.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga cututtukan numfashi da kuma ciwon ciki ta wajen sauya halaye masu sauƙi, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwa daga cutar da kusan kashi 50.
Yin amfani da wanke hannu zai iya rage yawan cututtukan da ke faruwa a cikin gida da kusan kashi ɗaya bisa uku; ana iya yin hakan ta wajen samar da ruwa mai tsabta a yankunan da ba su da isashen kuɗi.
Rashin shan ruwa da sabulu na iya rage yawan cututtukan ciki da kashi 48 cikin dari, kuma wanke hannu da sabulu shine hanya mafi inganci da rahusa don hana cututtukan ciki da cututtukan huhu (ISPA), a matsayin halin da ba a sani ba a gidaje, makarantu, da kuma al'ummomi a duk faɗin duniya.
Ciwon huhu, wanda shi ne babban ISPA, shi ne sanadin mutuwar yara ƙanana; yana kashe kusan yara miliyan 1.8 a kowace shekara.
Ana kashe kusan yara miliyan 3.5 a kowace shekara saboda ciwon zuciya da ciwon huhu.
UNICEF ta ce yin wanke hannu da sabulu kafin cin abinci da kuma bayan yin amfani da bayan gida ya zama al'ada mai kyau zai iya ceton rayuka fiye da allurar rigakafi ko wani magani, kuma zai iya rage mutuwar da ake yi a cikin diarrhea zuwa kusan rabin kuma mutuwar da ake yi a cikin cututtukan huhu zuwa kashi ɗaya bisa huɗu.
Ana yin amfani da wanke hannu a cikin wasu ayyuka na tsabtace jiki a matsayin ɓangare na shirin ruwa, tsabtace jiki, da tsabtace jiki (WASH).
Yin wanka yana kāre kanka daga rashin tausayi da ke tattare da yin jima'i da kai.
Ƙananan sakamako na wanke hannu shi ne cewa wanke hannu sau da yawa zai iya haifar da lalacewar fata daga bushewar fata.
Wani bincike da aka yi a shekara ta 2012 a Denmark ya gano cewa yin wanka sosai a hannu zai iya sa mutum ya yi saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin yin saurin saurin yin saurin yin saurin yin saurin yin saurin saurin yin saurin saurin yin saurin yin saurin saurin yin saurin yin saurin saurin yin saurin yin saurin saurin yin saurin yin saurin saurin yin saurin yin saurin.
Yin wanka sau da yawa a hannu yana nuna cewa muna fama da rashin tausayi.
Akwai lokatai biyar masu muhimmanci a rana lokacin da wanke hannu da sabulu ke da muhimmanci don rage kamuwa da cutar ta hanyar magana, wato: kafin da bayan yin amfani da toilet (tash, zubar da jini), bayan wanke bayan yaro (canja kwandon), kafin cin abinci, kafin cin abinci da kuma kafin/bayan shirya abinci ko sarrafa nama, kifi, ko raw kaji.
Sauran lokatai da ya dace a yi amfani da wanke hannu don hana kamuwa da cutar su ne kafin da bayan da aka yi wa raunuka; bayan da aka yi mani kumburi, tari, ko kuma a numfasa hanci; bayan da aka taɓa ƙazamar dabba ko kuma dabba; da kuma bayan da aka taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu yana da ƙaranci.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike a shekarar 2014 ya nuna cewa Saudiyya na da mafi girma a kashi 97 cikin dari; Amurka kusan a tsakiyar da kashi 77 cikin dari; da kuma China a mafi ƙasƙanci da kashi 23 cikin dari. Yanzu akwai wasu hanyoyin canza hali don haɓaka karɓar halayyar wanke hannu da sabulu a lokuta masu mahimmanci.
Shirin Kula da Lafiya na Ma'ana da Ma'aikatar Ilimi ta ƙasar Filifin ta yi amfani da shi a matsayin misali mai kyau na tallafi ga lafiyar yara da kuma iliminsu.
Yin maganin warts a shekara sau biyu, da kuma wanke hannuwanmu da sabulu a kowace rana da kuma wanke haƙoranmu da fluoride a kowace rana, shi ne ainihin shirin.
An yi amfani da wannan shirin sosai a Indonesia.
Ana ƙarfafa tsabtace ƙwayoyin cuta daga fata ta wajen ƙara sabulu ko kuma wankewa a cikin ruwa.
Babban aikin sabulu da kuma wankewa shi ne rage hana su warkewa da kuma ƙara yawan warkewa.
Ruwa kaɗai ba shi da tsabtace fata sosai domin kitse da furotin, wato, abubuwan da ke cikin ƙazanta, ba su da sauƙi su narke cikin ruwa.
Duk da haka, samun isasshen ruwa yana taimaka mana mu tsabtace kitse da kuma furotin.
Sabulu mai ƙarfi, saboda yadda ake sake amfani da shi, zai iya ƙunsar ƙwayoyin cuta da aka samu daga amfani da shi a dā.
Ƙananan bincike da suka yi game da yadda kwayoyin suke canja wurin su daga sabulu mai ƙonewa sun kammala cewa ba zai yiwu ba domin sun yi amfani da kumfa don su canja wurin su.
Duk da haka, CDC ta ce "abin da ya fi dacewa shi ne sabulu mai narkewa da za a cire daga cikin kwanon rufi ba tare da taɓa hannu ba".
Ana ba da shawarar yin amfani da sabulu na maganin rigakafi sosai ga mutanen da suke da sanadin lafiya.
Har zuwa yanzu, babu wata hujja da ta nuna cewa maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta da aka ba da shawarar ya fi kyau ga kwayoyin da suke da ƙwayoyin cuta a yanayi.
Amma, sabulu na antibacterial yana dauke da wasu kwayoyin cuta na yau da kullum kamar triclosan, wanda ke da jerin sunayen kwayoyin da ke da ƙarfi.
Saboda haka, ko da yake maganin maganin rigakafi ba ya magance maganin rigakafi, wannan sabulu ba zai yi tasiri sosai ba kamar yadda ake tallatawa.
Baya ga surfactants da kayan kare fata, ingantaccen tsari na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid a matsayin mai aiki na antimicrobial, da ƙarin kayan gyara fata (barbarbar crocodile, bitamin, man shanu, tsire-tsire). Wani bincike mai zurfi daga Kwalejin Kiwon Lafiya ta Jami'ar Oregon ya nuna cewa sabulu na yau da kullum yana da tasiri kamar sabulu na maganin kwayoyin cuta na masu amfani wanda ya ƙunshi triclosan a cikin hana cututtuka da kuma tsabtace ƙwayoyin cuta daga hannu.
Ruwan da ke da dumi da za a wanke hannayenmu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin suna girma da sauri a jiki (37 °C).
Ruwan sanyi da ruwan sanyi da sabulu ya fi kyau wajen kawar da man fetur na halitta da ke hana ƙazanta da ƙwayoyin cuta.
Amma, a kan abin da mutane da yawa suka gaskata, binciken kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba ya rage yawan ƙwayoyin cuta a hannunka.
Sanitizer ko maganin hana hana shan magani na hannu wani abu ne mai tsabta wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990 da kuma farkon ƙarni na 21, an san wasu kayan tsabtace hannu da ba a amfani da su a matsayin ruwan sha ba (wanda ake kira wanke hannu da giya, wanke hannu da aka yi amfani da su a maganin hana kumburi, ko kuma wanke hannu).
Yawancin waɗannan magungunan tsabta suna da tushen isopropyl na barasa ko ethanol wanda aka tsara tare da kayan daskararre kamar Carbomer (acrylic acid polymer) zuwa gel ko tare da humektan kamar glycerine zuwa ruwa ko kumfa don sauƙin amfani da kuma rage tasirin bushewa na barasa.
Ƙarin hydrogen peroxide mai laushi yana ƙara ƙarin aikin antimicrobial.
Shan giya yana kashe kwayoyin cuta, ƙwayoyin cuta masu yawa (MRSA da VRE), ƙwayoyin cuta, ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza, da hepatitis), da kuma fungi.
Shan giya mai dauke da kashi 70% na giya ya kashe kashi 99.97% (rage na log 3.5, kwatankwacin rage na 35 decibels) na kwayoyin a hannayen mutum na dakika 30 bayan amfani da kashi 99.99% zuwa 99.999% (rage na log 4 zuwa 5) na kwayoyin a hannayen mutum na minti 1 bayan amfani.
Ana amfani da maganin hana shan giya don hana cutar ta hanyar amfani da maganin hana shan magani da kuma maganin hana shan magani da kuma maganin hana shan magani.
Ka shafa gaba da baya na hannunka biyu da kuma gefen yatsunsu da kuma gefen yatsunsu na tsawon dakika 30 har sai an bushe su da ruwa, kumfa, ko gel.
Ƙungiyoyin Kula da Cututtuka na Amirka sun ba da shawarar yin wanka maimakon wanke hannu, musamman ma idan hannu ya zama kamar ba ya da kyau.
Ana amfani da kayan wankewa da yawa saboda sauƙin amfani da su da kuma saurin kashe kwayoyin cuta; duk da haka, ba za a yi amfani da su a matsayin maye gurbin wanke hannu ba, sai dai idan sabulu da ruwa ba su da.
Yin amfani da maganin shan giya na hannu zai iya sa fata ta bushe, sai dai idan an ƙara emollients da/ko moisturizers ga kayan aikin.
Ana iya rage ko kawar da sakamakon shan giya ta wajen ƙara glycerin da/ko wasu emollients zuwa ga maganin.
A cikin gwaji na asibiti, shan giya mai ƙanshi wanda ya ƙunshi emollients ya sa jiki ya yi fushi da kuma bushe fiye da sabulu da kuma maganin hana ƙwayoyin cuta.
Cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ƙananan cututtuka na cututtukan da ke shafan mutum suna jawo hankalin wannan samfurin fiye da wanke hannu da ruwa da sabulu.
Duk da cewa yana da tasiri, wakilai marasa ruwa ba sa tsabtace hannayenmu daga abubuwa masu ƙanshi, amma suna ƙazantar da su.
Saboda haka, wanke hannu ba ya da amfani sosai kamar sabulu da ruwa wajen hana kamuwa da cutar da yawa domin har yanzu akwai cutar a hannunka.
Samun nasara a yin amfani da hannayen hannu ba tare da giya ba ya dogara da kayan da kuma yadda aka tsara shi, kuma a tarihi, wannan samfurin ya fi yin aiki da yawa fiye da giya da kuma giya.
A kwanan nan, an nuna cewa maganin da ke amfani da benzalkonium chloride yana da ci gaba da aiki mai tsanani da kuma ƙwayoyin cuta bayan amfani, ba kamar giya ba, wanda aka nuna cewa yana da ƙarancin amfani bayan amfani da shi sau da yawa, wataƙila saboda ci gaba da sakamako masu illa.
Mutane da yawa a cikin al'ummomin da ba su da kuɗi ba za su iya sayen sabulu kuma su yi amfani da toka ko ƙasa a maimakon haka.
Ƙura ko ƙasa za su iya yin aiki sosai fiye da ruwa, amma ba su da amfani fiye da sabulu.
Wani abin da ya sa mutane suke damuwa shi ne, idan an gurɓata su da kwayoyin, ƙasa ko toka za su iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ash yana da tsabtace jiki domin idan ya zo cikin ruwa, zai zama alkaline.
Hukumar ta duniya ta ba da shawarar ash da yashi a matsayin madadin sabulu idan babu sabulu.
Daidaicin fasahar wanke hannu bisa ga shawarar Cibiyar Kula da Cututtuka ta Amurka don hana yaduwar cututtuka ya ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwa mai dumi ko sanyi.
Ana ba da shawarar cewa a yi amfani da ruwa mai gudana domin wanka da aka yi a cikinsa zai iya zama mai gurɓataccen ruwa, amma yanayin ruwan ba zai iya shafan yanayin ba.
Ka wanke hannunka da sabulu mai yawa, har da baya, yatsunsu, da kuma ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannu sosai sa'ad da suke amfani da sabulu fiye da idan suke amfani da ruwa kawai.
Ka shafe aƙalla na biyu.
Yin taƙaitaccen shafawa yana haifar da taƙaitaccen shafawa, wanda ke taimaka wa mutum ya kawar da ƙwayoyin cuta daga fata, kuma yin taƙaitaccen shafawa yana kawar da ƙwayoyin cuta da yawa.
Ƙarƙashin ruwa yana gudana a hankali.
Yin wanka a cikin kwandon zai iya sa hannu ya sake yin gurbatawa.
Ka bushe shi da takalma ko ka bar shi ya bushe a cikin iska.
Hannun da suka yi ruwa da kuma rigarsu suna da sauƙi su sake kamuwa da cutar.
Ƙusa da aka yi da ƙusa da kuma zanen ƙusa da aka cire za su iya ajiye ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da kayan shafawa don kiyaye hannuwanka daga bushewa; fata mai bushewa na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya yin zaɓuɓɓukan da suka dace don sauƙaƙe wanke hannu lokacin da famfo da/ko sabulu ba su samuwa ba, misali, zubar da ruwa daga sarƙoƙi ko kwalabe da aka rataye da kuma tanƙwasawa da/ko amfani da toka, idan ya cancanta, a cikin ƙasashen da ke tasowa. A cikin yanayi inda samar da ruwa ya takaita (kamar makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin da za su iya rage yawan ruwa, kamar "tippy-tap", da sauran zaɓuɓɓukan da suka dace.
Kayan ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai
Yin amfani da bushewar hannu yana da muhimmanci a tsabtace hannu, amma akwai muhawara game da yadda za a yi amfani da bushewar hannu a cikin gidajen wanka.
Ƙari da ƙari, bincike ya nuna cewa takarda mai tsabta ta fi tsabta fiye da na'urorin bushewa na lantarki da ake samu a cikin gidajen wanka da yawa.
A shekara ta 2008, wani bincike da Jami'ar Westminster ta gudanar, a London, kuma masana'antar ta tallafa wa taron taro na Turai, ya kwatanta yawan tsabtace takarda, bushewar iska mai dumi, da kuma bushewar iska mai zamani.
Bayan an wanke hannayenmu kuma an bushe su da iska mai dumi, an samu ƙaruwa da yawan kwayoyin a cikin yatsunsu da kuma hannayensu da kashi 254.
Drying tare da jet air dryer ya haifar da karuwar adadin kwayoyin a matsakaita 42% a cikin yatsunsu da 15% a cikin hannayensu.
Bayan wanke da kuma bushe hannu da takarda, adadin kwayoyin ya ragu da kashi 76% a kan yatsunsu da kuma 77% a hannayensu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don ƙayyade yiwuwar gurɓataccen gurɓataccen abu a cikin sauran masu amfani da gidan wanka da kuma yanayin gidan wanka saboda kowane irin tsarin bushewa.
Jirgin sama mai bushewa, wanda ke busa iska daga na'ura a da'awar saurin 180 m/s (650 km/h; 400 mph), yana iya busa ƙwayoyin cuta daga hannayensu da na'urorin kuma yana iya gurɓata sauran masu amfani da gidajen wanka da kuma yanayin wanka har zuwa mita 2.
Yin amfani da bushewar hannu ta iska mai zafi yana sa ƙwayoyin cuta su yadu zuwa mita 0.25 daga bushewar.
A shekara ta 2005, a cikin wani bincike da TÜV Produkt und Umwelt ya yi, an gwada hanyoyin bushewa na hannayensu.
Bayan an bushe hannu, an lura da canje-canje a yawan kwayoyin:
Akwai masana'antun bushewa da yawa, kuma an kwatanta bushewa da bushewa ta amfani da takarda.
Yin wanka da hannu da takardar wanke hannu zai iya zama hanya ta musamman a lokacin tafiya idan babu sabulu da ruwa.
Dole ne a yi amfani da giya a hannu a cikin ruwa aƙalla kashi 60 cikin ɗari na giya.
An bukaci a yi amfani da wanke hannu na likita tun bayan da masanin kimiyyar lissafi na Hungary Ignaz Semmelweis ya gano (a shekara ta 1846) cewa yana da tasiri wajen hana cututtuka a asibiti.
Akwai na'urori na lantarki da ke ba da bayanai don tunatar da ma'aikatan asibiti su wanke hannu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cuta ya ragu sa'ad da aka yi amfani da na'urar.
Ana yin wanke hannu na likita na aƙalla naƙiƙa 15, ta amfani da sabulu da ruwa da yawa ko kuma gel don shafawa da kuma shafa kowane ɓangaren hannu.
Dole ne a shafa hannayensu da yatsunsu a kan juna.
Idan akwai ƙazanta a ƙarƙashin ƙusa, za a iya amfani da goga don cire shi.
Domin ƙwayoyin cuta suna iya rayuwa a cikin ruwa da ke hannayenmu, muna bukatar mu wanke hannayenmu sosai kuma mu bushe su da tsabta.
Bayan an bushe, ana amfani da takarda don kashe famfo (da kuma buɗe ƙofar fita idan ya cancanta).
Wannan ya hana a sake gurɓata hannayensu daga wannan farfajiya.
Manufar wanke hannu a tsarin kula da lafiya ita ce kawar da kwayoyin cuta ("muman") da kuma hana su kamuwa da su.
The New England Journal of Medicine ta ruwaito cewa rashin wanke hannu yana da wuya a yawancin yanayin likita, da yawa daga cikin likitoci da ma'aikatan aikin jinya suna manta da wanke hannu kafin su taɓa marasa lafiya kuma suna iya kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi suna iya rage yawan cututtukan jini da ke tattare da kateter da kashi 66 cikin ɗari.
Za a iya samun jagororin da ke nuna yadda ake tsabtace hannu na WHO a shafin yanar gizonsa don yin tsokaci ga jama'a.
Whitby et al. sun yi nazari a kan wannan batu.
Kayan aiki na kasuwanci na iya auna da kuma tabbatar da tsabtace hannu idan ana bukatar nuna bin doka.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" don wanke hannu:
bayan an fallasa shi ga jini/ruwa na jiki
kafin aikin aseptic, kuma
Bayan an yi wa marasa lafiya magani, an ƙara sinadarai masu saurin kashewa a sabulu don kashe kayan wanke hannu.
Ana iya yin amfani da wannan aikin kafin a yi aiki ko kuma a lokacin da kwayoyin da ke da maganin rigakafi suke da yawa. Don 'sand' hannayenka kafin a yi aiki, kana bukatar ka kunna famfo da kuma kashe hannu ba tare da ka taɓa shi ba, ka wanke chlorhexidin ko iodine, ka yi amfani da lappin da ba shi da amfani don bushe hannunka bayan ka wanke shi, ka yi amfani da goga mai amfani da ba shi da amfani don yin amfani da shi da kuma wasu kayan aikin da ba su da amfani don tsabtace ƙusa.
Dole ne a cire kayan ado.
Wannan aikin yana bukatar a wanke hannayenmu da hannayenmu har zuwa wuyanmu, yawanci na tsawon minti 2 zuwa 6.
Ba a buƙatar dogon lokacin shafawa (minti 10) ba.
Idan aka wanke hannu, dole ne a hana ruwa daga hannunka.
Bayan an gama wanke hannu, sai a yi wa hannayensu wanka da rigar da ba ta da amfani kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu kafin a yi maganin da kuma bayan an yi maganin.
Don hana kamuwa da cutar staphylokococcus a asibiti, an gano cewa amfanin mafi girma na wanke hannu ya fito ne daga kashi 20 cikin 100 na wanke hannu, kuma cewa amfanin da aka samu yana da ƙarancin gaske idan an ƙara yawan wanke hannu sama da kashi 35 cikin ɗari.
Yin wanka da sabulu na yau da kullum yana haifar da sau uku na kamuwa da cututtukan cututtuka zuwa abinci fiye da yin wanka da sabulu na antibacterial.
Duk da haka, sabulu da ruwa sun fi tasiri fiye da wanke hannu na tushen giya don rage cutar influenza A H1N1 da Clostridium difficile spora daga hannu. Hanyoyin da za a inganta tsabtace hannu a cikin tsarin kula da lafiya na iya haɗawa da ilmantarwa ga ma'aikatan game da wanke hannu, haɓaka wadatar wanke hannu na tushen giya, da kuma tunatarwa ta rubuce da ta baki ga ma'aikatan.
Ana bukatar ƙarin bincike don sanin yadda za a yi amfani da maganin da ya fi dacewa a fannoni dabam-dabam na kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai sauƙi da ba ta da tsada don samun koshin lafiya ko kuma abinci mai gina jiki.
Amma, rashin isashen ruwa mai kyau, sabulu, ko kuma kayan wanke hannu a gidaje da makarantu da kuma wuraren aiki yana sa a yi wa mutane wuya su cim ma maƙasudin yin amfani da wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, ba a samun famfo a kusa da gidajen wanka na kowa ko kuma na sirri ba, ko da yake akwai zaɓuɓɓukan yin wanka na hannu mai rahusa.
Ko ta yaya, rashin tsabtace hannu zai iya faruwa ne domin halin da aka riga aka kafa, ba don rashin sabulu ko ruwa ba.
Ƙarfafawa da kuma ƙarfafawa don wanke hannu da sabulu na iya shafar yanke shawara, ya sa a san amfanin wanke hannu, kuma ya haifar da canji a cikin halayyar yawan jama'a na dogon lokaci.
Don yin aiki da kyau, ana bukatar saka idanu da kuma tantancewa.
Binciken da aka yi na nazarin bincike 70 ya gano cewa tsarin da aka kafa na al'umma yana da tasiri wajen inganta wanke hannu a LMIC, yayin da yakin neman tallace-tallace na zamantakewa bai da tasiri. Misali daya na wanke hannu a makarantu shine "Taron Star-Taro" na UNICEF wanda ya ƙarfafa makarantu su dauki matakan sauki da kuma araha don tabbatar da cewa dalibai suna wanke hannu da sabulu, a tsakanin sauran bukatun tsabta.
Idan aka kai ga mafi ƙarancin ma'auni, makarantar za ta iya motsawa daga taurari ɗaya zuwa taurari uku.
Gina wuraren wanke hannu zai iya zama wani ɓangare na kamfen na wanke hannu da ake yi don rage rashin lafiya da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na wani yunkurin wayar da kan jama'a da ke ƙoƙarin cimma burin canjin hali.
Wasu bincike sun bincika yadda ake kashe kuɗi wajen wanke hannu a ƙasashe masu tasowa don hana shekara ta rayuwa mai ƙarancin ƙwarewa (DALY) ko kuma rashin lafiya.
Wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi tsada fiye da yin amfani da ruwa da kuma wasu hanyoyin tsabta.
A tsakiyar ƙarni na 19, wasu majagaba biyu na tsabtace hannu sun san muhimmancin wanke hannu ga lafiyar mutane, musamman ma waɗanda suke cikin yanayi mai wuya, kamar su uwa da ta haifi jariri ko kuma sojoji da suka ji rauni a asibiti. Su ne Ignaz Semmelweis, wani likita na Hungary da ke aiki a Vienna, Austria, da Florence Nightingale, "mahimmanciyar aikin jinya na zamani" a ƙasar Ingila.
A lokacin, mutane da yawa sun yi imani cewa miyagun ƙwayoyi ne suke jawo kamuwa da cutar.
A shekarun 1980, annobar da ake samu ta hanyar abinci da kuma cututtukan da ke tattare da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amirka suka fi ƙarfafa tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cututtuka.
Cutar da aka yi wa naman alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa mutane a ƙasashe da yawa sun san muhimmancin wanke hannu da sabulu don kare kansu daga cututtukan da ke kamuwa da su.
Alal misali, an saka wani sanarwa da ke ɗauke da "hanyar wanke hannu" a kusa da bayan gida a cikin gidajen wanka na jama'a da kuma a wuraren wanka na ofisoshinmu da kuma filayen jirgin sama a Jamus.
Kalmar nan "wanke hannuwan" tana nufin cewa mutum ya ƙi yin wani abu ko kuma ya ƙi yin wani abu.
Wannan furucin ya fito ne daga wani nassi da ke littafin Matta sa'ad da Bilatus ya yi wa Yesu alkawari cewa zai mutu, amma ya zama sananne a cikin mutanen Ingila.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a kai a kai don tsabtace tunaninta; wani aiki da ya nuna cewa ta yi laifi ga muguntar da ta yi kuma saboda ta rinjayi mijinta ya yi hakan.
An kuma lura cewa bayan mutum ya tuna ko ya yi bimbini a kan wani abu marar kyau, yana iya yin wanka da hannu sosai kuma yana daraja kayan wanka.
Bugu da ƙari, waɗanda aka bar su su yi wanka bayan an yi musu wanka ba su da zarafin yin aikin "tsabtace" kamar su ba da kansu.
Addini ya umarci wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, wanda ke amfani da ruwa, amma ba tare da sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu a cikin addinai da yawa, ciki har da Baha'i, Hindu, tevilah da netilat yadayim a cikin Yahudawa, Lavabo a cikin Kiristanci, da Wudhu a cikin Musulunci.
Addinai kamar Hindu, Yahudawa, da kuma Musulmi sun bukaci a wanke hannuwanmu bayan yin amfani da gidan wanka.
Bugu da ƙari, addinai kamar su Hindu, Buddha, Sikh, Yahudawa, da kuma Musulmi sun ce a wanke hannu kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki don COVID-19
Gudanar da haɗarin aiki don COVID-19 shine amfani da hanyoyin aminci da lafiya na aiki don kula da haɗari don hana cutar coronavirus 2019 (COVID-19).
Gudanar da haɗarin da ya dace a wurin aiki ya dogara da wurin aiki da aikin aiki, wanda ya dogara da kimantawar haɗarin tushen fallasa, matakin rashin lafiyar jama'a, da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OSHA), ayyukan da ke da haɗari mai yawa suna da ƙarancin aiki tare da jama'a da sauran abokan aiki; don wannan aikin, ana ba da shawarar matakan hana kamuwa da cuta na asali, wanda ya haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi, da kuma yin tsabtace da kuma kashe kamuwa da cuta a cikin aikin a kai a kai.
Ayyukan da ke da haɗarin haɗari na aiki na yanzu sun haɗa da aiki da ke buƙatar kusanci ko sau da yawa tare da mutanen da ba a san su ba ko kuma waɗanda ake zaton suna fama da COVID-19, amma suna iya kamuwa da cutar ta hanyar kamuwa da cutar a cikin al'umma ko tafiya ta duniya.
Wannan rukunin ya ƙunshi ma'aikata da ke da dangantaka da jama'a kamar makaranta, wuraren aiki da ke da yawan jama'a, da kuma manyan ayyukan kasuwanci.
Gudanar da haɗari ga wannan rukunin, ban da matakan hana kamuwa da cuta na asali, ya haɗa da iska ta amfani da matattarar iska mai inganci, kariya daga kumburi, da kuma samar da kariya ta kai tsaye idan kun haɗu da masu cutar COVID-19.
OSHA ta dauki ma'aikatan kiwon lafiya da dakunan gawa da aka fallasa ga mutanen da aka sani ko ake zargi da cutar COVID-19 suna da haɗarin haɗari mai yawa, wanda ya karu zuwa haɗarin haɗari mai yawa idan ma'aikata suka yi aikin samar da aerosol a kan, ko suka ɗauki ko kuma suka yi aiki da samfurin, mutanen da aka sani ko ake zargi da cutar COVID-19.
Wannan aikin yana nufin cewa za a iya sarrafa haɗarin da ya dace da ma'aikata, kamar na'urar iska mai ƙarancin ƙarfi da kuma na'urar kāre kai da ta dace da aikin.
Cutar COVID-19 na iya samun tasiri a wuraren aiki.
Wataƙila ma'aikaci ba zai zo aiki ba domin yana rashin lafiya, yana bukatar ya kula da wasu, ko kuma yana tsoron haɗari.
Hanyoyin kasuwanci na iya canzawa, ko dai game da irin kayan da ake nema ko kuma yadda ake samun waɗannan abubuwa (kamar sayayya a waje da lokutan aiki, ta hanyar jigilar kaya, ko kuma ta hanyar layi).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ke da tasiri sosai na iya zama abin damuwa. Ana iya amfani da shiri da shirin magance cututtukan cututtukan cututtukan cututtukan cututtukan don jagorantar matakan kariya.
Shirin yana la'akari da matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, ya haɗa da tushen haɗari, abubuwan haɗari da ke tasowa daga tsarin gida da al'umma, da kuma abubuwan haɗari ga kowane ma'aikaci, kamar tsufa ko yanayin likita na kullum.
Wannan shirin ya kuma bayyana matakan da ake bukata don magance irin wannan hadarin da kuma shirin gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen da ake yi don magance cututtuka masu yaduwa na iya kasancewa bisa ga shawarwarin ƙasa ko ƙasa.
Manufofin magance annobar sun haɗa da rage kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan lafiya, kula da ayyukan kasuwanci, da rage mummunan tasirin da ke shafar sauran kamfanoni a cikin sarkar samarwa.
Matsayin da ake fama da cutar a cikin al'ummomin da ake kasuwanci yana shafar matakan da ake ɗauka.
Tsarin kula da haɗari shine tsarin da aka yi amfani dashi sosai a cikin aminci da lafiyar aiki don rarraba kula da haɗari bisa ga ingancinsa.
Idan ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafawa ta fasaha, sannan gudanarwa, kuma ƙarshe, kayan kariya.
Gudanar da fasaha ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba kuma yana iya zama mafi kyawun maganin da za a yi amfani da shi.
Gudanar da aikin gwamnati canji ne a cikin manufofin aiki ko hanyoyin aiki wanda ke buƙatar aiki na ma'aikaci ko mai aiki.
Ana ganin cewa kayan aikin kariya ta kai (APD) ba su da tasiri sosai idan aka kwatanta da na'urorin fasaha da na gudanarwa, amma suna iya taimakawa wajen hana wasu daga cikin abubuwan da suka faru.
Dole ne a zaɓi duk nau'ikan APDs bisa ga haɗarin da ke tattare da ma'aikata, a sanya su yadda ya kamata (misali, masu numfashi), a sanya su yadda ya kamata, a bincika su, a kula da su, kuma a maye gurbin su lokaci-lokaci, idan ya cancanta, kuma a cire su, a tsabtace su, kuma a adana su yadda ya kamata ko a zubar da su don kauce wa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OSHA), ayyukan da ke da haɗari mai yawa suna da ƙarancin aiki tare da jama'a da sauran abokan aiki.
Abubuwan da ake ba da shawarar don hana kamuwa da cuta a duk wuraren aiki sun haɗa da wanke hannu sosai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, halayyar numfashi ta ƙunshi rufe tari da kumburi, samar da raga da kwandon shara, shirya aiki daga nesa ko aiki a kan lokaci tare da dawowa a hankali, idan ya cancanta, sanar da ma'aikata kada su yi amfani da kayan aikin wasu, da kuma yin tsabtace da kuma kashe ƙwayoyin cuta a cikin aikin a kai a kai.
Gano mutane da sauri da kuma ware su daga waɗanda za su iya kamuwa da cutar yana da muhimmanci wajen kāre ma'aikata, abokan ciniki, baƙi, da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amirka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun kasance ba tare da zazzabi ba, alamun zazzabi, da sauran alamun cututtuka aƙalla awanni 24 ba tare da yin amfani da maganin rage zazzabi ko wasu magungunan da ke canza alamun ba, kuma cewa manufofin izinin rashin lafiya su kasance masu sassauƙa don ba ma'aikata damar zama a gida don kula da danginsu masu rashin lafiya, kuma su sanar da ma'aikata wannan manufofin.
A cewar OSHA, aikin da ke da haɗarin haɗari na aiki na yanzu ya haɗa da aiki wanda ke buƙatar kusanci ko sau da yawa a cikin ƙafa shida (1.8 mita) tare da mutanen da ba a san su ba ko kuma waɗanda ake zargin suna fama da COVID-19, amma suna iya kamuwa da SARS-CoV-2 saboda kamuwa da cutar a cikin al'ummomin da ke kusa da wurin kasuwanci, ko kuma saboda wani ya yi tafiya ta duniya zuwa wurin da ke da yaduwar COVID-19.
Wannan rukunin ya haɗa da ma'aikata da ke da hulɗa da jama'a kamar makaranta, wuraren aiki masu yawan jama'a, da tsarin sayar da kaya mai girma. Gudanar da fasaha ga waɗannan rukunin da manyan haɗari ya haɗa da sanya matatun iska mai inganci, haɓaka yawan iska, shigar da shinge na jiki kamar filastik mai tsabta na mai kula da tsatsa, da sanya windows na drive-thru ko layin don sabis na abokin ciniki. Gudanar da gudanarwa ga waɗannan rukunin da manyan haɗari ya haɗa da ƙarfafa ma'aikatan marasa lafiya su zauna a gida, maye gurbin tarurruka na gani da ido tare da sadarwar aiki ta hanyar sadarwar aiki, yin aiki tare da lokacin dawowar lokaci na gaba ɗaya / dawowa, dakatar da ba dole ba tafiya zuwa wuraren da ke fuskantar COVID-19, haɓaka shirin sadarwa na gaggawa ya haɗa da haɗuwa da damuwa ga ma'aikata, ba da kayan aiki na yau da kullun da horo game da abubuwan haɗarin COVID-19 da abubuwan da ke tattare da ayyukan tsaro da halayyar masu amfani da kayan aiki, horar da ma'aikata game da yadda ake amfani da kayan aiki da kayan aiki da kayan aiki da kayan aiki da ke tallafawa da taimakon hannu da hannu da ke rufe fuska, ko kuma kiyayewa da yanayin aiki, ƙuntata matakan da ake buƙata na amfani da su a cikin COVID-19, ƙuntatawar kiyaye lafiyar jiki da kuma kiyayewa da hannu ko kuma kiyayewa da ke tattare da yanayin aiki, ƙuntatawa na yau da kullun, ƙarancin matakan da kullun na sirri na sirri da ke tattare da ke tattare da yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin, ƙarancin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin.
Ma'aikata da ke cikin wannan rukunin haɗari ba sa bukatar na'urar numfashi.
Idan wani ya yi rashin lafiya a jirgin sama, yin amfani da matakan da za su kāre ma'aikatan da sauran fasinjoji ya ƙunshi ware mai rashin lafiya daga wasu a nesa da ƙafa 6, sanya ma'aikatan jirgin sama su kula da marasa lafiya, kuma su ba da abin rufe fuska ga marasa lafiya ko kuma su gaya musu su rufe bakinsu da hancinsu da takalma idan suna tari ko suna yin kumburi.
Ma'aikatan jirgin suna bukatar su saka safofin hannu na likita sau ɗaya a lokacin da suke kula da wani mai haƙuri ko kuma suna taɓa wani jiki ko wani abu mai cutarwa da zai iya shafar jiki ko kuma wasu kayan kāre kansu idan mai haƙuri yana da zazzabi, tari ko kuma numfashi.
Dole ne a jefa safofin hannu da sauran kayan amfani a cikin jaka mai haɗari na rayuwa, kuma dole ne a tsabtace da kuma kashe ƙwayoyin cuta bayan haka. Don jiragen ruwa na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa masu fasinjoji, kula da haɗari ya haɗa da jinkirta tafiya idan suna rashin lafiya, keɓe kansu, da kuma sanar da cibiyar likitanci a jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun bayyanar cututtuka yayin da yake cikin jirgin.
A matsayin mai kyau, ana bin diddigin likita a cikin gidajen mutane masu keɓewa. Ba tare da la'akari da yadda aka yada shi a cikin jama'a ba, don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashewa idan mutum ya taɓa kasancewa a cikin makarantar.
Idan akwai yaduwar cutar a cikin al'umma a matsakaici zuwa matsakaici, ana iya aiwatar da dabarun hana zamantakewa, wanda ya haɗa da: soke ziyara a filin wasa, taro, da sauran manyan taro, kamar koyar da jiki, ajiyar mawaƙa, ko cin abinci a kantin, ƙara nesa tsakanin tebur, jinkirin isa da dawowa, iyakance baƙi marasa mahimmanci, da amfani da wuraren ofis na kiwon lafiya daban don yara da ke da alamun cutar.
Idan akwai karuwar kamuwa da cutar a cikin al'ummomin gida, ban da dabarun hana zamantakewa, ana iya la'akari da tsawaita rufe makarantu. Ga jami'an tsaro da ke gudanar da ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar kai tsaye a matsayin ƙasa.
Jami'an tsaro da ke bukatar tuntuɓar mutanen da aka tabbatar ko ake zaton suna da cutar COVID-19 an ba da shawarar su bi ka'idoji iri ɗaya da masu aikin likita na gaggawa, gami da yin amfani da kayan kariya na kai.
Idan akwai kusanci a lokacin kamawa, ma'aikata suna bukatar su tsabtace da kuma kashe belun da kayan aikin kafin su sake amfani da su ta amfani da fesa ko layin tsabtace gida kuma su bi hanyoyin aiki na yau da kullum don sarrafawa da kuma kawar da APD da aka yi amfani da su da kuma don sarrafawa da kuma wanke tufafi masu tsabta.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da kuma dakunan gawa suna cikin haɗarin haɗari mai girma ko kuma mai girma.
Ayyukan da ke da haɗari mai yawa sun haɗa da ba da kulawar lafiya, tallafi, dakunan gwaje-gwaje, da kuma aikin sufuri na likita da aka fallasa da marasa lafiya da aka sani ko ake zaton suna da COVID-19.
Wannan aikin yana da matukar haɗarin haɗari idan ma'aikata suka yi aikin samar da aerosol a kan, ko kuma suka ɗauki ko kuma suka yi aiki da samfurin, wanda aka sani ko ake zaton yana da cutar COVID-19.
Ayyukan da ake yi don yin aerosol sun haɗa da intubation, aikin shigar da tari, aikin bronchoscopy, wasu ayyuka da kuma duba haƙori, ko kuma ɗaukar samfurin da ya shafi mutum.
Ayyukan dakin gawa masu haɗari da yawa sun haɗa da ma'aikata da ke aiki don shirya gawawwakin waɗanda aka sani ko ake zaton suna da cutar COVID-19 a lokacin mutuwa; wannan aikin yana da haɗarin haɗari sosai idan ma'aikata suka yi autopsy. Ƙarin aikin fasaha don waɗannan rukunin haɗari ya haɗa da ɗakin keɓewa don marasa lafiya da aka sani ko ake zaton COVID-19, ya haɗa da lokacin da aka yi aikin samar da aerosol.
Ƙa'idodin iska na musamman na rashin ƙarfi na iya dacewa a wasu wuraren kula da lafiya da kuma dakunan gawa.
Dole ne a yi amfani da matakan tsaro na Level 3 na Biological Safety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya da ke zuwa zuwa a cikin ɗakunan jiran daban-daban dangane da idan ana zargin su da cutar COVID-19. Baya ga sauran APDs, OSHA ta ba da shawarar masu numfashi ga mutanen da ke aiki a cikin nisan ƙafa 6 daga marasa lafiya da aka sani ko ake zargin suna da cutar SARS-CoV-2, da mutanen da ke yin aikin samar da aerosol.
A Amurka, an amince da N95 mai tsabta na fuska mai tsabta na fuska ko mafi kyau don amfani a cikin tsarin rubutaccen shirin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo, da kuma duba likita.
WHO ba ta ba da shawarar yin ado ko rufe tufafi gaba ɗaya saboda COVID-19 cuta ce ta numfashi kuma ba ta wuce ta cikin ruwan jiki ba.
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata don yin bincike a wuraren shiga.
Ga mutanen da ke daukar samfurin numfashi, kula da, ko kuma sufuri na marasa lafiya na COVID-19 ba tare da yin aikin samar da aerosol ba, WHO ta ba da shawarar yin amfani da masks na tiyata, tabarau masu kariya, ko takalman fuska, riguna, da safar hannu.
Idan an yi aikin yin aerosol, an maye gurbin masks na tiyata da N95 ko FFP2 respirators.
Ganin cewa samar da APD bai isa ba a duniya, WHO ta ba da shawarar rage buƙatun APD ta hanyar sabis na likita na nesa, iyakancewar jiki kamar windows na gani, tare da mutanen da ke cikin kulawa kai tsaye kawai za su iya shiga cikin ɗakunan da ke dauke da marasa lafiya na COVID-19, ta amfani da APD kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da numfashi iri ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da irin wannan binciken, saka idanu da daidaita sarkar samar da APD, kuma ba ta ƙarfafa amfani da masks ga mutanen da ba su da alamun bayyanar cututtuka.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
KYAUTA: Dukan ma'aikatan Wikimedia Foundation
BABU: [Covid-19] Rage nauyi da kuma shirya don nan gaba
Lokaci da za a yi amfani da shi:
LISSIYA: CC0: Babu haƙƙoƙin da aka kāre
Mun sami kanmu cikin yanayi mai ban mamaki a wannan watan.
Cutar COVID-19 ta bayyana yadda mutane suke da alaka da juna a duniya da kuma yadda muke da alhakin juna.
Ba mu taɓa fuskantar kalubalen ba, amma mun san cewa amsar da za mu iya ba ta dogara ne akan irin tausayi, haɗin kai, da kuma gina al'umma ta duniya, wanda shine ainihin wannan ƙungiyar.
Abokantaka da kuma kulawar da muka samu tsakanin abokan aiki ta hanyar imel, kira, da tattaunawa, na tabbatar da cewa akwai mutane masu ban mamaki, waɗanda muke da sa'a sosai, don yin aiki tare da su.
Ina godiya sosai kuma ina alfahari da ku sosai don na kira ku abokan aikina.
A makon da ya gabata, wani ya ba ni kyauta don aikinmu.
Sun tunatar da ni yadda yake da muhimmanci a duniyarmu a yau a samu damar shiga Wikipedia kuma yadda yake da alama mai karfi ga wannan muhimmin albarkatun don kasancewa a yanar gizo ga kowa.
Aikinku yana sa hakan ya faru, ko kuna tabbatar da cewa shafin yana aiki, ko kuna taimaka wa abokan aikinmu, ko kuma kuna taimaka wa jama'armu su kasance cikin aminci.
Duniya tana bukatar bayanan da Wikipedia ta bayar, musamman a wannan lokacin.
Wannan lokaci ne da ba kawai aikin da muke yi ba, amma yadda muke yi zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da kuke takawa a ciki, za mu yi wasu muhimman canje-canje ga yadda muke aiki tare, wanda zai fara a mako mai zuwa.
Yin gyara ga aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata a baya, kungiyoyin C sun hadu a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muka yi tunanin zai iya magance matsalolin da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da haɗin kai a wannan lokacin.
Muna son mu kawar da matsin lamba kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka rage jadawalin aikinka, to, kana da lafiya.
Ga dukan ma'aikatan, 'yan kwangila, da ma'aikatan kwangila:
Muna sa ran yin aiki na tsawon sa'o'i hudu a rana, ko kuma 20 a mako, har sai an ba mu ƙarin bayani.
Ba mu da hutu, idan za ka iya yin aiki a lokutan yau da kullum, wannan aikin yana bukatar ka.
Amma, ba za a iya sanin abin da zai faru a yau ba, kuma ko kana bukatar ka kula da ƙaunatattunka, ka je ka sayi kayayyakin da ake bukata, ko ka je ka je likita, lafiyarka ita ce abin da muke fifitawa.
Ba mu lura da lokutan aikinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne a ce hakan, amma mun faɗa.
Ba a bukatar a cire ciwo ko kuma a cire PTO ba, kawai ka sanar da manajanka kuma ka taimaka wa ƙungiyarka ta sake duba kalandar da jadawalin don tabbatar da cewa za a iya kammala manyan ayyukan.
(Idan an gano cewa kana da cutar COVID-19, ka sanar da Bryan a cikin T&C Ops don T&C ta taimaka wajen tallafawa yanayin ka kuma tabbatar da cewa kana samun kulawa mai kyau daga gudanarwa).
Abokan aikin da suke biyan albashi bisa sa'a za su samu cikakken albashin.
Mun faɗi haka, kuma mun sake faɗi haka, don girmama alƙawarinmu ga abokan aikinmu da ma'aikatan da ke aiki a kan lokaci.
Za a biya kowa bisa ga yawan aikinsa a lokacin da yanayin ya kasance daidai.
Hakan ya haɗa da idan kana rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son ka yi aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aikin su wajen ba da gudummawa ga duniya.
Aikin da muke yi yana iya kawo gamsuwa sosai, musamman ma a irin wannan lokacin.
A wannan yanayin, abin da ya fi muhimmanci shi ne ka kula da kanka.
Muna rokon ka ka yi magana da manajanka don mu san abin da za mu yi tsammani kuma mu ɗauki mataki.
Aikin da aka yi yana da muhimmanci.
Akwai wasu ayyuka da za a ci gaba da yi.
SRE, HR, Trust & Safety Operations, da kuma Tattalin Arzikin Tattalin Arzikin, sun haɗa da yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu kuma mu mayar da hankalinmu ga tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za mu yi, za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka rage gudu a yanzu, ba za mu yi nasara ba.
Ba ma shirin yin "aikin lokaci bayan lokaci" bayan annobar ta shuɗe.
Ba za a sa ran ka yi aiki a kan lokaci ba don ka cika takaddun da ba za a iya cim ma ba.
Mun fahimci cewa yanayin yana canjawa kuma za mu yi ƙoƙari mu kafa sababbin manufofi da kuma jadawalin lokacin da ya dace.
Mene ne game da APP?
Don daidaitawa da sabon yanayi da kuma tsammanin sa'o'in aiki na yau da kullun, muna nufin daidaita jadawalin lokaci don aiwatar da Shirin Shekara na 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita shirin 2019-2020 wanda zai ba da ƙarin lokaci don tsara kasafin kuɗi don haka ma'aikata za su iya ba da fifiko ga aiki mai mahimmanci, kula da kansu, da kula da ƙaunatattun su yayin da suke maraba da waɗanda suke buƙata ko son aiki tare da ƙasa da jadawalin a cikin makonni masu zuwa.
Wannan tsawaita lokaci ya rage yawan aiki da kuma matsin lamba a kan tsarin da ake ciki a yanzu a dukan ƙungiyoyi.
Za mu gabatar da shawarwarinmu ga Majalisar mako mai zuwa kuma za mu sabunta tawagar da tawagar a mataki na gaba da zarar mun samu tabbaci.
Na gode da tawagar APP saboda jagorancinku a wannan batun.
Yanayin, bayyanar, da kuma tsabtace ofishin
A makon da ya gabata, an gaya mana cewa wani abokin aikinmu da ke SF na iya kamuwa da cutar COVID-19.
Amma, saboda muna da damuwa sosai, mun ɗauki ma'aikatan tsabtace riga-kafi don su tsabtace dukan wuraren da ke ofis ɗinmu a San Francisco.
Suna amfani da maganin rigakafi na asibiti don kashe dukkan farfajiyar da ke cikin bene, da kuma dukkan lif da ke shiga bene.
Ƙungiyoyin gine-gine suna amfani da tsarin tabbatar da lafiyarsu ta amfani da kayayyakin da ke tallafawa lafiyar mazaunan.
Muna farin ciki cewa za mu iya yin amfani da ofishin sa'ad da muka soma komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya ba mu tsarin COVID-19 da kuma duk ma'aikatanmu na DC.
Tun makon da ya gabata, ofishinmu na DC ya koma tsarin aiki na nesa, daidai da jagorar da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu da ke birnin New York suka sani, muna tattaunawa game da yin hayar wani wuri a Brooklyn.
Wannan tattaunawar tana ci gaba, amma za ta iya jinkirta.
Wasu abokan aikinmu suna aiki a nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki a nesa sun fahimci cewa hakan na iya bukatar gyara kuma suna so su ba ku shawara:
Aƙalla sa'a ɗaya ko biyu ne kawai taron zai ɗauki.
Idan ana bukatar ƙarin lokaci, ka yi la'akari da yadda za ka raba shi zuwa kwanaki da yawa.
Ka bayyana taron a fili, ka tsara jadawalin, kuma ka aika da littattafan da za a karanta a gaba.
Ka sa bidiyon ta zama tsoho, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai tsaye.
Ka naɗa shugabanni su taimaka wa kowane taro, wani ya lura da tattaunawar don tambayoyi da kuma rubuta jerin masu magana, kuma wani ya taimaka wajen yin rikodin taron (ko yin rikodin rikodin aiki tare).
Ka aika da imel zuwa goyon bayan fasaha idan kana bukatar wani belun kunne mai sauƙi.
Ka yi amfani da kuɗin da kake samu don ka sayi abinci.
Ka shiga tashar #remoties ta Slack don ka yi magana da abokan aikinka game da aikin da aka raba
Ƙungiyar Ayyukan HR tana neman jagororin ergonomics na yanar gizo don tallafawa haɓaka aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karbar tallafin al'umma su soke taron jama'a na Wikimedia, kamar Edit-a-thon, har sai WHO ta bayyana cewa annobar ta kare.
Mun gaya musu cewa mun fahimci cewa bukatarmu ta sokewa da kuma wasu takunkumi na iya hana su kammala ayyukan tallafin da aka amince da su kuma cewa babu wanda za a yi masa hukunci saboda jinkirta ko gyara wannan manufa.
A mako mai zuwa za mu ci gaba da yin bayani game da Wikimania da kuma sauran taron yanki da na al'umma.
A general, ji daga dukan al'umma na duniya ya bayyana a cikin baƙin ciki saboda wannan rikici, amma a lokaci guda an warware a kan bayyanar da kuma ikon mayar da hankali a kan kansa al'umma, duka Wikimedia da sauransu.
A nan gaba, CRT na aiki don kafa shafuka a cikin Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyoyinmu na sadarwa tare da su.
Kasancewa a cikin haɗi yayin yanayin COVID-19
Za mu aika da gayyatar zuwa kalandarku a ranar Alhamis mai zuwa, da karfe 14:00 UTC/07:00 PT don taron ma'aikatan musamman.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ba da lokaci don haɗa kai.
Muna cikin wannan yanayin kuma muna so mu taimaka wa mutane da yawa.
A halin yanzu, za ka iya ci gaba da samun bayanai daga wannan imel ɗin da kuma duk wasu muhimman bayanai game da COVID-19 a cikin Office Wiki.
CRT za ta ci gaba da sabunta wannan shafin kuma ta tabbata cewa duk bayanan suna cikin wuri ɗaya.
Muna kuma ƙoƙari mu ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da ake fama da cutar sosai.
Idan kana da tambayoyi game da tafiya, wani abu, babban aiki, ko kuma matsaloli game da ɗaukar hoto, ko kuma wani abu da zai iya buƙatar taimako, kada ka yi shakka ka sanar da shi kuma ka yi aiki tare da CRT.
Muna nan don taimaka wajan tallafawa da kuma kasancewa a matsayin mai ba da shawara idan ana bukatar hakan.
Idan kana da wata matsala mai rikitarwa ko kuma ta sirri, ka aika da imel zuwa ga Bryan Judan, Darakta na Ayyukan Duniya na Hadin Kan Kan Kan Kan Kasa.
Kada a ɗauki kowane irin wannan canji a matsayin watsi da aikinmu da kuma hakkinmu.
Maimakon haka, wannan canjin ya nuna cewa a yanzu, aikinmu da kuma ayyukanmu suna bukatar a daidaita su a hanyar da ba mu taɓa yi ba.
Waɗannan canje-canjen sune matakan da muka yi imanin suna da mahimmanci don tallafawa juna a wannan yanayin don mu ci gaba da aiki, samar da tallafin da motsinmu yake buƙata, da kuma samar da sabis ɗin da duniya ke dogara da shi.
Ayyukan da muka yi a gaba za su kasance a wurin a lokacin da suka dace.
A yanzu, lokaci ya yi da za mu goyi bayan juna kuma mu samar da sarari don muhimmin aikin da zai faru a cikin makonni da watannin da za su zo.
Muna bukatar ku yi hakan, kuma muna so ku kula da kanku da iyalanku don ku yi aiki sosai a lokacin da ake bukata.
A ƙarshe, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran mambobin kungiyar Leadership (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
B'Angiotensin 2 (ACE2) mai canzawa enzyme ne wanda yake haɗe da farfajiya na waje (membrane) a cikin huhu, jijiyoyi, zuciya, koda, da hanji.
ACE2 yana da aiki na gaba da na angiotensin-converting enzyme (ACE), ta hanyar rage yawan angiotensin-II da kuma kara Angiotensin (1-7), yana mai da shi wata manufa mai ban sha'awa don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin shigarwa zuwa cikin kwayoyin halitta don wasu coronavirus.
Ana kiran juyin halitta na ɗan adam na ACE2 hACE2.
Angiotensin 2 mai juyawa enzyme ne mai dauke da zinc wanda yake a farfajiyar endothelial da sauran kwayoyin halitta.
Protein ACE2 yana da yankin M2 na terminal-N peptidase da kuma yankin transporter na terminal-C na renal amino acid collectrin.
ACE2 shine furotin mai ɗaukar hoto guda ɗaya na nau'in I, tare da yankin aiki mai aiki wanda aka fallasa a saman sel a cikin huhu da sauran kayan.
Ƙungiyar ACE2 ta cire daga cikin ƙwayoyin transmembrane ta wani enzyme, wanda aka sani da sheddase, kuma an saki furotin mai narkewa a cikin jini kuma an fitar da shi cikin fitsari.
ACE2 yana cikin mafi yawan gabobin jiki: ACE2 yana haɗe da membranes na ƙwayoyin halitta musamman na ƙwayoyin cuta na huhu na nau'i na II, ƙwayoyin gut, ƙwayoyin endothelial na arteries da veins, da ƙwayoyin jijiyoyin jini a mafi yawan gabobin jiki.
Ana kuma samun ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus, da kuma ƙwaƙwalwar ƙwaƙwalwa.
Babban aikin ACE2 shine daidaita ACE.
ACE ta raba hormone angiotensin I zuwa angiotensin II na vasosuccontraction.
A ƙarshe, ACE2 ta yanke amino acid phenylalanine na karboxyl terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ta hydrolyzed shi zuwa vasodilator angiotensin (1-7) (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya karya wasu peptides ciki har da [des-Arg9] -bradikinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana daidaita zirga-zirgar membrane na amino acid SLC6A19 wanda ba shi da amfani kuma yana da hannu a cikin cutar Hartnup.
A matsayin furotin mai transmembrane, ACE2 yana aiki a matsayin babban shigarwa a cikin sel don wasu coronavirus, wanda ya haɗa da HCoV-NL63; SARS-CoV (virus wanda ke haifar da SARS); da kuma SARS-CoV-2 (virus wanda ke haifar da COVID-19).
Ƙari ga haka, haɗuwa da furotin S1 a spike ko spike na SARS-CoV da SARS-CoV2 tare da yankin ACE2 enzymatic a saman sel yana haifar da endositosis da kuma canzawar ƙwayoyin cuta da enzymes zuwa endosomes da ke cikin sel.
Wannan tsarin shigar da kwayar cutar yana buƙatar priming na S-protein ta hanyar TMPRSS2 mai karɓar bakuncin protease serine, wanda ake bincike a halin yanzu don hana shi a matsayin magani mai yiwuwa.
Duk da haka, yawancin masana da kuma hukumomi suna ba da shawarar ci gaba da maganin ACE da ARB na yau da kullum.
Wani bincike da aka yi a kan tsarin da kuma nazarin da aka yi, wanda aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "amfani da masu hana ACE ya haifar da raguwa mai muhimmanci na 34% a cikin hadarin cutar ta huhu idan aka kwatanta da na iko".
Bugu da ƙari, "amfani da masu hana ACEs ya rage haɗarin kamuwa da cutar huhu a cikin marasa lafiya da ke da haɗarin kamuwa da cutar, musamman waɗanda ke fama da bugun jini da rashin zuciya.
Ana kuma danganta amfani da ACE inhibitors da rage yawan mutuwar da ke tattare da cutar huhu, ko da yake sakamakon bai da ƙarfi idan aka kwatanta da haɗarin cutar huhu gaba ɗaya".
Ana tsammanin ACE2 na mutum (rhACE2) zai zama sabon magani don cututtukan huhu na gaggawa, kuma yana da alama yana haɓaka haemodynamics na huhu da kuma saturated oxygen a cikin alade tare da cututtukan huhu na gaggawa wanda lipoplysaccharides ke haifar.
RHACE2 yana da rabin lokaci na kimanin sa'o'i 10 a cikin mutum tare da aiki na minti 30 ban da tsawon sa'o'i 24.
Wasu binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga marasa lafiya da ba su yarda da tsarin renin-angiotensin (RAS) na gargajiya ba ko kuma a cikin cututtuka da angiotensin II a cikin jini ya karu. An gwada rhACE2 a cikin gwaji na asibiti don maganin cututtukan huhu.
b'Aikace-aikacen COVID-19 aikace-aikace ne na wayar hannu wanda aka tsara don taimakawa bin diddigin lamba don magance cutar coronavirus ta 2019-2020, wato, tsarin gano mutane ("taɓawa") waɗanda zasu iya yin hulɗa da mutanen da suka kamu.
An yi amfani da aikace-aikacen da yawa ko kuma an gabatar da su, kuma an ba su goyon baya na gwamnati a wasu yankuna da kuma hukumomi.
An gina wasu tsarin da za su iya yin amfani da su wajen bin diddigin lambobin sadarwa.
An yi tambaya game da batun tsare sirri, musamman ma game da tsarin da ke dogara da bin diddigin yanayin masu amfani da aikace-aikacen.
Wani zaɓi da ba ya ɓata sirrin mutum ya ƙunshi yin amfani da siginar Bluetooth don yin rikodin yadda mai amfani yake kusa da wata wayar hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa waɗannan aikace-aikacen na Bluetooth kai tsaye zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta kaddamar da aikace-aikacen da ke ba 'yan ƙasa damar duba idan sun yi hulɗa da masu cutar COVID-19.
Ana amfani da shi a birane fiye da 200 a kasar Sin. A Singapore, ana amfani da shi da wani app mai suna TraceTogether.
Kungiyar IT ta ci gaba da samar da wannan app, ta saki shi a matsayin tushen budewa kuma za a mika shi ga gwamnatoci. Arewacin Macedonia ta kaddamar da "StopKorona!", wani app na Bluetooth don bin diddigin bayyanar da mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Kiwon Lafiya ne suka samar da wannan aikace-aikacen.
Har zuwa 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin lamba yana cikin ci gaba da ci gaba kuma zai kasance a cikin 'yan makonni don rarrabawa.
Australia da New Zealand suna la'akari da aikace-aikacen da ke dogara da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na son gabatar da aikace-aikacen geofencing ga marasa lafiyar da aka gano COVID-19 da ke zaune a Moscow; an tsara wannan aikace-aikacen don tabbatar da cewa ba sa barin gida.
Ross Anderson, wani farfesa a jami'ar Cambridge, ya ambata wasu matsaloli masu amfani da za su iya faruwa a tsarin da aka yi amfani da shi, wanda ya haɗa da rashin tabbataccen sakamako da kuma yiwuwar rashin tasiri idan an yi amfani da bayanan da aka yi amfani da su a cikin ƙananan ƙananan mutane.
Don magance damuwar game da ɓarna ko ɓarna na aikace-aikacen "coronavirus", Apple ya sanya takunkumi kan nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, wato, iyakance kawai ga ƙungiyoyi "masu izini" ko masu suna.
Google da Amazon sun yi amfani da irin wannan takunkumin.
Masu goyon bayan tsare sirri sun nuna damuwarsu game da tasirin saka idanu da yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a dakatar da tsarin saka idanu da aka gina don magance cutar coronavirus bayan barazanar ta wuce.
Amnesty International da fiye da kungiyoyi 100 sun fitar da sanarwa da ke kira ga a takaita irin wannan sa ido.
Ƙungiyar ta bayyana abubuwa takwas da ake bukata don aikin gwamnati:
Masu kula da ayyukan dole ne su kasance "daidai da doka, da bukata, da kuma daidaitacce".
Ƙarin kula da kulawa da kulawa dole ne ya ƙunshi sashe na rana;
amfani da bayanai ya kamata a iyakance ga dalilai na COVID-19;
Ana buƙatar tabbatar da cewa an tabbatar da tsaro da kuma bayanan bayanan bayanan.
a yi amfani da shi wajen tsara tsarin tsaro na zamani da kuma na zamani.
duk wani raba bayanai tare da ɓangare na uku dole ne a ayyana shi a cikin doka;
ya kamata a kare shi daga cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi;
Wannan yana nufin cewa ana bukatar 'yan'uwa masu ruwa da tsaki masu dacewa' su shiga, wanda ya hada da masana kiwon lafiya da kuma kungiyoyin da ba su da alaka da aikin.
Manufar da Google/Apple ta gabatar tana nufin magance matsalolin ci gaba da saka idanu ta hanyar cire hanyoyin bin diddigin daga tsarin aiki na na'urar bayan ba ta da mahimmanci.
Wasu ƙasashe suna amfani da bin diddigin cibiyar sadarwa, ba aikace-aikace ba, don haka suna kawar da buƙatar sauke aikace-aikace da kuma ikon guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da ke kan layi.
Maganin da ke kan hanyar sadarwa wanda ke da damar shiga bayanan wuri na asali yana da babbar matsalar sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne ke buƙatar samun damar bayanan wuri na sirri; an kirkiro wasu tsarin da ke kare sirrin kuma suna amfani da cibiyar sadarwa kawai don sadarwa (duba ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba a dogara da aikace-aikace ba don bin diddigin lambobin sadarwa.
Maimakon yin amfani da aikace-aikace na musamman, tsarin yana tattara bayanan bin diddigin daga tushe daban-daban, yana haɗa da bayanan bin diddigin wayar hannu da bayanan ma'amala na katin, kuma yana haɗa wannan bayanin don samar da sanarwa ta saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Ban da yin amfani da wannan bayanin don faɗakar da yiwuwar tuntuɓar, gwamnatoci suna kuma ba da bayanin wurin ga jama'a, abin da aka ba da izinin yin canje-canje masu yawa a dokokin tsare sirri na bayanai bayan barkewar cutar ta MERS a ƙasar.
Ana samun wannan bayanin ta hanyar wasu aikace-aikace da kuma shafukan yanar gizo. Kasashe kamar Jamus suna la'akari da amfani da tsarin da ke da cibiyar sadarwa da kuma tsarin da ke kare sirrin mutum.
Har zuwa 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Kula da hulɗa da ke kare sirrin mutum ra'ayi ne mai kyau, tare da adadi mai yawa na wallafe-wallafen bincike tun daga aƙalla 2013. A ranar 7 ga Afrilu, 2020, fiye da rukuni na masana sun yi aiki a kan hanyoyin da ke da alaƙa da sirrin mutum, kamar amfani da Bluetooth Low Energy (BLE), don yin rikodin kusanci ga mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ya ƙunshi tsarin daidaitawa da rarrabawa, ba yarjejeniya guda ba. Tsarin daidaitawa ya haɗa da Tsare-tsare na Tsare-tsare wanda ke kare Tsare-tsare na Tsare-tsare (DP-PPT/DP-3T), Lambar Sadarwa ta Waya (TCN, da aka kira Lambar Taron Sadarwa, CEN), Lambar Tsare-tsare da Tsarin Tsare-tsare don Kula da Sadarwar Sadarwa (PACT), da sauransu.
A cikin wannan yarjejeniya, bayanan sirri da za a iya ganowa ba su taɓa barin na'urar ba, kuma duk daidaitawa suna faruwa a cikin na'urar.
Ƙungiyar Masu Kare Sirri a MIT Media Lab ta haɓaka SafePaths, dandamali don amfani da fasahar kare sirrin yayin tattarawa da amfani da wurare ko bayanan haɗakarwa don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka yi daga takardar farin "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" da aka saki a watan Maris na 2020. Wani irin wannan shiri shi ne dandamali na SafeTrace na Enigma MPC, kamfanin da ke bunkasa fasahar tsare sirri kuma an kafa shi ne a MIT Media Lab.
SafeTrace yana amfani da ingantaccen fasahar kayan aiki don bawa masu amfani damar raba wurare da bayanan kiwon lafiya masu mahimmanci tare da sauran masu amfani da jami'an ba tare da yin sadaukar da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da ke da tsarin daidaitaccen tsarin da ke da yawa sun kafa haɗin gwiwar TCN na duniya, tare da nufin rage rarrabuwa da ba da damar haɗin gwiwar duniya don aikace-aikacen bin diddigin da gargadi, wanda shine babban ɓangare na cimma karbuwa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar BlueTrace da aikace-aikacen hukuma na gwamnatin ta ke amfani da ita a matsayin tushen budewa.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri don bin diddigin lambobin sadarwa, wanda suka yi ikirarin zai kare sirrin mutum, bisa ga haɗin fasahar Bluetooth Low Energy da kuma boye-boye masu kare sirrin mutum.
Sun kuma wallafa takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, ana nufin a fara wannan tsarin a matakai uku:
ƙaddamar da kayan aiki don ba da damar gwamnati ta ƙirƙiri aikace-aikacen bin diddigin coronavirus wanda ke kare sirrin mutum
Google da Apple suna shirin magance matsalar tattara bayanai da kuma ci gaba da saka idanu ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan kuma cire shi ta wannan hanyar bayan barazanar ta wuce.
B'A maye gurbin magani (wanda ake kira sabon aiki, sabon salo, ko sabon aiki a kan magani ko kuma sauyawa) shine amfani da magani wanda aka amince da shi don sabon magani, wato, don wani cuta ko yanayin likita wanda ya bambanta da burin farko na ci gaban magani.
Wannan hanya ita ce hanyar bincike na kimiyya da ake yi a halin yanzu don haɓaka ingantacciyar magani ga COVID-19.
Sauran hanyoyin bincike sun hada da ci gaban allurar COVID-19 da kuma karuwar jini na jini. SARS-CoV-2 yana da kimanin sunadarai 66 da zasu iya zama maganin maganin, kowannensu yana da wasu wuraren ɗaurewar ligand.
Nazarin waɗannan rukunin haɗin haɗin gwiwa na iya zama tushen aikin haɓaka maganin riga-kafi mai tasiri ga furotin COVID-19.
Wasu daga cikin manyan sunadarai na SARS-CoV-2 sune proteases masu kama da papain, RNA-dependent polymerase-RNA, helikase, S protein, da ADP ribophosphatease.
Hussein A, et al sun bincika wasu kwayoyin candidates da aka inganta sannan suka bincika kamanceceniya da su da magungunan da aka amince da su kuma suna da mafi girman dacewa don hanzarta ci gaban magungunan anti-SARS-CoV-2 a cikin binciken su na farko don a ba da shawarar a cikin ƙirar binciken asibiti.
Chlorokuin magani ne na maganin malaria wanda ake amfani da shi wajen magance wasu cututtuka na autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chlorokuin da kuma hydrochlorokuin da suka shafi su ne biyu daga cikin magunguna hudu da za a yi nazari a kansu a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa gwajin chlorokuin da hydrochlorokuin a New York zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydrochlorokuin sulfate da chlorokuin phosphate bisa ga Izinin Amfani da Gaggawa (EUA).
Hukumar kula da lafiya ta FDA ba ta amince da wannan magani ba kuma an ba shi izini bisa ga EUA a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da ke cikin asibiti, amma ba za su iya karɓar magani a cikin gwaji ba.
CDC ta ce "amfani, sashi, ko tsawon hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2" bai riga ya ƙayyade ba.
Likitoci sun ce suna amfani da maganin ne a lokacin da "ba su da wani zaɓi".
Wani rukuni na masu bincike a Turkiyya a Istanbul suna yin wani karamin bincike game da amfani da chloroquine a hade da zinc, bitamin A, bitamin C, da bitamin D.
Ana ci gaba da bincike a jami'ar Duke da kuma jami'ar Oxford.
Makarantar likitancin NYU Langone tana gudanar da gwajin aminci da ingancin amfani da hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun ce favipiravir ya tabbatar da "a bayyane yake cewa yana da tasiri".
A Shenzhen, marasa lafiya 35 sun yi gwajin rashin lafiya a matsakaiciyar kwanaki 4, yayin da marasa lafiya 45 da ba su karɓi magani ba sun yi kwanaki 11 suna shan cutar.
A wani bincike da aka yi a Wuhan a kan mutane 240 da ke fama da cutar huhu, an ba rabin su favipiravir kuma an ba sauran rabin su umifenovir.
Hukumar Kula da Magunguna ta Italiya ta yi wa jama'a gargaɗi cewa babu wata hujja da ta nuna cewa maganin yana da kyau kuma ba a riga an yi hakan ba.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don wadata da kuma amfani da sojoji don aikawa da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don magance marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump tayin sayan maganin, wanda zai iya zama da rashin inganci a cikin yanayin rashin lafiya mai tsanani da cutar ta riga ta ninka.
Wataƙila ba shi da lafiya idan mata masu ciki ko kuma waɗanda suke ƙoƙarin yin ciki suka yi amfani da shi.
Wani bincike na lopinavir/ritonavir (Kaletra), wanda ya haɗa da maganin maganin maganin maganin maganin lopinavir da ritonavir, ya kammala cewa babu amfanin da aka lura.
An tsara wannan magani don hana kwayar cutar ta HIV ta hanyar ɗaure shi zuwa protease.
Wani rukuni na masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magungunan don gano mahaɗan da za su yi aiki tare da protease na SARS-CoV-2. Akwai zargi a cikin masana kimiyya game da jagorantar albarkatu don sanya magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta kirkiro Remdesivir kuma ta ci gaba da shi a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg.
Wata matsala da maganin riga-kafi yake jawowa ita ce, ana samun rigakafi ta hanyar canji wanda zai iya haifar da cututtuka da kuma wucewa.
Wasu bincike na farko sun nuna cewa remdesivir na iya samun babban juriya na kwayoyin halitta. Akwai wasu gwaje-gwaje na asibiti a yanzu, wanda ya haɗa da gwaje-gwaje biyu da asibitin Jami'ar Cleveland suka gudanar, ɗaya ga mutanen da ke da cututtuka masu matsakaici da kuma wani ga waɗanda ke da ciwon gaske.
Akwai gwaji uku na asibiti a cikin jiki na Vitamin C ga mutanen da ke cikin gida da kuma waɗanda ke fama da cutar COVID-19, wato, placebo biyu da aka sarrafa (Tungkok, Kanada) da kuma wanda ba a sarrafa ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Lafiya ta Kasa (NCGM) ta Japan tana shirin yin gwaji na asibiti don Alvesco (ciclesonide) Teijin, wani corticosteroid mai numfashi don asma, don kula da marasa lafiya da ke da sabon kamuwa da cutar coronavirus.
A wani nau'i na angiotensin 2 mai sauya enzyme, ana gudanar da wani gwaji na Phase II da za a yi da marasa lafiya 200 daga cikin marasa lafiya masu tsanani da aka yi a cikin gida a Denmark, Jamus, da kuma Austria don a san yadda magani zai yi tasiri.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a yanzu suna nazarin rawar da kolkisin ke takawa wajen rage kumburi da rikitarwa a cikin marasa lafiya da ke fama da bayyanar cututtukan COVID-19.
Wannan binciken, wanda ake kira COLCORONA, ya yi amfani da manya 6,000 masu shekaru 40 da haihuwa da aka gano suna da cutar COVID-19 kuma suna da alamun rashin lafiya wanda ba su buƙatar shiga asibiti.
Mata da suke ciki ko suna shayarwa ko kuma ba sa amfani da maganin hana haihuwa da ya dace ba su cancanci yin hakan.
Ana gwada wasu maganin hana hawan jini a Italiya.
Ana amfani da ƙananan kwayoyin heparin sosai wajen kula da marasa lafiya kuma hakan ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa wasu shawarwari game da amfani da shi.
An sanar da wani bincike mai zurfi a kan marasa lafiya 300 da ke nazarin amfani da sodium enoxaparin a allurai masu kare lafiyar da kuma magani a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, yawancin kimiyya sun mai da hankali kan ba da sabon magani ga maganin rigakafi da aka amince da su da aka haɓaka don annobar da ta gabata, kamar MERS, SARS, da West Nile virus.
Ribavirin: ana ba da shawarar ribavirin don maganin COVID-19 bisa ga jagorar fitowar 7 ta kasar Sin
Umfenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagorar fitowar 7 ta kasar Sin
Wasu kwayoyin da aka gano suna iya zama magunguna waɗanda za a iya ba su sabon manufa don maganin COVID-19:
Tocilizumab (Anti-receptor IL-6): An amince da shi a kasar Sin.
Bugu da ƙari, an yi gwaji a Italiya da China, duba kuma Tocilizumab#COVID-19.
B'Ayyukan rigakafin COVID-19 sune rigakafin cutar coronavirus 2019 (COVID-19).
Ko da yake babu wani magani da ya kammala gwajin asibiti, ana yin ƙoƙari sosai don samar da maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce, a cewar WHO, allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, ba za ta kasance cikin ƙasa da watanni 18 ba.
'Yan takarar rigakafin guda biyar suna cikin binciken tsaro na Phase I a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Babban annobar ta bazu ko'ina cikin duniya a shekarar 2020, wanda ya haifar da saka hannun jari mai yawa da kuma ayyukan bincike don bunkasa allurar rigakafi.
Yawancin kungiyoyi suna amfani da bayanan da aka wallafa don samar da allurar rigakafi da za ta iya yaki da SARS-CoV-2.
CEPI ta ba da sanarwar a watan Afrilu cewa abin da ya kamata a lura da shi wajen bunkasa allurar rigakafi shine saurin, ƙarfin samarwa, yaduwar da ake bukata, da kuma samun damar duniya.
A watan Afrilu, jami'an CEPI sun ruwaito cewa dandamali daban-daban 10 na fasaha suna cikin bincike da ci gaba a farkon shekarar 2020 don samar da allurar rigakafi mai tasiri ga COVID-19.
Babban manufofin dandamali da ke ci gaba zuwa binciken tsaro na Phase I sun hada da:
nucleic acid (DNA da RNA) (mai haɓaka Fasa I da kuma candidate na allurar rigakafi: Moderna, mRNA-1273)
masu ɗaukar hoto na cutar (mai haɓaka Phase I da mai neman allurar rigakafi: CanSino Biologics, masu ɗaukar hoto na adenovirus nau'i 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimillar masu neman allurar rigakafi 115 suna cikin matakai na farko na ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma wasu 37 da aka sanar, amma tare da karancin bayanan da ake samu (da ake zaton suna cikin shiri ko suna cikin shiri).
A cikin gwajin Phase I-II, an fara gwada lafiyar jiki da kuma rigakafin rigakafi, yawanci a bazuwar, a ƙarƙashin placebo, da kuma a wasu wurare, yayin da ake tantance mafi ingancin maganin.
A cikin gwaji na III, yawanci mutane da yawa suna halarta, har da masu kula da su, kuma suna gwada ingancin allurar rigakafi don hana cututtuka, yayin da suke lura da sakamako masu illa a mafi kyawun sashi.
Daga cikin masu neman allurar rigakafi 79 da ake ci gaba da su (wanda aka tabbatar a farkon watan Afrilu na 2020), 74 daga cikinsu ba su shiga cikin kimantawar mutum ba (har yanzu suna cikin binciken "kayan aiki").
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa suna binciken yiwuwar allurar rigakafin kwayoyin da za ta iya canza kwayoyin cutar don motsa halayen rigakafi.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa sun fara bunkasa allurar, tare da burin gwaji a kan mutane a shekarar 2021.
An sanar da aikin samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Company, wanda Hanneke Schuitemaker ke jagorantar, ya sanar da cewa sun fara bunkasa allurar rigakafi.
Janssen ta yi aiki tare da abokinta na fannin halittu, Vaxart, don samar da allurar baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar samarwa tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda game da ƙirar allurar rigakafi tare da fasahar da ta yi kama da na maganin allurar rigakafin neoantigen na ciwon daji.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada-hadar allurar kuma za su fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin yin allurar rigakafi don yin allurar peptide Ii-Key na COVID-19.
Suna son su samar da takardar allurar rigakafi da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Kwamandan Bincike da Kayan Aiki na Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna ci gaba da samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi aiki tare da Novavax Inc.
a cikin ci gaba da kuma samar da allurar rigakafi.
Bugu da ƙari, wannan haɗin gwiwar ya sanar da shirin gwaji na farko da gwaji na farko a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki a kan kwayoyi 11, kuma ko da a kan hanyar sauri, ci gaban allurar zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere na rayuwa a Quebec City, Quebec, ya ba da rahoton ci gaban kwayoyin cutar coronavirus tare da wani ɓangare na kudade daga Cibiyoyin Kula da Lafiya na Kanada.
Ana gudanar da bincike a cikin dakin gwaje-gwaje, kuma ana shirin gwada su a jikin mutum a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa shugaban Amurka, Donald Trump, ya ba da "'babban kuɗi' don samun damar yin amfani da allurar COVID-19" ga CureVac, wanda gwamnatin Jamus ta yi zanga-zanga a kai.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin Jamus, BioNTech, don haɓaka allurar rigakafin mRNA.
A halin yanzu, mai neman allurar rigakafin mRNA, BNT162, yana cikin gwaji na farko tare da gwajin gwaji da ake sa ran zai fara a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020 a Italiya, kamfanin nazarin halittu na Italiya, Takis Biotech, ya sanar da cewa za su sami sakamakon gwajin gwaji a watan Afrilu na 2020 kuma za a iya fara gwajin kwayoyin cutar a kan mutane a cikin kaka.
A ranar 19 ga Maris, 2020 a Faransa, Coalition for Epidemic Prevention Innovation (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar COVID-19 da ta haɗa da Cibiyar Pasteur, Themis Bioscience (Wina, Austria), da Jami'ar Pittsburgh, tare da saka hannun jari na CEPI a cikin haɓaka allurar COVID-19 da ya kai dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin 'yan takarar rigakafi shida a kan dabbobi.
Masu binciken a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna ci gaba da samar da allurar RNA da za ta iya karawa kanta ga COVID-19.
An yi amfani da allurar rigakafi a cikin kwanaki 14 bayan an samu samfurin daga kasar Sin.
A ƙarshen Maris, gwamnatin Kanada ta sanar da kudade na dala miliyan 275 don ayyukan bincike na maganin COVID-19, wanda ya haɗa da wasu masu neman allurar rigakafi a kamfanoni da jami'o'i na Kanada, kamar shirin Medicago da Jami'ar Saskatchewan.
A daidai wannan lokaci, gwamnatin Kanada ta sanar da kudade na dala miliyan 192 don samar da allurar rigakafin COVID-19, tare da shirin kafa "tashar allurar rigakafi" ta ƙasa da ke dauke da wasu sabbin alluran rigakafi da za a iya amfani da su idan wani annobar coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, mai neman allurar COVID-19, a cikin beraye; sun bayyana cewa "MNA da ke ba da allurar S1 SARS-CoV-2 ta haifar da amsa ga takamaiman antigen antibody wanda ke da ƙarfi [a cikin beraye] wanda ya fara bayyana makonni 2 bayan rigakafi".
A ranar 16 ga Afrilu, 2020 a Kanada, Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da ƙirar takarar allurar rigakafin DNA a matsayin yiwuwar fesa hanci.
Ta amfani da bacteriophages, an tsara DNA don sake fasalin cikin kwayoyin mutum don samar da ƙwayoyin da ba su da lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnati, masana'antu, da jami'o'i uku na Amurka sun tattara albarkatu don samun damar supercomputers daga IBM, a hade tare da albarkatun girgije na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako mai banƙyama, wanda ake kira sakamako marar ƙayyadaddun.
Wannan yana nufin cewa alluran za su iya amfanar da mutane fiye da cututtukan da suke hanawa.
Ƙari ga haka, an yi gwaji a Ostiraliya a kan ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa allurar da ake ci gaba da samarwa ba za ta kasance da aminci ko tasiri ba.
Nazarin farko don tantance tasirin allurar rigakafi ta amfani da takamaiman samfurin dabbobi na COVID-19, kamar su berayen ACE2-transgenic, sauran dabbobi na dakin gwaje-gwaje, da kuma primates ba mutane, ya nuna buƙatar matakan hanawa don cimma matakin aminci na 3 a cikin magance kwayar cutar mai rai, da kuma daidaitaccen haɗin gwiwar duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada rigakafin SARS da MERS a kan wasu dabbobi.
Har zuwa shekarar 2020, babu wani magani ko allurar rigakafi ga SARS da ta tabbatar da cewa tana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma ci gaban sabbin magungunan rigakafi da magunguna don magance SARS na da fifiko ga gwamnatoci da cibiyoyin kiwon lafiyar jama'a a duniya. Bugu da ƙari, ba a sami tabbacin rigakafin MERS ba.
Lokacin da cutar ta MERS ta zama ruwan dare, ana ganin cewa binciken SARS da ake yi zai iya zama samfurin da zai taimaka wajen samar da allurar rigakafi da kuma maganin kamuwa da cutar MERS-CoV.
A watan Maris na shekarar 2020, an samu allurar rigakafin MERS guda daya (wanda ta danganci DNA) da ta kammala gwajin gwaji na farko a cikin mutane, kuma an samu wasu alluran rigakafin guda uku a cikin tsari, dukansu alluran rigakafin da ke dauke da kwayar cutar, biyu na adenovirus (ChAdOx1-MERS, BVRS-GamVac), da kuma daya na MVA-MERS-S.
Shafukan sada zumunta sun yi ikirarin cewa an riga an san cutar da ke bayan COVID-19 kuma an riga an sami allurar rigakafi.
Patents da kafofin watsa labarun suka yi magana a kai sun yi magana ne game da patents na asali da kuma alluran rigakafi don wasu cututtukan coronavirus, kamar SARS.
B'Cutar coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da cutar coronavirus ta cutar ta 2 (SARS-CoV-2).
Alamun da ake nunawa a yau sun ƙunshi zazzabi, tari, da kuma rashin numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, ciwon ciki, ciwon wuya, rashin numfashi, da kuma ciwon ciki.
Lokaci daga bayyanar zuwa bayyanar cututtuka yana da kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna haifar da bayyanar cututtuka masu sauƙi, wasu suna ci gaba da kamuwa da cutar pneumonia da kuma rashin aiki na kwayoyin halitta.
Har zuwa ranar 17 ga Afrilu, 2020, an samu karin mutane miliyan 2.24 a kasashe 210 da yankuna, wanda ya haifar da mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 ne suka warke, kuma cutar tana yaduwa tsakanin mutane a lokacin da suka yi kusa da juna, sau da yawa ta hanyar tsutsa ko ƙananan saukad da ke haifar da tari ko kumburi ko magana.
Ko da yake ana yin sa sa sa'ad da yake numfashi, sa'ad da ya fāɗi, yakan fāɗi ƙasa ko kuma ya fāɗi a ƙasa, ba ya kai ga nesa.
Mutum zai iya kamuwa da cutar ta wurin taɓa ruɓaɓɓen wuri kuma ya taɓa idanunsa ko hanci ko bakinsa.
A saman, kwayar cutar tana iya wucewa har zuwa awanni 72.
Wannan ƙwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma bayan matakan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargin sun kamu da cutar da kuma waɗanda ke kula da su.
Shawarwari game da amfani da abin rufe fuska ta hanyar jama'a sun bambanta; wasu hukumomi sun ba da shawarar kada a yi amfani da abin rufe fuska, wasu sun ba da shawarar yin amfani da shi, wasu kuma sun bukaci yin amfani da shi.
A halin yanzu, babu takamaiman allurar rigakafi ko maganin rigakafi ga COVID-19.
An samu karuwar cutar a kusan dukkanin ƙasashe shida na WHO.
Mutumin da ya kamu da cutar zai iya zama marar bayyanar cututtuka ko kuma ya fuskanci alamun mura, kamar zazzabi, tari, gajiya, da kuma numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko kuma taurin kai a kirji, rikicewa, wahalar tashi, da kuma fuska ko lebe mai launin shuɗi; ana ba da shawarar samun taimako na likita nan da nan idan waɗannan alamun suka bayyana.
Ana iya samun alamun numfashi na sama, kamar su kumburi, kumburi, ko kuma ciwon wuya, amma ba sa faruwa.
Ana lura da cututtukan ciki, kamar su naƙuda, zubar da ciki, da kuma ciwon ciki a cikin kashi dabam dabam.
Wasu cututtuka a kasar Sin sun fara ne kawai da asibiti na ciwon kirji da palpitations.
A wasu mutane, cutar tana iya zama pneumonia, rashin aiki na gabobin jiki, da kuma mutuwa.
Wannan lokaci ne da ake kira lokacin yin amfani da shi.
Lokacin incuba don COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5 cikin 100 na mutanen da ke da alamun cutar za su nuna alamun cutar a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke da cutar za su nuna alamun cutar ba.
Ba a san cikakken matsayin waɗannan masu ɗaukar hoto ba; duk da haka, an riga an nuna cewa suna iya taimakawa wajen yaduwar cutar.
A halin yanzu, ba a san adadin mutanen da suka kamu da cutar ba da alamun bayyanar cututtuka kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka na Koriya (KCDC) suna ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar sun kasance marasa bayyanar cututtuka yayin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta fara hada da marasa bayyanar cututtuka a cikin al'amuran yau da kullum a ranar 1 ga Afrilu; daga cikin kamuwa da cututtuka 166 a wannan rana, 130 (78%) sun nuna babu alamun cututtuka a lokacin gwaji.
Sputum da saliva suna iya ɗaukar nauyin ƙwayoyin cuta a kan babban sikelin.
Yin magana da ƙarfi yana sa a yi karin magana ko kuma saɓo fiye da yadda ake yi a kullum.
Wani bincike a Singapore ya gano cewa idan ba a rufe tari ba, za a iya tura ruwa zuwa tsawon mita 15 ko kuma mita 15.
Ko da yake ba a yawan watsa wannan kwayar ta iska ba, National Academy of Sciences na Amurka ta nuna cewa watsa kwayoyin halitta na iya faruwa kuma tarin iska da aka sanya a cikin kwandon da ke waje da ɗakin mutane yana haifar da samfurin RNA mai kyau ga kwayar.
Wasu hanyoyin magani, kamar su intubation da kuma numfashi na zuciya (RJP), suna iya sa numfashi ya zama aerosol kuma ya bazu ta iska.
Ko da yake akwai damuwa cewa cutar za ta iya yadawa ta hanyar fitsari, an yi imanin cewa wannan haɗarin yana da ƙananan. Kwayar cutar tana da yawa a lokacin da mutum yake da alamun; ko da yake yaduwar na iya faruwa kafin bayyanar cututtuka, haɗarin yana da ƙananan.
Cibiyoyin Turai don Rigakafin Cututtuka da Kulawa (ECDC) sun ce ko da yake ba a san yadda cutar ta iya yaduwa ba, mutum ɗaya yana kamuwa da mutane biyu zuwa uku.
Musamman, an gano cewa ana iya gano kwayar cutar a cikin yini ɗaya a kan kwali, har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), kuma har zuwa sa'o'i huɗu a kan 99% jan ƙarfe.
Amma, yanayin ya bambanta bisa ga yanayin zafi da kuma yanayin zafi.
Sabulu da kuma wankewa suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna lalata ƙwayar ƙwayar cuta, suna kashe ƙwayar cuta, da kuma kawar da shi daga fata da sauran farfajiyar.
Wasu maganin, kamar su benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai. A wani bincike a Hong Kong, an ɗauki samfurin saliva a matsakaici kwana biyu bayan an fara asibiti.
A cikin mutum biyar cikin shida, samfurin farko ya nuna mafi yawan ƙwayar cutar, kuma mutum na shida ya nuna mafi yawan ƙwayar cutar a rana ta biyu.
Cutar coronavirus ta 2 (SARS-CoV-2) sabon cuta ce ta coronavirus ta 2 (CSA), wanda aka fara ware daga mutane uku da ke fama da cutar huhu da ke tattare da cutar ta Wuhan.
Dukkanin halayen SARS-CoV-2 sun kasance a cikin coronavirus na halitta.
A waje da jikin mutum, ana kashe kwayar ta ta sabulu na gida, wanda ke lalata kumfa mai kare ta. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
Fum shine mafi yawan kwayoyin da COVID-19 ya shafa saboda ƙwayoyin cuta suna shiga cikin ƙwayoyin mai karɓar baƙi ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Wannan ƙwayar ta yi amfani da wani ƙwayoyin halitta na musamman da ake kira "spike" (peplomer) don haɗa kai da ACE2 kuma su shiga cikin ƙwayoyin mahaifar.
Ana samun cututtukan zuciya a cikin kashi 12 cikin 100 na mutanen da ke da cutar a Wuhan, China, kuma suna da yawa a cikin cututtuka masu tsanani.
Ana nuna alamun cututtukan zuciya da yawa saboda amsawar kumburi da kuma rashin lafiyar tsarin garkuwar jiki a lokacin da cutar ta ci gaba, amma cututtukan myocardial na iya kasancewa suna da alaƙa da masu karɓar ACE2 a zuciya.
Ana nuna masu karɓar ACE2 sosai a zuciya kuma suna da hannu a aikin zuciya.
An gano cewa an samu karuwar cutar hawan jini (31%) da kuma karuwar hawan jini (25%) a cikin marasa lafiya da ke da cutar COVID-19 a ICU kuma yana iya kasancewa yana da alaƙa da mummunan hangen nesa.
Ko da yake SARS-COV-2 yana da tropism ga ƙwayoyin epithelial na numfashi waɗanda ke bayyana ACE2, marasa lafiya masu nauyi na COVID-19 suna da alamun hyperinflammatory systemic.
Musamman, ƙwayoyin T da ke ɓoye GM-CSF masu cutar sun kasance suna da alaƙa da karɓar kwayoyin monocyte waɗanda ke ɓoye IL-6 mai kumburi da cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma yi rahoton yin aikin da aka yi a lokacin da aka yi wa mutum jana'izar.
Hukumar ta WHO ta wallafa wasu takardun gwaji don cutar.
Hanyar gwaji ta misali ita ce ainihin lokacin rikodin polymerase reverse-transcription chain reaction (rRT-PCR).
Ana yin wannan gwajin ne a kan samfurori na numfashi da aka samu ta hanyar nasopharynx; duk da haka, ana iya amfani da samfurori na nasal or sputum.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini biyu da aka yi mako biyu a tsakanin juna don a samu ƙaramin sakamako a lokacin.
Masana kimiyya na kasar Sin sun iya ware wannan cutar ta coronavirus kuma sun wallafa tsarin kwayoyinta don haka dakunan gwaje-gwaje a duk faɗin duniya za su iya ci gaba da gwajin polymerase chain reaction (PCR) da kansa don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki kuma idan mutum ya riga ya kamu da cutar) amma ba a yi amfani da shi sosai ba.
Kwarewar kasar Sin game da gwajin ya nuna cewa an gwada shi da kashi 60 zuwa 70 cikin ɗari.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagoran bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga tsarin asibiti da haɗarin annoba.
Ana samun ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan.
Domincin subpleural, paving na hauka (zafin lobular septum tare da cika alveolar ya bambanta), da kuma karfafawa na iya bayyana yayin da cutar ta ci gaba.
Babu bayanai da yawa game da cutar ta COVID-19 da kuma cutar kansa.
Babban binciken da aka samu a kan maganin kashe kansa shi ne:
Ana yin amfani da microscopy: pleurisy, pericarditis, lung consolidation, da kuma kumburi na huhu
Ana iya lura da nau'i hudu na cutar pneumonia:
ƙananan ƙwayar cuta: kumburi na huhu, ƙwayar cuta mai yawa, ƙwayar cuta mai girma, ƙwayar cuta mai yawa, ƙwayar cuta mai yawa da kuma ƙwayar cuta mai yawa
mummunan ciwon huhu: lalacewar alveolar diffuse (DAD) tare da diffuse alveolar exudate.
DAD yana haifar da cututtukan cututtukan numfashi na yau da kullum (ARDS) da kuma matsanancin hypoxia.
cututtukan huhu a cikin lokaci na warkarwa: tsarin exudate a cikin alveolar cavity da pulmonary interstitial fibrosis
Jinin: ƙwayar ƙwayar cuta ta jini (DIC); maganin leukoeyrotroplastic
Matakan da za a iya ɗauka don rage yiwuwar kamuwa da cuta su ne: kasancewa a gida, guje wa wuraren da mutane suke, wanke hannuwanku da sabulu da ruwa a kai a kai na akalla dakika 20, yin amfani da tsabta a numfashi, da kuma guje wa taɓa idanu, hanci, ko baki da hannaye da ba a wanke ba.
Hukumar ta CDC ta ba da shawarar rufe baki da hanci da takalma idan kana tari ko kuka kuma ta ba da shawarar yin amfani da ciki na ƙugu idan takalma ba su da wuri.
Ana ba da shawarar yin tsabtace hannu a lokacin da kuka ko kumburi ya faru.
CDC ta ba da shawarar yin amfani da sutura ta fuska a wuraren jama'a, wani ɓangare don rage kamuwa da cutar ta mutane marasa bayyanar cututtuka. Dabarun hana jama'a suna nufin rage haɗuwa da mutane masu kamuwa da cutar da mutane da yawa, ta hanyar rufe makarantu da wuraren aiki, iyakance tafiya, da soke manyan tarurruka a wuraren jama'a.
Ƙuntatawa ta kuma haɗa da kiyaye nesa da ta kai aƙalla mita 6.
Babu wani magani da aka sani da zai iya hana COVID-19. Tun da ana tsammanin ba a sami allurar rigakafi ba har zuwa farkon 2021, babban ɓangare na magance COVID-19 shine ƙoƙarin rage ƙarancin annobar, wanda aka sani da "taƙaitawar layin".
Cibiyar ta kuma ba da shawarar cewa a riƙa wanke hannuwanmu da sabulu da ruwa na tsawon sa'o'i 20, musamman bayan sun fita daga gidan wanka ko kuma idan hannuwanmu sun yi ƙazanta, kafin cin abinci, da kuma bayan sun shiga cikin hanci, sun yi tari ko sun yi kumburi.
CDC ta kuma ba da shawarar yin amfani da maganin hana shan giya da ke dauke da barasa aƙalla kashi 60 cikin dari, amma kawai idan sabulu da ruwa ba su samuwa. A yankunan da ba a samun maganin hana shan giya na kasuwanci ba, WHO ta samar da maganganu biyu don samarwa a gida.
A cikin wannan tsari, antimicrobial aiki ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin barasa; wannan abu ne "ba abu ne mai aiki ba don maganin hannayen hannu".
Ana ƙara glycerol a matsayin humektan.
Ana kula da mutane da taimakon da za su iya yi, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma tallafa wa wasu gabobin da suka shafi rayuwa.
Hukumar ta shawarci mutanen da suka yi zaton suna dauke da cutar su saka abin rufe fuska mai sauki.
Ana amfani da oxygenation na membrane extracorporeum (ECMO) don magance matsalar rashin numfashi, amma ana la'akari da amfanin.
Ana ba da shawarar yin tsabta da kuma yin rayuwa mai kyau da kuma cin abinci mai kyau don ƙarfafa rigakafi.
Kulawa mai taimako na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon matakin kamuwa da cuta. WHO da Hukumar Lafiya ta Kasa ta kasar Sin sun wallafa shawarwari don magance COVID-19 da ke cikin gida.
Masana ilimin halayyar cuta da na huhu a Amirka sun tsara shawarwarin da ke ba da magani daga cibiyoyi dabam-dabam zuwa ga IBCC, wanda ba a biya shi ba.
Har zuwa watan Afrilu na shekarar 2020, babu takamaiman magani ga COVID-19.
Domin bayyanar cututtuka, wasu likitoci sun fi ba da shawarar acetaminophen (parasetamol) fiye da ibuprofen don amfani da layi na farko.
Ya kamata a dauki matakan tsaro don rage haɗarin kamuwa da cutar, musamman a tsarin kula da lafiya lokacin da ake gudanar da hanyoyin da za su iya samar da aerosol, kamar intubation ko iska ta hannu.
Ga ma'aikatan kiwon lafiya da ke kula da masu cutar COVID-19, CDC ta ba da shawarar sanya su a cikin Rufin Keɓewa na Cutar Kwayar cuta (AIIR) ban da yin amfani da matakan kariya na yau da kullun, matakan tuntuɓar, da matakan hana yaduwar iska. CDC ta tsara jagororin don amfani da kayan kariya ta kai tsaye (APD) yayin annobar.
Kayan aiki da aka ba da shawarar su ne: rigar APD, abin numfashi ko abin rufe fuska, abin rufe idanu, da kuma safar hannu na likita. Idan akwai, mai numfashi (ba abin rufe fuska ba) ya fi kyau.
An amince da N95 respirator don umarni na masana'antu, amma FDA ta ba da izinin amfani da wannan mask din bisa ga Izinin Amfani da Gaggawa (EUA).
An tsara N95 respirator don kare daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancinsa ga wasu kwayoyin halitta ba don amfani da ba a ambata a cikin lakabin.
Idan ba a samun abin rufe fuska ba, CDC ta ba da shawarar yin amfani da kariya ta fuska ko, a matsayin ƙoƙari na ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai har suna buƙatar iska ta inji ko kuma madadin, amma wasu sun kasance masu tsanani.
Ana gudanar da bincike sosai kan irin taimakon numfashi ga mutanen da ke fama da matsalar rashin numfashi da ke tattare da COVID-19 ga mutanen da ke cikin gida, kuma akwai shaidar cewa ana iya kauce wa intubation ta hanyar hawan nasal mai tsayi ko matsin iska mai kyau.
Ba a san ko waɗannan hanyoyin biyu za su iya amfanar marasa lafiya ba.
Wasu likitoci sun fi son yin amfani da iska mai guba, idan ana iya samun ta, saboda wannan fasaha ta rage yaduwar ƙwayoyin aerosol fiye da na nasal canula mai zurfi.
Yawancin ƙasashe masu tasowa ba su da isasshen asibitocin asibiti a kowace mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance tashin hankali na COVID-19 wanda ya isa ya zama mai tsanani sosai wanda ke buƙatar shiga asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na masu shiga cikin cibiyar kula da gaggawa, kashi 2.3 cikin 100 na bukatar taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kimanin kashi 30 cikin dari na mutanen da ke fama da cutar COVID-19 da aka yi musu asibiti sun shiga ICU.
Hanyoyin iska na inji sun zama da rikitarwa yayin da cutar ta hanyar numfashi ta yau da kullun (ARDS) ta faru a COVID-19 kuma oxygenation ya zama da wuya.
Ana buƙatar fan da ke iya yin yanayin sarrafa matsa lamba da kuma PEEP mai girma don haɓaka isar da iskar oxygen yayin rage haɗarin cutar huhu da pneumothorax da ke tattare da fan.
Za a iya samun PEEP mai yawa a tsofaffin iska.
An fara bincike a kan yiwuwar maganin a watan Janairun 2020 kuma wasu magungunan riga-kafi suna cikin gwaji.
Remdesivir ya yi alkawari sosai.
Ko da yake ci gaban sabon magani zai iya ɗaukar har zuwa 2021, an riga an amince da wasu magunguna don wasu amfani ko kuma suna cikin gwaji na gaba.
Ana iya gwada maganin rigakafi a kan waɗanda suke da ciwo mai tsanani.
Masu aikin sa kai da aka ba da shawarar WHO sun shiga cikin gwajin tasirin da kuma lafiyar magani na iya. FDA ta ba da izini na wucin gadi ga plasma mai warkewa a matsayin magani na gwaji a yayin da rayuwar mutum ke cikin haɗari sosai ko nan da nan.
Ba a yi nazarin asibiti ba da ake bukata don tabbatar da lafiyar da kuma ingancin maganin cutar.
A watan Fabrairun 2020, kasar Sin ta kaddamar da aikace-aikacen hannu don magance annobar cutar.
Ana bukatar masu amfani su saka sunayensu da lambar ID.
Wannan app ɗin zai iya gano 'ƙananan lambobi' ta amfani da bayanan kulawa don haka ya iya gano yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin sauran masu amfani uku.
Idan aka gano yiwuwar haɗari, ba wai kawai aikace-aikacen yana ba da shawarar yin keɓewa ba, amma kuma yana sanar da jami'an kiwon lafiya na gida. Ana amfani da nazari akan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu, da kuma ilimin kere kere don bin diddigin masu kamuwa da cutar da kuma mutanen da suka tuntube su a Koriya ta Kudu, Taiwan, da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su bi bayanan wayar salula na mutanen da ake zargin sun kamu da cutar coronavirus.
An yi hakan ne don a yi dokar hana fita da kuma kare mutanen da za su iya yin hulɗa da mutanen da suka kamu da cutar.
Bugu da ƙari, a watan Maris na 2020, Deutsche Telekom ta ba da bayanan haɗin gwiwar wurin waya ga hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar fuska don gano masu bin dokar killacewa.
Kwamishinan lafiya na ƙasar Italiya, Giulio Gallera, ya ce an gaya wa masu amfani da wayoyin hannu cewa "kashi 40 cikin ɗari na 'yan ƙasar suna ci gaba da yin yawo".
Gwamnatin Jamus ta gudanar da hackathon na tsawon sa'o'i 48 a karshen mako tare da fiye da mutane 42,000.
Bugu da ƙari, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane suna iya fuskantar matsi daga yin rigakafi, ƙuntatawa a tafiya, sakamako na rashin lafiya, ko kuma tsoron kamuwa da cuta.
BBC ta yi ƙaulin Rory O'Connor da ya ce: "Ƙara yawan zaman zaman lafiya, kaɗaici, damuwa game da lafiyar jiki, damuwa, da kuma matsalar tattalin arziki, babban hadari ne da ke kawo hatsari ga lafiyar hankali da kuma lafiyar jama'a".
Wannan cuta tana iya faruwa a hankali ko kuma ba tare da bayyanar cututtuka ba, kamar sauran cututtukan iska na yau da kullum, kamar mura.
A wasu lokatai, ana iya warkar da marasa lafiya cikin makonni biyu, amma a wasu, ana iya warkar da marasa lafiya cikin makonni uku zuwa shida.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanan daga irin wannan kwayar cutar, kamar SARS da MERS, amma bayanan COVID-19 har yanzu basu da yawa. A wasu mutane, COVID-19 na iya shafar huhu kuma yana haifar da cutar huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya zama cututtukan cututtukan numfashi (ARDS) da ke haifar da rashin numfashi, bugun jini, ko rashin aiki na gabobin jiki.
Abubuwan rikitarwa da ke tattare da COVID-19 sun haɗa da sepsis, ƙwayoyin jini na yau da kullun, da kuma lalacewar zuciya, koda, da hanta.
Rashin hawan jini, musamman karuwar protrombin lokaci, an lura da shi a cikin kashi 6% na marasa lafiya na COVID-19 da ke cikin asibiti, yayin da rashin aikin koda ya bayyana a cikin kashi 4% na wannan rukuni.
Kimanin kashi 20-30 cikin dari na mutanen da ke da cutar COVID-19 sun nuna karuwar enzymes na hanta (transaminase).
Wannan rahoton ya nuna cewa, a tsakanin bayyanar cututtuka da mutuwa, ana yin kwanaki goma, kuma ana yin kwana biyar a asibiti.
Amma, marasa lafiya da aka yi wa ICU za su sami matsakaicin lokaci na kwana bakwai tsakanin shiga asibiti da mutuwa.
A wani bincike da aka yi a farkon shari'o'in, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, tare da cikakken kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar, maza sun samu kashi 2.8 cikin dari na mutuwa, yayin da mata suka samu kashi 1.7 cikin dari.
Binciken histopathological na samfurin huhu na postmortem ya nuna lalacewar alveolar da aka yada tare da exudate na fibromycosid cell a cikin huhu biyu.
An lura da canjin cytopathic na kwayar cutar a cikin ƙwayoyin cuta.
Hoton da aka yi na huhu ya yi kama da cututtukan annobar numfashi mai tsanani (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya, tare da karuwar matakan troponin ko kuma bugun zuciya.
A watan Maris na shekara ta 2015, an ba da rahoton cewa kashi 89 cikin 100 na mutanen da aka yi wa asibiti suna da cututtuka na asali, kuma samun wadataccen magani da kuma tattalin arziki na zamantakewa na yankin yana iya shafar yawan mutuwa.
Yawan mutuwar da ake samu daga yanayin ya bambanta saboda bambancin yankuna, amma kuma saboda wahalar da ake samu ta hanyar aiki.
Rashin ƙididdigar ƙananan shari'o'i na iya sa adadin mutuwar ya yi yawa.
Amma, gaskiyar cewa mutuwar ta faru ne a lokatan da suka gabata na iya nufin cewa adadin mutuwar da ake yi a yanzu ba shi da yawa.
Masu shan sigari suna da damar sau 1.4 na fuskantar alamun COVID-19 mai tsanani kuma kusan sau 2.4 na iya buƙatar kulawa mai tsanani ko mutuwa fiye da waɗanda ba masu shan sigari ba. Akwai damuwa game da dogon lokacin da cutar ke faruwa.
Hukumar asibitocin Hong Kong ta gano cewa a wasu mutanen da suka warke daga cutar, yawan ƙarfin huhu ya ragu da kashi 20 zuwa 30 cikin dari, kuma binciken huhu ya nuna cewa gabobin sun lalace.
Hakan kuma zai iya haifar da ciwon hankula bayan an warke.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar ta baya ta ba da rigakafi mai inganci da na dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana iya samun rigakafin idan aka duba wasu halayen coronavirus, amma an bayar da rahoton samun nasarar COVID-19 wanda aka bi da gwajin coronavirus mai kyau kwanaki bayan haka.
An yi imanin cewa wannan cuta ce da ta rage, ba reinfection ba.
Ana zaton cewa kwayar halitta ce kuma ta fito ne daga dabbobi, ta hanyar kamuwa da cuta.
Ba a san asalinsa ba, amma a watan Disamba na 2019, yaduwar kamuwa da cuta ta kasance ne kawai saboda yaduwar mutum zuwa mutum.
Wani binciken da aka yi na farko na mutane 41 da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana ranar farko da alamun cutar suka fara bayyana a ranar 1 ga Disamba, 2019.
Hukumar ta WHO ta ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da wasu alamu don ƙididdige mutuwar.
Wannan adadi ya bambanta bisa yankuna da kuma tsawon lokaci, kuma yana shafar yawan gwaji, ingancin tsarin kula da lafiya, zaɓuɓɓukan kulawa, lokacin da ya fara barkewar cutar, da kuma yanayin yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ICD-10 ta gaggawa U07.1 don mutuwar daga kwayar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar COVID-19 da aka gano a asibiti ko kuma cutar ta cutar ba tare da tabbacin dakin gwaje-gwaje ba don cutar SARS-CoV-2.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane zuwa shari'o'i a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran ma'auni sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu saboda wata cuta, da kuma yawan mutuwar mutum (IFR), wanda ke nuna yawan mutanen da suka kamu (suna da cutar da ba a gano ba) da suka mutu saboda wata cuta.
Wannan ƙididdigar ba ta da iyaka a kan lokaci kuma tana bin wani yanki na al'umma daga kamuwa da cuta zuwa warwarewar hali.
Ko da yake ba dukan waɗanda suka kamu da cutar suke yin rigakafi ba, kasancewa da rigakafi zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, ƙaramar ƙauye ce da ke da mazauna 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ta hanyar bikin Carnival, wanda ya bazu cikin matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba ne za a iya rarraba su a matsayin mutuwar COVID-19.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai cika ba.
A Netherlands, kusan kashi 3 cikin 100 na yawan jama'a na iya samun rigakafi, kamar yadda aka yi nazari a kan masu ba da jini.
Mutane 69 (0.004% na yawan jama'a) sun mutu saboda COVID-19.
Sakamakon annobar da kuma mutuwar mata sun bambanta ga maza da mata.
A cikin binciken da aka yi a kasar Sin da Italiya, mutuwar ta fi girma a cikin maza.
Mafi yawan haɗarin ga maza a cikin shekaru 50s, tare da bambancin haɗari tsakanin maza da mata ba a gani a cikin shekaru 90.
A ƙasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin ɗari, mata kuma kashi 1.7 cikin ɗari.
Ba a san ainihin dalilin da ya sa ake nuna bambancin tsakanin maza da mata ba, amma ana iya ganin cewa akwai wasu dalilai na halitta da kuma halaye.
Bambancin rigakafi bisa jinsi, ƙananan yawan shan sigari a cikin mata, da kuma maza da ke da cututtuka masu haɗari, kamar hawan jini, a cikin shekaru masu ƙanana fiye da mata na iya taimakawa wajen ƙaruwa a cikin mutuwar maza.
A Turai, maza ne suka kai kashi 57 cikin 100 na mutanen da suka kamu da cutar, kuma maza ne suka kai kashi 72 cikin 100 na mutanen da suka mutu sakamakon COVID-19.
Har zuwa watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta gano bayanan jima'i na kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa cututtukan cuta, kamar Ebola, HIV, mura, da kuma SARS, suna shafan maza da mata dabam-dabam.
Mata masu aikin kiwon lafiya, musamman ma ma mata, sun fi kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan hukuma na cutar shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na cutar, D na cuta, da kuma 19 don lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa tunani game da wani wuri na musamman (misali China), nau'in dabba, ko rukuni na mutane, daidai da shawarwarin duniya don sanya suna da nufin hana lalata.
WHO ta kuma yi amfani da "COVID-19" da "COVID-19 virus" a cikin sadarwa ta jama'a.
Ana kiran cutar da kuma kwayar cutar "coronavirus".
A farkon annobar a Wuhan, China, an san wannan cutar da cutar da "coronavirus" da kuma "coronavirus Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da cutar numfashi mai tsanani 2019-nCov a matsayin sunayen wucin gadi don ƙwayoyin cuta da cututtuka daidai da jagorar 2015 wanda ya ba da shawarar kada a yi amfani da sunan wuri a cikin sunan cutar da cutar.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin ƙarfin da ake samu a cikin jerin kayayyakin da ake samarwa, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su na'urar numfashi da na'urorin iska.
Alal misali, a lokacin da asibiti a Italiya yake bukatar kwandon iska sosai, kuma mai ba da kayayyaki ba ya iya ba da isashen isashen isashen lokacin da ake bukata, wani kamfani a wurin ya yi aikin da ya yi da kuma buga kwandon iska 100 da dare.
Bayan barkewar cutar COVID-19, ka'idodin makirci, rashin fahimta, da rashin fahimta sun taso game da asalin, sikelin, rigakafi, magani, da sauran fannoni na cutar, wanda ke yaduwa cikin sauri akan layi.
Da alama mutane suna iya watsa kwayar cutar zuwa wasu dabbobi.
Bincike ya kasa samun tabbacin cewa cutar ta yi yawa a cikin alade, ducks, da kuma kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance wannan cuta.
Binciken duniya kan alluran rigakafi da magungunan COVID-19 na faruwa ne ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi, da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Taliban Solidarity" don nazarin tasirin maganin maganin riga-kafi guda huɗu da suka fi alkawari.
Ba a samu allurar ba tukuna, amma cibiyoyin da yawa suna aiki don samar da takarar.
An yi amfani da binciken da aka yi a kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Ana yin bincike a kan dabarun rigakafi guda uku.
Na farko, masu bincike sun yi niyyar yin allurar rigakafin cutar gaba ɗaya.
Yin amfani da wannan kwayar cutar, ko dai ita ce cutar da ba ta aiki ko kuma ta mutu, yana nufin hanzarta haifar da amsawar garkuwar jikin mutum ga sabon kamuwa da COVID-19.
Hanyar ta biyu, wato, allurar rigakafi, tana nufin samar da allurar rigakafi da za ta sa tsarin garkuwar mutum ya zama mai saurin kamuwa da cutar.
A cikin SARS-CoV-2, binciken ya mayar da hankali ne akan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin masu karɓar ACE2 enzymes.
Hanyar ta uku ita ce yin allurar nucleic acid (DNA ko RNA, sabuwar fasaha don yin allurar).
Ana bukatar a gwada alluran rigakafi na gwaji da aka yi da wadannan dabarun don tabbatar da lafiyarsu da kuma ingancinsu. A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar ne da masu aikin sa kai hudu a Seattle.
An yi shawarar cewa an yi amfani da maganin maganin maganin rigakafi don ci gaba da ci gaban maganin SARS-COV-2, amma har yanzu ana jayayya game da wannan.
Akwai gwaji na asibiti sama da 300 da ke gudana a watan Afrilu na 2020.
Gwaje-gwaje bakwai da suka yi nazarin maganin da aka amince da shi don cutar zazzabi sun haɗa da nazarin hydroxychloroquine ko chlorokuin guda huɗu.
Sabbin magungunan rigakafin da aka ba da manufa sun ƙunshi yawancin binciken da aka yi a kasar Sin, tare da gwaji tara na Phase III a kan remdesivir a wasu ƙasashe tare da ƙarshen rahoton rahoton a ƙarshen Afrilu.
A watan Afrilu na shekarar 2020, an samu cikakken nazari kan ci gaban asibiti na masu neman allurar rigakafi da magungunan COVID-19. Ana tantance wasu magungunan rigakafin riga-kafi don maganin COVID-19, wadanda suka hada da remdesivir, chlorokuin da hydroxychloroquine, lopinavir/ritonavir, da lopinavir/ritonavir a hade da interferon beta.
A watan Maris na shekarar 2020, akwai wata hujja ta wucin gadi game da nasarar remdesivir.
An samu ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir a lokacin gaggawa.
Ana gudanar da gwajin gwaji na Phase III a Amurka, China, da Italiya. Chlorokuin, wanda aka yi amfani da shi don magance cutar zazzabin cizon sauro, an yi nazari a kasar Sin a watan Fabrairun 2020, tare da sakamako na farko.
Duk da haka, ana bukatar a yi nazari a kan wannan binciken.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun ba da shawarar yin amfani da chlorokuin.
Amma, Cibiyar Kwayar cutar Wuhan, duk da shawarar da ta bayar na gram guda a kowace rana, ta lura cewa sau biyu yana da haɗari sosai kuma yana iya kashe mutum.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chlorokuin a kan manufofin likitoci da ke kula da marasa lafiya na COVID-19. Jagorar kasar Sin ta 7th edition ta hada da interferon, ribavirin, ko umifenovir don amfani da su don yaki da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban ribavirin don hana SARS-CoV-2 a cikin in vitro.
An ba da shawarar yin nazarin nitasoxannan don ƙarin nazarin in vivo bayan sun nuna hana SARS-CoV-2 a ƙananan taro.Bincike ya nuna cewa farkon priming na tsokoki na proteins ta hanyar serine protease transmembrane 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da masu karɓar ACE2.
Nazarin chlorokuin da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da iyakancewar da ta hana al'umma ta likita amfani da wannan magani ba tare da ƙarin bincike ba. Oseltamivir bai hana SARS-CoV-2 a cikin in vitro ba kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Rikicin hadari na cytokine na iya faruwa a cikin COVID-19 mai tsanani na gaba.
Akwai hujja cewa hydroxychloroquine na iya zama maganin antisocin. Tocilizumab an sanya shi cikin jagororin magani na Hukumar Lafiya ta kasar Sin bayan an kammala karamin bincike.
Ana gwada wannan magani a matakin kasa a Italiya bayan ya nuna sakamako mai kyau a cikin mutane da ke fama da mummunan cutar.
A hade da gwajin jini na serum ferritin don gano hadarin cytokine, an yi amfani da wannan magani don magance hadarin cytokine, wanda ake zargin yana haifar da mutuwa a wasu mutanen da aka shafa.
A shekara ta 2017, FDA ta amince da antagonist na interleukin-6 mai karɓa bisa ga nazarin harka na baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Har zuwa yanzu, babu wata hujja ta bazuwar da ta yi amfani da ita don nuna cewa tocilizumab magani ne mai kyau ga CRS.
Ana nazarin canja wurin antibodies da aka tsabtace da kuma adhesives da tsarin mutanen da suka warke daga COVID-19 ke samarwa ga waɗanda suke bukatar su a matsayin hanyar yin allurar rigakafi mara kyau.
An gwada wannan dabarar a kan SARS amma ba a samu sakamako mai kyau ba.
Kwayar cuta ta zama aikin da ake tsammanin maganin antibody mai guba zai iya daidaita kariya daga SARS-CoV-2.
Amma, wasu hanyoyin, kamar su cytotoxicity na cellular da ke dogara da antibodies da/ko phagocytosis, suna iya kasancewa.
Wani nau'i na maganin rigakafi na jiki, misali, ta amfani da kwayoyin halitta guda biyu, suna ci gaba.
Ana iya inganta samar da ƙwayar ƙwayar cuta, wadda ta ƙunshi ruwa daga jinin mai haƙuri da ya warke kuma tana dauke da ƙwayoyin rigakafi na musamman ga ƙwayar cuta don yin amfani da shi da sauri.
Cutar korona, wata cuta da ke da nasaba da juna
Li Wenliang, wani likita a asibitin Wuhan na tsakiya, wanda ya kamu da cutar kuma ya mutu saboda COVID-19 bayan ya haifar da sanarwa game da yaduwar cutar.
